SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allianz Life of NY Variable Account C – ‘N-VPFS’ for 12/31/23

On:  Tuesday, 4/9/24, at 5:16pm ET   ·   Effective:  4/9/24   ·   For:  12/31/23   ·   Accession #:  845775-24-4   ·   File #:  811-05716

Previous ‘N-VPFS’:  ‘N-VPFS’ on 4/10/23 for 12/31/22   ·   Latest ‘N-VPFS’:  This Filing   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/09/24  Allianz Life of NY Var Account C  N-VPFS     12/31/23    1:5.3M
          → Allianz Life of NY Variable Account C 12 Classes/Contracts

Financial Statements of a Variable Annuity/Life Contract   —   Form N-VPFS   —   ICA’40

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: N-VPFS      Allianz of Ny Var Acct C N-VPFS 4-9-24              HTML   5.39M 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 












ALLIANZ LIFE OF NY VARIABLE ACCOUNT C

of

ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK


Financial Statements

December 31, 2023

(With Report of Independent Registered Public Accounting Firm Thereon)




Report of Independent Registered Public Accounting Firm

To the Board of Directors of Allianz Life Insurance Company of New York and the Contract Owners of Allianz Life of NY Variable Account C

Opinions on the Financial Statements

We have audited the accompanying statements of assets and liabilities of each of the subaccounts of Allianz Life of NY Variable Account C indicated in the table below (other than AZL DFA Five-Year Global Fixed Income Fund, AZL Gateway Fund, AZL MetWest Total Return Bond Fund, AZL MSCI Emerging Markets Equity Index Class 1, AZL MSCI Emerging Markets Equity Index Class 2, AZL MVP Fusion Balanced Fund, AZL MVP Fusion Conservative Fund, AZL MVP Fusion Moderate Fund, BlackRock Equity Dividend V.I. Fund, Delaware Ivy VIP Asset Strategy Portfolio, Delaware Ivy VIP Energy Portfolio, Delaware Ivy VIP Science and Technology Portfolio, Eaton Vance VT Floating-Rate Income Fund, Fidelity VIP Emerging Markets Portfolio, Franklin Multi-Asset Dynamic Multi-Strategy VIT Portfolio, Invesco V.I. Balanced-Risk Allocation Fund, Lazard Retirement International Equity Portfolio, JPMorgan Insurance Trust Core Bond Portfolio, Lazard Retirement U.S. Small-Mid Cap Equity Portfolio, T. Rowe Price Blue Chip Growth Portfolio, and T. Rowe Price Health Sciences Portfolio which do not present a statement of assets and liabilities) as of December 31, 2023, and the related statements of operations and of changes in net assets for each of the periods indicated in the table below, including the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the subaccounts of Allianz Life of NY Variable Account C (other than AZL DFA Five-Year Global Fixed Income Fund, AZL Gateway Fund, AZL MetWest Total Return Bond Fund, AZL MSCI Emerging Markets Equity Index Class 1, AZL MVP Fusion AZL MSCI Emerging Markets Equity Index Class 2, AZL MVP Fusion Balanced Fund, AZL MVP Fusion Conservative Fund, AZL MVP Fusion Moderate Fund, BlackRock Equity Dividend V.I. Fund, Delaware Ivy VIP Asset Strategy Portfolio, Delaware Ivy VIP Energy Portfolio, Delaware Ivy VIP Science and Technology Portfolio, Eaton Vance VT Floating-Rate Income Fund, Fidelity VIP Emerging Markets Portfolio, Franklin Multi-Asset Dynamic Multi-Strategy VIT Portfolio, Invesco V.I. Balanced-Risk Allocation Fund, Lazard Retirement International Equity Portfolio, JPMorgan Insurance Trust Core Bond Portfolio, Lazard Retirement U.S. Small-Mid Cap Equity Portfolio, PIMCO VIT All Asset Portfolio, T. Rowe Price Blue Chip Growth Portfolio, and T. Rowe Price Health Sciences Portfolio which do not present a statement of assets and liabilities) as of December 31, 2023, and the results of each of their operations and the changes in each of their net assets for the periods indicated in the table below, in conformity with accounting principles generally accepted in the United States of America.










Subaccounts of Allianz Life of NY Variable Account C
AZL Balanced Index Strategy Fund(1)
AZL MVP Moderate Index Strategy Fund(1)
Invesco V.I. American Value Fund(1)
AZL DFA Five-Year Global Fixed Income Fund(3)
AZL MVP T. Rowe Price Capital Appreciation Plus Fund(1)
Invesco V.I. Balanced-Risk Allocation Fund(5)
AZL DFA Multi-Strategy Fund(1)
AZL Russell 1000 Growth Index Fund Class 1(1)
Invesco V.I. Global Strategic Income Fund(1)
AZL Enhanced Bond Index Fund(1)
AZL Russell 1000 Growth Index Fund Class 2(1)
JPMorgan Insurance Trust Core Bond Portfolio(6)
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 1(2)
AZL Russell 1000 Value Index Fund Class 1(1)
Lazard Retirement International Equity Portfolio(5)
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 2(1)
AZL Russell 1000 Value Index Fund Class 2(1)
Lazard Retirement U.S. Small-Mid Cap Equity Portfolio(5)












AZL Fidelity Institutional Asset Management Total Bond Fund Class 1(1)
AZL S&P 500 Index Fund(1)
LVIP JPMorgan Core Bond Fund(2)
AZL Fidelity Institutional Asset Management Total Bond Fund Class 2(1)
AZL Small Cap Stock Index Fund Class 1(1)
MFS International Intrinsic Value Portfolio(1)
AZL Gateway Fund(3)
AZL Small Cap Stock Index Fund Class 2(1)
MFS VIT Total Return Bond Portfolio(1)
AZL Government Money Market Fund(1)
AZL T. Rowe Price Capital Appreciation Fund(1)
MFS VIT Utilities Portfolio(1)
AZL International Index Fund Class 1(1)
BlackRock Equity Dividend V.I. Fund(5)
PIMCO VIT Balanced Allocation Portfolio(1)
AZL International Index Fund Class 2(1)
ClearBridge Variable Aggressive Growth Portfolio(1)
PIMCO VIT CommodityRealReturn Strategy Portfolio(1)
AZL MetWest Total Return Bond Fund(3)
Columbia Variable Portfolio – Seligman Global Technology Fund(1)
PIMCO VIT Emerging Markets Bond Portfolio(1)
AZL Mid Cap Index Fund Class 1(1)
Davis VA Financial Portfolio(1)
PIMCO VIT Global Core Bond (Hedged) Portfolio(1)
AZL Mid Cap Index Fund Class 2(1)
Delaware Ivy VIP Asset Strategy Portfolio(5)
PIMCO VIT High Yield Portfolio(1)
AZL Moderate Index Strategy Fund(1)
Delaware Ivy VIP Energy Portfolio(5)
PIMCO VIT Long-Term U.S. Government Portfolio(1)
AZL MSCI Emerging Markets Equity Index Class 1(3)
Delaware Ivy VIP Growth Portfolio(1)
PIMCO VIT Low Duration Portfolio(1)
AZL MSCI Emerging Markets Equity Index Class 2(3)
Delaware Ivy VIP Mid Cap Growth Portfolio(1)
PIMCO VIT Real Return Portfolio(1)
AZL MSCI Global Equity Index Fund Class 1(1)
Delaware Ivy VIP Natural Resources Portfolio(4)
PIMCO VIT StocksPLUS Global Portfolio(1)
AZL MSCI Global Equity Index Fund Class 2(1)
Delaware Ivy VIP Science and Technology Portfolio(5)
PIMCO VIT Total Return Portfolio(1)
AZL MVP Balanced Index Strategy Fund(1)
Eaton Vance VT Floating-Rate Income Fund(5)
T. Rowe Price Blue Chip Growth Portfolio(1)
AZL MVP DFA Multi-Strategy Fund(1)
Fidelity VIP Emerging Markets Portfolio(4)
T. Rowe Price Equity Income Portfolio(1)
AZL MVP Fidelity Institutional Asset Management Multi-Strategy Fund(1)
Fidelity VIP Mid Cap Portfolio(1)
T. Rowe Price Health Sciences Portfolio(6)
AZL MVP Fusion Balanced Fund(3)
Fidelity VIP Strategic Income Portfolio(1)
Templeton Global Bond VIP Fund(1)












AZL MVP Fusion Conservative Fund(3)
Franklin Multi-Asset Dynamic Multi-Strategy VIT Portfolio (5)

AZL MVP Fusion Moderate Fund(3)
Franklin Rising Dividends VIP Fund (1)

AZL MVP Global Balanced Index Strategy Fund(1)
Franklin U.S. Government Securities VIP Fund(1)

AZL MVP Growth Index Strategy Fund(1)
Invesco Oppenheimer V.I. International Growth Fund(1)


1.Statement of operations for the year ended December 31, 2023 and statement of changes in net assets for the years ended December 31, 2023 and 2022
2.Statement of operations and statement of changes in net assets for the period April 28, 2023 (commencement of operations) through December 31, 2023
3.Statement of operations and statement of changes in net assets for the period January 1, 2023 to March 10, 2023 (date of liquidation) and statement of changes in net assets for the year ended December 31, 2022
4.The fund had no activity for the year ended December 31, 2023.
5.The fund had no activity for the years ended December 31, 2023 and 2022
6.Statement of operations and statement of changes in net assets for the period January 1, 2023 to April 28, 2023 (date of liquidation) and statement of changes in net assets for the year ended December 31, 2022

Basis for Opinions

These financial statements are the responsibility of Allianz Life Insurance Company of New York management. Our responsibility is to express an opinion on the financial statements of each of the subaccounts of Allianz Life of NY Variable Account C based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to each of the subaccounts of Allianz Life of NY Variable Account C in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of investments owned as of December 31, 2023 by correspondence with the custodians of the investee mutual funds. We believe that our audits provide a reasonable basis for our opinions.

/s/PricewaterhouseCoopers LLP

Minneapolis, Minnesota
April 8, 2024

We have served as the auditor of one or more of the subaccounts of Allianz Life of NY Variable Account C of Allianz Life Insurance Company of New York since 2019.



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Assets and Liabilities
(In thousands)



















AZL Balanced Index Strategy Fund AZL DFA Multi-Strategy Fund AZL Enhanced Bond Index Fund AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 1 AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 2
 Assets:




    Investments at Net Asset Value $ 23,130 
$ 65,648 
$ 5,022 
$ 5,290 
$ 118,803 
         Total Assets 23,130 
65,648 
5,022 
5,290 
118,803 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 23,130 
65,648 
5,022 
5,290 
118,803 






 Net Assets:




    Contracts in Accumulation Period 23,130 
65,648 
5,022 
5,252 
118,787 
    Contracts in Annuity Payment Period — 
— 
— 
38 
16 
         Total Net Assets $ 23,130 
$ 65,648 
$ 5,022 
$ 5,290 
$ 118,803 






           Investment Shares 1,620 
5,462 
511 
622 
8,565 
           Investments at Cost $ 24,174 
$ 72,669 
$ 5,465 
$ 5,999 
$ 123,168 





















AZL Fidelity Institutional Asset Management Total Bond Fund Class 1 AZL Fidelity Institutional Asset Management Total Bond Fund Class 2 AZL Government Money Market Fund AZL International Index Fund Class 1 AZL International Index Fund Class 2
 Assets:




    Investments at Net Asset Value $ 1,004 
$ 16,392 
$ 44,998 
$ 5,079 
$ 15,448 
         Total Assets 1,004 
16,392 
44,998 
5,079 
15,448 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 1,004 
16,392 
44,998 
5,079 
15,448 






 Net Assets:




    Contracts in Accumulation Period 1,003 
16,392 
44,987 
5,045 
15,448 
    Contracts in Annuity Payment Period
— 
11 
34 
— 
         Total Net Assets $ 1,004 
$ 16,392 
$ 44,998 
$ 5,079 
$ 15,448 






           Investment Shares 121 
1,889 
44,998 
458 
886 
           Investments at Cost $ 1,178 
$ 18,543 
$ 44,998 
$ 4,620 
$ 13,413 
See accompanying notes to financial statements
Page 5 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Assets and Liabilities
(In thousands)



















AZL Mid Cap Index Fund Class 1 AZL Mid Cap Index Fund Class 2 AZL Moderate Index Strategy Fund AZL MSCI Global Equity Index Fund Class 1 AZL MSCI Global Equity Index Fund Class 2
 Assets:




    Investments at Net Asset Value $ 2,186 
$ 14,165 
$ 88,662 
$ 1,864 
$ 3,943 
         Total Assets 2,186 
14,165 
88,662 
1,864 
3,943 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 2,186 
14,165 
88,662 
1,864 
3,943 






 Net Assets:




    Contracts in Accumulation Period 2,165 
14,165 
88,662 
1,864 
3,930 
    Contracts in Annuity Payment Period 21 
— 
— 
— 
13 
         Total Net Assets $ 2,186 
$ 14,165 
$ 88,662 
$ 1,864 
$ 3,943 






           Investment Shares 101 
667 
7,150 
213 
259 
           Investments at Cost $ 4,220 
$ 13,429 
$ 100,369 
$ 2,023 
$ 3,923 





















AZL MVP Balanced Index Strategy Fund AZL MVP DFA Multi-Strategy Fund AZL MVP Fidelity Institutional Asset Management Multi-Strategy Fund AZL MVP Global Balanced Index Strategy Fund AZL MVP Growth Index Strategy Fund
 Assets:




    Investments at Net Asset Value $ 82,872 
$ 149,649 
$ 37,088 
$ 63,849 
$ 283,305 
         Total Assets 82,872 
149,649 
37,088 
63,849 
283,305 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 82,872 
149,649 
37,088 
63,849 
283,305 






 Net Assets:




    Contracts in Accumulation Period 82,867 
149,645 
37,088 
63,844 
283,305 
    Contracts in Annuity Payment Period

— 

— 
         Total Net Assets $ 82,872 
$ 149,649 
$ 37,088 
$ 63,849 
$ 283,305 






           Investment Shares 6,754 
13,434 
3,033 
6,205 
20,236 
           Investments at Cost $ 79,242 
$ 135,054 
$ 35,606 
$ 70,583 
$ 282,917 
See accompanying notes to financial statements
Page 6 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Assets and Liabilities
(In thousands)



















AZL MVP Moderate Index Strategy Fund AZL MVP T. Rowe Price Capital Appreciation Plus Fund AZL Russell 1000 Growth Index Fund Class 1 AZL Russell 1000 Growth Index Fund Class 2 AZL Russell 1000 Value Index Fund Class 1
 Assets:




    Investments at Net Asset Value $ 50,205 
$ 160,903 
$ 3,928 
$ 17,366 
$ 14,032 
         Total Assets 50,205 
160,903 
3,928 
17,366 
14,032 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 50,205 
160,903 
3,928 
17,366 
14,032 






 Net Assets:




    Contracts in Accumulation Period 50,205 
160,903 
3,910 
17,366 
13,926 
    Contracts in Annuity Payment Period — 
— 
18 
— 
106 
         Total Net Assets $ 50,205 
$ 160,903 
$ 3,928 
$ 17,366 
$ 14,032 






           Investment Shares 3,910 
13,320 
437 
1,003 
1,705 
           Investments at Cost $ 52,388 
$ 161,782 
$ 4,219 
$ 15,074 
$ 15,715 





















AZL Russell 1000 Value Index Fund Class 2 AZL S&P 500 Index Fund AZL Small Cap Stock Index Fund Class 1 AZL Small Cap Stock Index Fund Class 2 AZL T. Rowe Price Capital Appreciation Fund
 Assets:




    Investments at Net Asset Value $ 16,914 
$ 28,593 
$ 443 
$ 12,390 
$ 16,486 
         Total Assets 16,914 
28,593 
443 
12,390 
16,486 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 16,914 
28,593 
443 
12,390 
16,486 






 Net Assets:




    Contracts in Accumulation Period 16,898 
28,555 
443 
12,390 
16,467 
    Contracts in Annuity Payment Period 16 
38 
— 
— 
19 
         Total Net Assets $ 16,914 
$ 28,593 
$ 443 
$ 12,390 
$ 16,486 






           Investment Shares 1,332 
1,416 
60 
1,012 
1,005 
           Investments at Cost $ 17,155 
$ 22,733 
$ 527 
$ 12,299 
$ 16,990 
See accompanying notes to financial statements
Page 7 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Assets and Liabilities
(In thousands)



















ClearBridge Variable Aggressive Growth Portfolio Columbia Variable Portfolio – Seligman Global Technology Fund Davis VA Financial Portfolio Delaware Ivy VIP Growth Portfolio Delaware Ivy VIP Mid Cap Growth Portfolio
 Assets:




    Investments at Net Asset Value $ 27 
$ 55 
$ 899 
$ 10 
$ 10 
         Total Assets 27 
55 
899 
10 
10 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 27 
55 
899 
10 
10 






 Net Assets:




    Contracts in Accumulation Period 27 
55 
899 
10 
10 
    Contracts in Annuity Payment Period — 
— 
— 
— 
— 
         Total Net Assets $ 27 
$ 55 
$ 899 
$ 10 
$ 10 






           Investment Shares

69 


           Investments at Cost $ 42 
$ 41 
$ 860 
$
$ 10 





















Delaware Ivy VIP Natural Resources Portfolio Fidelity VIP Mid Cap Portfolio Fidelity VIP Strategic Income Portfolio Franklin Rising Dividends VIP Fund Franklin U.S. Government Securities VIP Fund
 Assets:




    Investments at Net Asset Value $ 13 
$ 31 
$ 80 
$ 14,933 
$ 14,271 
         Total Assets 13 
31 
80 
14,933 
14,271 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 13 
31 
80 
14,933 
14,271 






 Net Assets:




    Contracts in Accumulation Period 13 
31 
80 
14,865 
14,261 
    Contracts in Annuity Payment Period — 
— 
— 
68 
10 
         Total Net Assets $ 13 
$ 31 
$ 80 
$ 14,933 
$ 14,271 






           Investment Shares


537 
1,374 
           Investments at Cost $
$ 30 
$ 86 
$ 11,959 
$ 16,644 
See accompanying notes to financial statements
Page 8 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Assets and Liabilities
(In thousands)



















Invesco Oppenheimer V.I. International Growth Fund Invesco V.I. American Value Fund Invesco V.I. Global Strategic Income Fund LVIP JPMorgan Core Bond Fund MFS International Intrinsic Value Portfolio
 Assets:




    Investments at Net Asset Value $
$ 24 
$ 99 
$ 1,457 
$ 36 
         Total Assets
24 
99 
1,457 
36 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets:
24 
99 
1,457 
36 






 Net Assets:




    Contracts in Accumulation Period
24 
99 
1,457 
36 
    Contracts in Annuity Payment Period — 
— 
— 
— 
— 
         Total Net Assets $
$ 24 
$ 99 
$ 1,457 
$ 36 






           Investment Shares

23 
149 

           Investments at Cost $
$ 28 
$ 121 
$ 1,452 
$ 35 





















MFS VIT Total Return Bond Portfolio MFS VIT Utilities Portfolio PIMCO VIT Balanced Allocation Portfolio PIMCO VIT CommodityRealReturn Strategy Portfolio PIMCO VIT Emerging Markets Bond Portfolio
 Assets:




    Investments at Net Asset Value $ 4,732 
$
$ 19,752 
$ 1,263 
$ 5,030 
         Total Assets 4,732 

19,752 
1,263 
5,030 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 4,732 

19,752 
1,263 
5,030 






 Net Assets:




    Contracts in Accumulation Period 4,732 

19,750 
1,263 
5,030 
    Contracts in Annuity Payment Period — 
— 

— 
— 
         Total Net Assets $ 4,732 
$
$ 19,752 
$ 1,263 
$ 5,030 






           Investment Shares 413 
— 
2,260 
236 
477 
           Investments at Cost $ 5,336 
$
$ 21,544 
$ 1,964 
$ 6,051 
See accompanying notes to financial statements
Page 9 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Assets and Liabilities
(In thousands)



















PIMCO VIT Global Core Bond (Hedged) Portfolio PIMCO VIT High Yield Portfolio PIMCO VIT Long-Term U.S. Government Portfolio PIMCO VIT Low Duration Portfolio PIMCO VIT Real Return Portfolio
 Assets:




    Investments at Net Asset Value $ 8,625 
$ 41,046 
$ 310 
$ 169 
$ 19,135 
         Total Assets 8,625 
41,046 
310 
169 
19,135 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 8,625 
41,046 
310 
169 
19,135 






 Net Assets:




    Contracts in Accumulation Period 8,625 
41,046 
310 
169 
19,131 
    Contracts in Annuity Payment Period — 
— 
— 
— 

         Total Net Assets $ 8,625 
$ 41,046 
$ 310 
$ 169 
$ 19,135 






           Investment Shares 981 
5,717 
39 
18 
1,654 
           Investments at Cost $ 9,294 
$ 43,574 
$ 435 
$ 173 
$ 21,321 





















PIMCO VIT StocksPLUS Global Portfolio PIMCO VIT Total Return Portfolio T. Rowe Price Equity Income Portfolio Templeton Global Bond VIP Fund Total All Funds
 Assets:




    Investments at Net Asset Value $ 7,771 
$ 64,621 
$ 104 
$ 37,396 
$ 1,591,568 
         Total Assets 7,771 
64,621 
104 
37,396 
1,591,568 






 Liabilities:




         Total Liabilities — 
— 
— 
— 
— 
 Net Assets: 7,771 
64,621 
104 
37,396 
1,591,568 






 Net Assets:




    Contracts in Accumulation Period 7,753 
64,621 
104 
37,380 
1,591,105 
    Contracts in Annuity Payment Period 18 
— 
— 
16 
463 
         Total Net Assets $ 7,771 
$ 64,621 
$ 104 
$ 37,396 
$ 1,591,568 






           Investment Shares 1,103 
7,039 

2,910 
173,410 
           Investments at Cost $ 8,982 
$ 75,481 
$ 106 
$ 46,487 
$ 1,632,563 




See accompanying notes to financial statements
Page 10 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Assets and Liabilities
(In thousands)


The following open/available funds had no assets or liabilities as of December 31, 2023 and therefore, were not listed in the Statements of Assets and Liabilities:



BlackRock Equity Dividend V.I. Fund
Delaware Ivy VIP Asset Strategy Portfolio
Delaware Ivy VIP Energy Portfolio
Delaware Ivy VIP Science and Technology Portfolio
Eaton Vance VT Floating-Rate Income Fund
Fidelity VIP Emerging Markets Portfolio
Invesco V.I. Balanced-Risk Allocation Fund
Lazard Retirement International Equity Portfolio
Lazard Retirement U.S. Small-Mid Cap Equity Portfolio
T. Rowe Price Blue Chip Growth Portfolio
T. Rowe Price Health Sciences Portfolio


See accompanying notes to financial statements
Page 11 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















AZL Balanced Index Strategy Fund AZL DFA Five-Year Global Fixed Income Fund AZL DFA Multi-Strategy Fund AZL Enhanced Bond Index Fund


(A)

 Investment Income:



    Dividends Reinvested in Fund Shares $ 420 
$
$ 1,856 
$ 81 





 Expenses:



    Mortality and Expense Risk Charges 410 

1,068 
71 
         Investment Income (Loss), Net 10 

788 
10 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 1,409 
— 
5,828 
— 
    Realized Gains (Losses) on Sales of Investments, Net (221)
(138)
(1,030)
(111)
         Realized Gains (Losses) on Investments, Net 1,188 
(138)
4,798 
(111)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 1,272 
123 
1,390 
281 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 2,460 
(15)
6,188 
170 
     Net Increase (Decrease) in Net Assets From Operations $ 2,470 
$ (10)
$ 6,976 
$ 180 

















AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 1 AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 2 AZL Fidelity Institutional Asset Management Total Bond Fund Class 1 AZL Fidelity Institutional Asset Management Total Bond Fund Class 2





 Investment Income:



    Dividends Reinvested in Fund Shares $ 158 
$ 1,894 
$ 71 
$ 986 





 Expenses:



    Mortality and Expense Risk Charges 75 
1,910 
16 
270 
         Investment Income (Loss), Net 83 
(16)
55 
716 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds — 
— 
— 
— 
    Realized Gains (Losses) on Sales of Investments, Net (150)
(2,198)
(60)
(444)
         Realized Gains (Losses) on Investments, Net (150)
(2,198)
(60)
(444)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 708 
15,674 
63 
459 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 558 
13,476 

15 
         Net Increase (Decrease) in Net Assets From Operations $ 641 
$ 13,460 
$ 58 
$ 731 
See accompanying notes to financial statements
Page 12 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















AZL Gateway Fund AZL Government Money Market Fund AZL International Index Fund Class 1 AZL International Index Fund Class 2

(A)


 Investment Income:



    Dividends Reinvested in Fund Shares $ 48 
$ 1,916 
$ 206 
$ 366 





 Expenses:



    Mortality and Expense Risk Charges 20 
507 
75 
347 
         Investment Income (Loss), Net 28 
1,409 
131 
19 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 3,565 
— 
— 
— 
    Realized Gains (Losses) on Sales of Investments, Net (2,274)
— 
28 
295 
         Realized Gains (Losses) on Investments, Net 1,291 
— 
28 
295 
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments (1,101)
— 
548 
1,726 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 190 
— 
576 
2,021 
         Net Increase (Decrease) in Net Assets From Operations $ 218 
$ 1,409 
$ 707 
$ 2,040 

















AZL MetWest Total Return Bond Fund AZL Mid Cap Index Fund Class 1 AZL Mid Cap Index Fund Class 2 AZL Moderate Index Strategy Fund

(A)


 Investment Income:



    Dividends Reinvested in Fund Shares $ 85 
$ 180 
$ 102 
$ 1,689 





 Expenses:



    Mortality and Expense Risk Charges
30 
312 
1,530 
         Investment Income (Loss), Net 78 
150 
(210)
159 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds — 
585 
463 
6,434 
    Realized Gains (Losses) on Sales of Investments, Net (640)
(215)
(73)
(2,229)
         Realized Gains (Losses) on Investments, Net (640)
370 
390 
4,205 
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 556 
(227)
1,645 
6,450 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments (84)
143 
2,035 
10,655 
         Net Increase (Decrease) in Net Assets From Operations $ (6)
$ 293 
$ 1,825 
$ 10,814 
See accompanying notes to financial statements
Page 13 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















AZL MSCI Emerging Markets Equity Index Class 1 AZL MSCI Emerging Markets Equity Index Class 2 AZL MSCI Global Equity Index Fund Class 1 AZL MSCI Global Equity Index Fund Class 2

(A) (A)

 Investment Income:



    Dividends Reinvested in Fund Shares $ 19 
$ 126 
$ 50 
$ 50 





 Expenses:



    Mortality and Expense Risk Charges
15 
27 
89 
         Investment Income (Loss), Net 18 
111 
23 
(39)
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 96 
669 


    Realized Gains (Losses) on Sales of Investments, Net (69)
(1,261)
(76)
(87)
         Realized Gains (Losses) on Investments, Net 27 
(592)
(71)
(81)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments (33)
565 
422 
871 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments (6)
(27)
351 
790 
         Net Increase (Decrease) in Net Assets From Operations $ 12 
$ 84 
$ 374 
$ 751 

















AZL MVP Balanced Index Strategy Fund AZL MVP DFA Multi-Strategy Fund AZL MVP Fidelity Institutional Asset Management Multi-Strategy Fund AZL MVP Fusion Balanced Fund




(A)
 Investment Income:



    Dividends Reinvested in Fund Shares $ 448 
$ 224 
$ 553 
$ 2,015 





 Expenses:



    Mortality and Expense Risk Charges 1,133 
1,744 
533 
179 
         Investment Income (Loss), Net (685)
(1,520)
20 
1,836 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 808 
84 
— 
2,944 
    Realized Gains (Losses) on Sales of Investments, Net (200)
475 
(77)
(15,550)
         Realized Gains (Losses) on Investments, Net 608 
559 
(77)
(12,606)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 8,158 
15,662 
3,812 
11,688 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 8,766 
16,221 
3,735 
(918)
         Net Increase (Decrease) in Net Assets From Operations $ 8,081 
$ 14,701 
$ 3,755 
$ 918 
See accompanying notes to financial statements
Page 14 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















AZL MVP Fusion Conservative Fund AZL MVP Fusion Moderate Fund AZL MVP Global Balanced Index Strategy Fund AZL MVP Growth Index Strategy Fund

(A) (A)

 Investment Income:



    Dividends Reinvested in Fund Shares $ 481 
$ 5,557 
$ 2,552 
$ 5,439 





 Expenses:



    Mortality and Expense Risk Charges 44 
450 
959 
4,230 
         Investment Income (Loss), Net 437 
5,107 
1,593 
1,209 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 521 
9,727 
— 
5,332 
    Realized Gains (Losses) on Sales of Investments, Net (3,439)
(38,790)
(1,462)
(1,904)
         Realized Gains (Losses) on Investments, Net (2,918)
(29,063)
(1,462)
3,428 
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 2,648 
26,985 
7,200 
34,224 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments (270)
(2,078)
5,738 
37,652 
         Net Increase (Decrease) in Net Assets From Operations $ 167 
$ 3,029 
$ 7,331 
$ 38,861 

















AZL MVP Moderate Index Strategy Fund AZL MVP T. Rowe Price Capital Appreciation Plus Fund AZL Russell 1000 Growth Index Fund Class 1 AZL Russell 1000 Growth Index Fund Class 2





 Investment Income:



    Dividends Reinvested in Fund Shares $ 964 
$ 12,636 
$ 53 
$ 61 





 Expenses:



    Mortality and Expense Risk Charges 770 
2,401 
51 
367 
         Investment Income (Loss), Net 194 
10,235 

(306)
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 678 
— 
452 
1,117 
    Realized Gains (Losses) on Sales of Investments, Net (809)
(765)
(58)
127 
         Realized Gains (Losses) on Investments, Net (131)
(765)
394 
1,244 
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 5,997 
13,453 
839 
4,753 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 5,866 
12,688 
1,233 
5,997 
         Net Increase (Decrease) in Net Assets From Operations $ 6,060 
$ 22,923 
$ 1,235 
$ 5,691 
See accompanying notes to financial statements
Page 15 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















AZL Russell 1000 Value Index Fund Class 1 AZL Russell 1000 Value Index Fund Class 2 AZL S&P 500 Index Fund AZL Small Cap Stock Index Fund Class 1





 Investment Income:



    Dividends Reinvested in Fund Shares $ 497 
$ 345 
$ 345 
$ 10 





 Expenses:



    Mortality and Expense Risk Charges 193 
373 
621 

         Investment Income (Loss), Net 304 
(28)
(276)

    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 1,074 
904 
1,052 
40 
    Realized Gains (Losses) on Sales of Investments, Net (177)
(177)
1,493 
(59)
         Realized Gains (Losses) on Investments, Net 897 
727 
2,545 
(19)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 125 
792 
3,830 
72 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 1,022 
1,519 
6,375 
53 
         Net Increase (Decrease) in Net Assets From Operations $ 1,326 
$ 1,491 
$ 6,099 
$ 55 

















AZL Small Cap Stock Index Fund Class 2 AZL T. Rowe Price Capital Appreciation Fund ClearBridge Variable Aggressive Growth Portfolio Columbia Variable Portfolio – Seligman Global Technology Fund





 Investment Income:



    Dividends Reinvested in Fund Shares $ 120 
$ 222 
$ — 
$ — 





 Expenses:



    Mortality and Expense Risk Charges 268 
369 
— 

         Investment Income (Loss), Net (148)
(147)
— 
(1)
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 652 
2,140 


    Realized Gains (Losses) on Sales of Investments, Net (173)
(144)
— 
— 
         Realized Gains (Losses) on Investments, Net 479 
1,996 


    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 1,107 
625 

15 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 1,586 
2,621 

17 
         Net Increase (Decrease) in Net Assets From Operations $ 1,438 
$ 2,474 
$
$ 16 
See accompanying notes to financial statements
Page 16 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















Davis VA Financial Portfolio Delaware Ivy VIP Growth Portfolio Delaware Ivy VIP Mid Cap Growth Portfolio Fidelity VIP Mid Cap Portfolio





 Investment Income:



    Dividends Reinvested in Fund Shares $ 18 
$ — 
$ — 
$ — 





 Expenses:



    Mortality and Expense Risk Charges 20 
— 
— 
— 
         Investment Income (Loss), Net (2)
— 
— 
— 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds 37 
— 


    Realized Gains (Losses) on Sales of Investments, Net
— 
— 
— 
         Realized Gains (Losses) on Investments, Net 38 
— 


    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 69 



         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 107 



         Net Increase (Decrease) in Net Assets From Operations $ 105 
$
$
$

















Fidelity VIP Strategic Income Portfolio Franklin Rising Dividends VIP Fund Franklin U.S. Government Securities VIP Fund Invesco Oppenheimer V.I. International Growth Fund





 Investment Income:



    Dividends Reinvested in Fund Shares $
$ 159 
$ 405 
$ — 





 Expenses:



    Mortality and Expense Risk Charges — 
249 
248 
— 
         Investment Income (Loss), Net
(90)
157 
— 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds — 
1,542 
— 
— 
    Realized Gains (Losses) on Sales of Investments, Net — 
437 
(552)
— 
         Realized Gains (Losses) on Investments, Net — 
1,979 
(552)
— 
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments
(401)
783 

         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments
1,578 
231 

         Net Increase (Decrease) in Net Assets From Operations $
$ 1,488 
$ 388 
$
See accompanying notes to financial statements
Page 17 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















Invesco V.I. American Value Fund Invesco V.I. Global Strategic Income Fund JPMorgan Insurance Trust Core Bond Portfolio LVIP JPMorgan Core Bond Fund



(A)
 Investment Income:



    Dividends Reinvested in Fund Shares $ — 
$ — 
$ 31 
$ 20 





 Expenses:



    Mortality and Expense Risk Charges — 


17 
         Investment Income (Loss), Net — 
(2)
22 

    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds
— 
— 
— 
    Realized Gains (Losses) on Sales of Investments, Net — 
(3)
(255)
(10)
         Realized Gains (Losses) on Investments, Net
(3)
(255)
(10)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments (1)
12 
294 

         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments

39 
(4)
         Net Increase (Decrease) in Net Assets From Operations $
$
$ 61 
$ (1)

















MFS International Intrinsic Value Portfolio MFS VIT Total Return Bond Portfolio MFS VIT Utilities Portfolio PIMCO VIT Balanced Allocation Portfolio





 Investment Income:



    Dividends Reinvested in Fund Shares $ — 
$ 154 
$ — 
$ 552 





 Expenses:



    Mortality and Expense Risk Charges — 
77 
— 
309 
         Investment Income (Loss), Net — 
77 
— 
243 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds
— 
— 
— 
    Realized Gains (Losses) on Sales of Investments, Net — 
(209)
— 
(472)
         Realized Gains (Losses) on Investments, Net
(209)
— 
(472)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments
387 
(1)
2,713 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments
178 
(1)
2,241 
         Net Increase (Decrease) in Net Assets From Operations $
$ 255 
$ (1)
$ 2,484 
See accompanying notes to financial statements
Page 18 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















PIMCO VIT CommodityRealReturn Strategy Portfolio PIMCO VIT Emerging Markets Bond Portfolio PIMCO VIT Global Core Bond (Hedged) Portfolio PIMCO VIT High Yield Portfolio





 Investment Income:



    Dividends Reinvested in Fund Shares $ 227 
$ 282 
$ 204 
$ 2,503 





 Expenses:



    Mortality and Expense Risk Charges 33 
83 
146 
702 
         Investment Income (Loss), Net 194 
199 
58 
1,801 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds — 
— 
— 
— 
    Realized Gains (Losses) on Sales of Investments, Net (130)
(190)
(251)
(1,707)
         Realized Gains (Losses) on Investments, Net (130)
(190)
(251)
(1,707)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments (208)
429 
718 
4,180 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments (338)
239 
467 
2,473 
         Net Increase (Decrease) in Net Assets From Operations $ (144)
$ 438 
$ 525 
$ 4,274 

















PIMCO VIT Long-Term U.S. Government Portfolio PIMCO VIT Low Duration Portfolio PIMCO VIT Real Return Portfolio PIMCO VIT StocksPLUS Global Portfolio





 Investment Income:



    Dividends Reinvested in Fund Shares $
$
$ 618 
$ 211 





 Expenses:



    Mortality and Expense Risk Charges

346 
148 
         Investment Income (Loss), Net

272 
63 
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds — 
— 
— 
— 
    Realized Gains (Losses) on Sales of Investments, Net (14)
— 
(667)
(298)
         Realized Gains (Losses) on Investments, Net (14)
— 
(667)
(298)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 23 

775 
1,634 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments

108 
1,336 
         Net Increase (Decrease) in Net Assets From Operations $ 12 
$
$ 380 
$ 1,399 
See accompanying notes to financial statements
Page 19 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

















PIMCO VIT Total Return Portfolio T. Rowe Price Blue Chip Growth Portfolio T. Rowe Price Equity Income Portfolio Templeton Global Bond VIP Fund





 Investment Income:



    Dividends Reinvested in Fund Shares $ 2,426 
$ — 
$
$ — 





 Expenses:



    Mortality and Expense Risk Charges 1,107 
— 
— 
622 
         Investment Income (Loss), Net 1,319 
— 

(622)
    Realized Gains (Losses) and Unrealized



      Appreciation (Depreciation) on Investments:



    Realized Capital Gain Distributions on Funds — 
— 

— 
    Realized Gains (Losses) on Sales of Investments, Net (3,212)

(1)
(2,355)
         Realized Gains (Losses) on Investments, Net (3,212)


(2,355)
    Net Change in Unrealized Appreciation



      (Depreciation) on Investments 4,599 


3,374 
         Total Realized Gains (Losses) & Changes in



         Appreciation (Depreciation) on Investments 1,387 


1,019 
         Net Increase (Decrease) in Net Assets From Operations $ 2,706 
$
$
$ 397 








Total All Funds


 Investment Income:
    Dividends Reinvested in Fund Shares $ 50,660 


 Expenses:
    Mortality and Expense Risk Charges 25,599 
         Investment Income (Loss), Net 25,061 
    Realized Gains (Losses) and Unrealized
      Appreciation (Depreciation) on Investments:
    Realized Capital Gain Distributions on Funds 48,183 
    Realized Gains (Losses) on Sales of Investments, Net (82,529)
         Realized Gains (Losses) on Investments, Net (34,346)
    Net Change in Unrealized Appreciation
      (Depreciation) on Investments 192,783 
         Total Realized Gains (Losses) & Changes in
         Appreciation (Depreciation) on Investments 158,437 
         Net Increase (Decrease) in Net Assets From Operations $ 183,498 






(A) Fund terminated in 2023. See Footnote 1 for further details.

See accompanying notes to financial statements
Page 20 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Operations
For the year or period ended December 31, 2023
(In thousands)

The following open/available funds had no activity for the year or period ended December 31, 2023 and therefore, were not listed in the Statements of Operations:



BlackRock Equity Dividend V.I. Fund
Delaware Ivy VIP Asset Strategy Portfolio
Delaware Ivy VIP Energy Portfolio
Delaware Ivy VIP Natural Resources Portfolio
Delaware Ivy VIP Science and Technology Portfolio
Eaton Vance VT Floating-Rate Income Fund
Fidelity VIP Emerging Markets Portfolio
Invesco V.I. Balanced-Risk Allocation Fund
Lazard Retirement International Equity Portfolio
Lazard Retirement U.S. Small-Mid Cap Equity Portfolio
T. Rowe Price Health Sciences Portfolio

See accompanying notes to financial statements
Page 21 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL Balanced Index Strategy Fund AZL DFA Five-Year Global Fixed Income Fund

2023 2022 2023 (A) 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 10 
$ 127 
$
$ 24 
       Realized Gains (Losses) on Investments, Net 1,188 
1,664 
(138)
(21)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 1,272 
(6,554)
123 
(87)
            Net Increase (Decrease) in Net Assets From Operations 2,470 
(4,763)
(10)
(84)
 Contract Transactions-All Products



    Purchase Payments 19 
24 
(170)
10 
    Transfers Between Funds or (to) from General Account 468 
112 
(690)
54 
    Surrenders and Terminations (2,519)
(1,222)
(11)
(123)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge (2)
(2)
— 
— 
    Rider Charge (288)
(299)

(13)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (2,322)
(1,387)
(865)
(72)
             Increase (Decrease) in Net Assets 148 
(6,150)
(875)
(156)
 Net Assets at Beginning of Period 22,982 
29,132 
875 
1,031 
 Net Assets at End of Period $ 23,130 
$ 22,982 
$ — 
$ 875 
 Changes in Units



      Issued 29 



      Redeemed (161)
(85)
(101)
(15)
      Net Increase (Decrease) (132)
(78)
(100)
(8)
















AZL DFA Multi-Strategy Fund AZL Enhanced Bond Index Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 788 
$ (367)
$ 10 
$ — 
       Realized Gains (Losses) on Investments, Net 4,798 
6,490 
(111)
(42)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 1,390 
(16,808)
281 
(703)
            Net Increase (Decrease) in Net Assets From Operations 6,976 
(10,685)
180 
(745)
 Contract Transactions-All Products



    Purchase Payments 90 
42 

24 
    Transfers Between Funds or (to) from General Account 42 
(1,549)
1,297 
332 
    Surrenders and Terminations (6,081)
(5,474)
(647)
(215)
    Rescissions (1)
— 
— 
— 
    Bonus (Recapture) — 
— 
— 

    Contract Maintenance Charge (6)
(6)
(1)
(1)
    Rider Charge (1,358)
(1,381)
(71)
(61)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (7,314)
(8,368)
580 
80 
             Increase (Decrease) in Net Assets (338)
(19,053)
760 
(665)
 Net Assets at Beginning of Period 65,986 
85,039 
4,262 
4,927 
 Net Assets at End of Period $ 65,648 
$ 65,986 
$ 5,022 
$ 4,262 
 Changes in Units



      Issued

125 
33 
      Redeemed (353)
(405)
(69)
(26)
      Net Increase (Decrease) (346)
(403)
56 

See accompanying notes to financial statements
Page 22 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 1 AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 2

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 83 
$
$ (16)
$ (867)
       Realized Gains (Losses) on Investments, Net (150)
505 
(2,198)
7,402 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 708 
(1,596)
15,674 
(29,907)
            Net Increase (Decrease) in Net Assets From Operations 641 
(1,087)
13,460 
(23,372)
 Contract Transactions-All Products



    Purchase Payments — 

153 
306 
    Transfers Between Funds or (to) from General Account (4)
(7)
4,949 
341 
    Surrenders and Terminations (719)
(698)
(13,187)
(10,359)
    Rescissions — 
— 
— 
(1)
    Bonus (Recapture) — 
— 


    Contract Maintenance Charge (2)
(3)
(19)
(19)
    Rider Charge — 
— 
(2,054)
(2,023)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (725)
(707)
(10,156)
(11,752)
             Increase (Decrease) in Net Assets (84)
(1,794)
3,304 
(35,124)
 Net Assets at Beginning of Period 5,374 
7,168 
115,499 
150,623 
 Net Assets at End of Period $ 5,290 
$ 5,374 
$ 118,803 
$ 115,499 
 Changes in Units



      Issued — 
— 
294 
36 
      Redeemed (75)
(75)
(846)
(679)
      Net Increase (Decrease) (75)
(75)
(552)
(643)
















AZL Fidelity Institutional Asset Management Total Bond Fund Class 1 AZL Fidelity Institutional Asset Management Total Bond Fund Class 2

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 55 
$ 22 
$ 716 
$ 132 
       Realized Gains (Losses) on Investments, Net (60)
20 
(444)
(31)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 63 
(275)
459 
(2,931)
            Net Increase (Decrease) in Net Assets From Operations 58 
(233)
731 
(2,830)
 Contract Transactions-All Products



    Purchase Payments — 
— 
41 
17 
    Transfers Between Funds or (to) from General Account (15)
(38)
2,928 
895 
    Surrenders and Terminations (333)
(68)
(1,893)
(2,500)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 

    Contract Maintenance Charge (1)
(1)
(3)
(3)
    Rider Charge — 
— 
(188)
(177)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (349)
(107)
885 
(1,767)
             Increase (Decrease) in Net Assets (291)
(340)
1,616 
(4,597)
 Net Assets at Beginning of Period 1,295 
1,635 
14,776 
19,373 
 Net Assets at End of Period $ 1,004 
$ 1,295 
$ 16,392 
$ 14,776 
 Changes in Units



      Issued — 
— 
292 
88 
      Redeemed (36)
(10)
(210)
(260)
      Net Increase (Decrease) (36)
(10)
82 
(172)
See accompanying notes to financial statements
Page 23 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL Gateway Fund AZL Government Money Market Fund

2023 (A) 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 28 
$ (89)
$ 1,409 
$ 11 
       Realized Gains (Losses) on Investments, Net 1,291 
229 
— 
— 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments (1,101)
(1,240)
— 
— 
            Net Increase (Decrease) in Net Assets From Operations 218 
(1,100)
1,409 
11 
 Contract Transactions-All Products



    Purchase Payments — 
— 
249,906 
187,478 
    Transfers Between Funds or (to) from General Account (6,637)
(94)
(237,313)
(167,729)
    Surrenders and Terminations (79)
(468)
(17,149)
(15,573)
    Rescissions — 
— 
(734)
(461)
    Bonus (Recapture) — 
— 
— 
18 
    Contract Maintenance Charge — 
— 
(7)
(7)
    Rider Charge (36)
(158)
(381)
(496)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (6,752)
(720)
(5,678)
3,230 
             Increase (Decrease) in Net Assets (6,534)
(1,820)
(4,269)
3,241 
 Net Assets at Beginning of Period 6,534 
8,354 
49,267 
46,026 
 Net Assets at End of Period $ — 
$ 6,534 
$ 44,998 
$ 49,267 
 Changes in Units



      Issued — 
— 
24,439 
14,316 
      Redeemed (494)
(51)
(24,439)
(14,057)
      Net Increase (Decrease) (494)
(51)
— 
259 
















AZL International Index Fund Class 1 AZL International Index Fund Class 2

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 131 
$ 140 
$ 19 
$ 65 
       Realized Gains (Losses) on Investments, Net 28 
172 
295 
537 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 548 
(1,168)
1,726 
(3,759)
            Net Increase (Decrease) in Net Assets From Operations 707 
(856)
2,040 
(3,157)
 Contract Transactions-All Products



    Purchase Payments
— 

42 
    Transfers Between Funds or (to) from General Account 410 

2,308 
(609)
    Surrenders and Terminations (429)
(259)
(1,926)
(2,309)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge (2)
(2)
(2)
(2)
    Rider Charge — 
— 
(20)
(37)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (20)
(258)
361 
(2,915)
             Increase (Decrease) in Net Assets 687 
(1,114)
2,401 
(6,072)
 Net Assets at Beginning of Period 4,392 
5,506 
13,047 
19,119 
 Net Assets at End of Period $ 5,079 
$ 4,392 
$ 15,448 
$ 13,047 
 Changes in Units



      Issued 32 
— 
198 

      Redeemed (32)
(21)
(150)
(234)
      Net Increase (Decrease) — 
(21)
48 
(232)
See accompanying notes to financial statements
Page 24 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL MetWest Total Return Bond Fund AZL Mid Cap Index Fund Class 1

2023 (A) 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 78 
$ (9)
$ 150 
$ 42 
       Realized Gains (Losses) on Investments, Net (640)
(60)
370 
1,306 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 556 
(402)
(227)
(1,743)
            Net Increase (Decrease) in Net Assets From Operations (6)
(471)
293 
(395)
 Contract Transactions-All Products



    Purchase Payments — 
16 
— 
— 
    Transfers Between Funds or (to) from General Account (2,409)
200 
(27)
— 
    Surrenders and Terminations (27)
(202)
(206)
(281)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
(1)
(1)
    Rider Charge (8)
(41)
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (2,444)
(27)
(234)
(282)
             Increase (Decrease) in Net Assets (2,450)
(498)
59 
(677)
 Net Assets at Beginning of Period 2,450 
2,948 
2,127 
2,804 
 Net Assets at End of Period $ — 
$ 2,450 
$ 2,186 
$ 2,127 
 Changes in Units



      Issued — 
23 
— 
— 
      Redeemed (265)
(25)
(14)
(17)
      Net Increase (Decrease) (265)
(2)
(14)
(17)
















AZL Mid Cap Index Fund Class 2 AZL Moderate Index Strategy Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ (210)
$ (259)
$ 159 
$ 458 
       Realized Gains (Losses) on Investments, Net 390 
4,025 
4,205 
5,124 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 1,645 
(7,228)
6,450 
(25,355)
            Net Increase (Decrease) in Net Assets From Operations 1,825 
(3,462)
10,814 
(19,773)
 Contract Transactions-All Products



    Purchase Payments
94 
57 
113 
    Transfers Between Funds or (to) from General Account (784)
(1,855)
(1,238)
(748)
    Surrenders and Terminations (2,863)
(2,085)
(9,865)
(8,196)
    Rescissions — 
— 
— 
(30)
    Bonus (Recapture) — 

— 
— 
    Contract Maintenance Charge (2)
(2)
(11)
(12)
    Rider Charge (34)
(63)
(1,808)
(1,847)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (3,679)
(3,908)
(12,865)
(10,720)
             Increase (Decrease) in Net Assets (1,854)
(7,370)
(2,051)
(30,493)
 Net Assets at Beginning of Period 16,019 
23,389 
90,713 
121,206 
 Net Assets at End of Period $ 14,165 
$ 16,019 
$ 88,662 
$ 90,713 
 Changes in Units



      Issued — 



      Redeemed (132)
(144)
(556)
(461)
      Net Increase (Decrease) (132)
(141)
(554)
(456)
See accompanying notes to financial statements
Page 25 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL MSCI Emerging Markets Equity Index Class 1 AZL MSCI Emerging Markets Equity Index Class 2

2023 (A) 2022 2023 (A) 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 18 
$
$ 111 
$ (38)
       Realized Gains (Losses) on Investments, Net 27 
19 
(592)
(11)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments (33)
(145)
565 
(861)
            Net Increase (Decrease) in Net Assets From Operations 12 
(125)
84 
(910)
 Contract Transactions-All Products



    Purchase Payments — 
— 
— 
— 
    Transfers Between Funds or (to) from General Account (417)
— 
(2,974)
137 
    Surrenders and Terminations (6)
(57)
(50)
(343)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
— 
— 
    Rider Charge — 
— 
(1)
(3)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (423)
(57)
(3,025)
(209)
             Increase (Decrease) in Net Assets (411)
(182)
(2,941)
(1,119)
 Net Assets at Beginning of Period 411 
593 
2,941 
4,060 
 Net Assets at End of Period $ — 
$ 411 
$ — 
$ 2,941 
 Changes in Units



      Issued — 
— 
— 
16 
      Redeemed (36)
(5)
(327)
(36)
      Net Increase (Decrease) (36)
(5)
(327)
(20)
















AZL MSCI Global Equity Index Fund Class 1 AZL MSCI Global Equity Index Fund Class 2

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 23 
$
$ (39)
$ (51)
       Realized Gains (Losses) on Investments, Net (71)
187 
(81)
190 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 422 
(695)
871 
(1,294)
            Net Increase (Decrease) in Net Assets From Operations 374 
(500)
751 
(1,155)
 Contract Transactions-All Products



    Purchase Payments — 
— 
— 
48 
    Transfers Between Funds or (to) from General Account — 
— 
(312)
(226)
    Surrenders and Terminations (392)
(306)
(546)
(699)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 

    Contract Maintenance Charge (1)
(1)
(1)
(1)
    Rider Charge — 
— 
(7)
(12)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (393)
(307)
(866)
(888)
             Increase (Decrease) in Net Assets (19)
(807)
(115)
(2,043)
 Net Assets at Beginning of Period 1,883 
2,690 
4,058 
6,101 
 Net Assets at End of Period $ 1,864 
$ 1,883 
$ 3,943 
$ 4,058 
 Changes in Units



      Issued — 
— 
— 

      Redeemed (41)
(32)
(43)
(49)
      Net Increase (Decrease) (41)
(32)
(43)
(46)
See accompanying notes to financial statements
Page 26 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL MVP Balanced Index Strategy Fund AZL MVP DFA Multi-Strategy Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ (685)
$ 278 
$ (1,520)
$ (48)
       Realized Gains (Losses) on Investments, Net 608 
2,162 
559 
571 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 8,158 
(9,146)
15,662 
(1,828)
            Net Increase (Decrease) in Net Assets From Operations 8,081 
(6,706)
14,701 
(1,305)
 Contract Transactions-All Products



    Purchase Payments 520 
489 
294 
65 
    Transfers Between Funds or (to) from General Account 53,762 
(1,261)
139,846 
(187)
    Surrenders and Terminations (10,226)
(2,902)
(10,913)
(447)
    Rescissions — 
(1)
— 
— 
    Bonus (Recapture) — 
— 
— 

    Contract Maintenance Charge (14)
(6)
(18)
(1)
    Rider Charge (1,313)
(579)
(2,292)
(148)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions 42,729 
(4,260)
126,917 
(716)
             Increase (Decrease) in Net Assets 50,810 
(10,966)
141,618 
(2,021)
 Net Assets at Beginning of Period 32,062 
43,028 
8,031 
10,052 
 Net Assets at End of Period $ 82,872 
$ 32,062 
$ 149,649 
$ 8,031 
 Changes in Units



      Issued 3,782 
30 
11,866 

      Redeemed (773)
(312)
(1,085)
(65)
      Net Increase (Decrease) 3,009 
(282)
10,781 
(60)
















AZL MVP Fidelity Institutional Asset Management Multi-Strategy Fund AZL MVP Fusion Balanced Fund

2023 2022 2023 (A) 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 20 
$ (225)
$ 1,836 
$ 489 
       Realized Gains (Losses) on Investments, Net (77)
1,167 
(12,606)
1,577 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 3,812 
(5,603)
11,688 
(13,328)
            Net Increase (Decrease) in Net Assets From Operations 3,755 
(4,661)
918 
(11,262)
 Contract Transactions-All Products



    Purchase Payments 122 
77 
20 
289 
    Transfers Between Funds or (to) from General Account 13,359 
(440)
(53,697)
(399)
    Surrenders and Terminations (3,797)
(2,313)
(1,267)
(4,409)
    Rescissions — 
— 
— 
(2)
    Bonus (Recapture)

— 
— 
    Contract Maintenance Charge (7)
(5)
(2)
(11)
    Rider Charge (597)
(418)
(200)
(1,015)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions 9,083 
(3,097)
(55,146)
(5,547)
             Increase (Decrease) in Net Assets 12,838 
(7,758)
(54,228)
(16,809)
 Net Assets at Beginning of Period 24,250 
32,008 
54,228 
71,037 
 Net Assets at End of Period $ 37,088 
$ 24,250 
$ — 
$ 54,228 
 Changes in Units



      Issued 1,025 


18 
      Redeemed (328)
(225)
(3,590)
(363)
      Net Increase (Decrease) 697 
(219)
(3,589)
(345)
See accompanying notes to financial statements
Page 27 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL MVP Fusion Conservative Fund AZL MVP Fusion Moderate Fund

2023 (A) 2022 2023 (A) 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 437 
$ 175 
$ 5,107 
$ 1,059 
       Realized Gains (Losses) on Investments, Net (2,918)
212 
(29,063)
5,329 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 2,648 
(3,276)
26,985 
(37,233)
            Net Increase (Decrease) in Net Assets From Operations 167 
(2,889)
3,029 
(30,845)
 Contract Transactions-All Products



    Purchase Payments 12 
62 
(563)
414 
    Transfers Between Funds or (to) from General Account (13,795)
(1,742)
(140,981)
(1,111)
    Surrenders and Terminations (287)
(2,675)
(2,726)
(13,411)
    Rescissions — 
— 
— 
(19)
    Bonus (Recapture)

— 

    Contract Maintenance Charge — 
(2)
(5)
(23)
    Rider Charge (49)
(260)
(485)
(2,782)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (14,118)
(4,616)
(144,760)
(16,927)
             Increase (Decrease) in Net Assets (13,951)
(7,505)
(141,731)
(47,772)
 Net Assets at Beginning of Period 13,951 
21,456 
141,731 
189,503 
 Net Assets at End of Period $ — 
$ 13,951 
$ — 
$ 141,731 
 Changes in Units



      Issued


25 
      Redeemed (1,014)
(308)
(9,138)
(1,055)
      Net Increase (Decrease) (1,013)
(303)
(9,135)
(1,030)
















AZL MVP Global Balanced Index Strategy Fund AZL MVP Growth Index Strategy Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 1,593 
$ 982 
$ 1,209 
$ 569 
       Realized Gains (Losses) on Investments, Net (1,462)
2,743 
3,428 
25,997 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 7,200 
(18,215)
34,224 
(83,297)
            Net Increase (Decrease) in Net Assets From Operations 7,331 
(14,490)
38,861 
(56,731)
 Contract Transactions-All Products



    Purchase Payments 82 
138 
1,152 
1,925 
    Transfers Between Funds or (to) from General Account (745)
587 
(1,821)
(1,132)
    Surrenders and Terminations (6,401)
(5,808)
(22,952)
(16,915)
    Rescissions — 
(6)
— 
(39)
    Bonus (Recapture) — 



    Contract Maintenance Charge (12)
(12)
(29)
(30)
    Rider Charge (1,138)
(1,188)
(4,567)
(4,600)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (8,214)
(6,288)
(28,214)
(20,789)
             Increase (Decrease) in Net Assets (883)
(20,778)
10,647 
(77,520)
 Net Assets at Beginning of Period 64,732 
85,510 
272,658 
350,178 
 Net Assets at End of Period $ 63,849 
$ 64,732 
$ 283,305 
$ 272,658 
 Changes in Units



      Issued
54 
58 
104 
      Redeemed (613)
(519)
(1,579)
(1,274)
      Net Increase (Decrease) (608)
(465)
(1,521)
(1,170)
See accompanying notes to financial statements
Page 28 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL MVP Moderate Index Strategy Fund AZL MVP T. Rowe Price Capital Appreciation Plus Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 194 
$ 244 
$ 10,235 
$ 9,881 
       Realized Gains (Losses) on Investments, Net (131)
4,542 
(765)
10,368 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 5,997 
(15,511)
13,453 
(49,351)
            Net Increase (Decrease) in Net Assets From Operations 6,060 
(10,725)
22,923 
(29,102)
 Contract Transactions-All Products



    Purchase Payments 152 
87 
923 
1,284 
    Transfers Between Funds or (to) from General Account (773)
829 
841 
(568)
    Surrenders and Terminations (5,158)
(3,787)
(16,416)
(10,469)
    Rescissions — 
(1)
— 
(3)
    Bonus (Recapture)


11 
    Contract Maintenance Charge (8)
(8)
(17)
(17)
    Rider Charge (868)
(891)
(2,771)
(2,789)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (6,653)
(3,770)
(17,436)
(12,551)
             Increase (Decrease) in Net Assets (593)
(14,495)
5,487 
(41,653)
 Net Assets at Beginning of Period 50,798 
65,293 
155,416 
197,069 
 Net Assets at End of Period $ 50,205 
$ 50,798 
$ 160,903 
$ 155,416 
 Changes in Units



      Issued
52 
97 
77 
      Redeemed (395)
(273)
(1,096)
(826)
      Net Increase (Decrease) (386)
(221)
(999)
(749)
















AZL Russell 1000 Growth Index Fund Class 1 AZL Russell 1000 Growth Index Fund Class 2

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $
$ (30)
$ (306)
$ (414)
       Realized Gains (Losses) on Investments, Net 394 
1,097 
1,244 
4,302 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 839 
(2,542)
4,753 
(12,136)
            Net Increase (Decrease) in Net Assets From Operations 1,235 
(1,475)
5,691 
(8,248)
 Contract Transactions-All Products



    Purchase Payments — 
— 

124 
    Transfers Between Funds or (to) from General Account (6)

(1,920)
(754)
    Surrenders and Terminations (413)
(498)
(2,776)
(2,419)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 

    Contract Maintenance Charge (1)
(1)
(2)
(2)
    Rider Charge — 
— 
(37)
(64)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (420)
(494)
(4,734)
(3,112)
             Increase (Decrease) in Net Assets 815 
(1,969)
957 
(11,360)
 Net Assets at Beginning of Period 3,113 
5,082 
16,409 
27,769 
 Net Assets at End of Period $ 3,928 
$ 3,113 
$ 17,366 
$ 16,409 
 Changes in Units



      Issued — 
— 
— 

      Redeemed (17)
(20)
(117)
(79)
      Net Increase (Decrease) (17)
(20)
(117)
(77)
See accompanying notes to financial statements
Page 29 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL Russell 1000 Value Index Fund Class 1 AZL Russell 1000 Value Index Fund Class 2

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 304 
$ 106 
$ (28)
$ (186)
       Realized Gains (Losses) on Investments, Net 897 
1,967 
727 
2,160 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 125 
(3,630)
792 
(4,432)
            Net Increase (Decrease) in Net Assets From Operations 1,326 
(1,557)
1,491 
(2,458)
 Contract Transactions-All Products



    Purchase Payments — 
— 

22 
    Transfers Between Funds or (to) from General Account (11)
(11)
(645)
(1,956)
    Surrenders and Terminations (1,328)
(1,354)
(2,356)
(2,467)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge (4)
(5)
(2)
(3)
    Rider Charge — 
— 
(33)
(65)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (1,343)
(1,370)
(3,034)
(4,469)
             Increase (Decrease) in Net Assets (17)
(2,927)
(1,543)
(6,927)
 Net Assets at Beginning of Period 14,049 
16,976 
18,457 
25,384 
 Net Assets at End of Period $ 14,032 
$ 14,049 
$ 16,914 
$ 18,457 
 Changes in Units



      Issued — 
— 
— 

      Redeemed (86)
(90)
(125)
(186)
      Net Increase (Decrease) (86)
(90)
(125)
(185)
















AZL S&P 500 Index Fund AZL Small Cap Stock Index Fund Class 1

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ (276)
$ (370)
$
$ (1)
       Realized Gains (Losses) on Investments, Net 2,545 
6,325 
(19)
144 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 3,830 
(14,551)
72 
(279)
            Net Increase (Decrease) in Net Assets From Operations 6,099 
(8,596)
55 
(136)
 Contract Transactions-All Products



    Purchase Payments
183 
— 
— 
    Transfers Between Funds or (to) from General Account (2,708)
(1,771)
— 
(1)
    Surrenders and Terminations (5,165)
(3,597)
(206)
(36)
    Rescissions — 
(1)
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge (4)
(5)
— 
— 
    Rider Charge (64)
(118)
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (7,939)
(5,309)
(206)
(37)
             Increase (Decrease) in Net Assets (1,840)
(13,905)
(151)
(173)
 Net Assets at Beginning of Period 30,433 
44,338 
594 
767 
 Net Assets at End of Period $ 28,593 
$ 30,433 
$ 443 
$ 594 
 Changes in Units



      Issued — 

— 
— 
      Redeemed (299)
(207)
(13)
(3)
      Net Increase (Decrease) (299)
(204)
(13)
(3)
See accompanying notes to financial statements
Page 30 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















AZL Small Cap Stock Index Fund Class 2 AZL T. Rowe Price Capital Appreciation Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ (148)
$ (204)
$ (147)
$ (299)
       Realized Gains (Losses) on Investments, Net 479 
2,331 
1,996 
3,032 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 1,107 
(5,088)
625 
(6,083)
            Net Increase (Decrease) in Net Assets From Operations 1,438 
(2,961)
2,474 
(3,350)
 Contract Transactions-All Products



    Purchase Payments
75 


    Transfers Between Funds or (to) from General Account 192 
(198)
(275)
(1,197)
    Surrenders and Terminations (1,481)
(1,112)
(2,719)
(3,367)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 

— 
— 
    Contract Maintenance Charge (1)
(1)
(2)
(2)
    Rider Charge (11)
(14)
(15)
(31)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (1,299)
(1,249)
(3,009)
(4,595)
             Increase (Decrease) in Net Assets 139 
(4,210)
(535)
(7,945)
 Net Assets at Beginning of Period 12,251 
16,461 
17,021 
24,966 
 Net Assets at End of Period $ 12,390 
$ 12,251 
$ 16,486 
$ 17,021 
 Changes in Units



      Issued 10 

— 
— 
      Redeemed (68)
(54)
(103)
(166)
      Net Increase (Decrease) (58)
(52)
(103)
(166)
















ClearBridge Variable Aggressive Growth Portfolio Columbia Variable Portfolio – Seligman Global Technology Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ — 
$ — 
$ (1)
$ (1)
       Realized Gains (Losses) on Investments, Net
— 

10 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments
(10)
15 
(28)
            Net Increase (Decrease) in Net Assets From Operations
(10)
16 
(19)
 Contract Transactions-All Products



    Purchase Payments — 
— 
— 
— 
    Transfers Between Funds or (to) from General Account — 
— 

— 
    Surrenders and Terminations (1)
(5)
— 
— 
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
— 
— 
    Rider Charge — 
— 
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (1)
(5)

— 
             Increase (Decrease) in Net Assets
(15)
17 
(19)
 Net Assets at Beginning of Period 22 
37 
38 
57 
 Net Assets at End of Period $ 27 
$ 22 
$ 55 
$ 38 
 Changes in Units



      Issued — 
— 
— 
— 
      Redeemed — 
— 
— 
— 
      Net Increase (Decrease) — 
— 
— 
— 
See accompanying notes to financial statements
Page 31 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















Davis VA Financial Portfolio Delaware Ivy VIP Growth Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ (2)
$ (5)
$ — 
$ — 
       Realized Gains (Losses) on Investments, Net 38 
32 
— 
(7)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 69 
(139)

(2)
            Net Increase (Decrease) in Net Assets From Operations 105 
(112)

(9)
 Contract Transactions-All Products



    Purchase Payments — 
— 
— 
— 
    Transfers Between Funds or (to) from General Account (5)
(35)

— 
    Surrenders and Terminations (49)
(53)
— 
(24)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
— 
— 
    Rider Charge — 
— 
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (54)
(88)

(24)
             Increase (Decrease) in Net Assets 51 
(200)
10 
(33)
 Net Assets at Beginning of Period 848 
1,048 
— 
33 
 Net Assets at End of Period $ 899 
$ 848 
$ 10 
$ — 
 Changes in Units



      Issued — 
— 
— 
— 
      Redeemed (2)
(5)
— 
— 
      Net Increase (Decrease) (2)
(5)
— 
— 
















Delaware Ivy VIP Mid Cap Growth Portfolio Delaware Ivy VIP Natural Resources Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ — 
$ — 
$ — 
$ — 
       Realized Gains (Losses) on Investments, Net
(4)
— 
— 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments
— 
— 

            Net Increase (Decrease) in Net Assets From Operations
(4)
— 

 Contract Transactions-All Products



    Purchase Payments — 
— 
— 
— 
    Transfers Between Funds or (to) from General Account — 

— 
— 
    Surrenders and Terminations — 
(10)
— 
(1)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
— 
— 
    Rider Charge — 
— 
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions — 
(1)
— 
(1)
             Increase (Decrease) in Net Assets
(5)
— 

 Net Assets at Beginning of Period
13 
13 
12 
 Net Assets at End of Period $ 10 
$
$ 13 
$ 13 
 Changes in Units



      Issued — 
— 
— 
— 
      Redeemed — 
— 
— 
— 
      Net Increase (Decrease) — 
— 
— 
— 
See accompanying notes to financial statements
Page 32 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















Fidelity VIP Emerging Markets Portfolio Fidelity VIP Mid Cap Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ — 
$ — 
$ — 
$ — 
       Realized Gains (Losses) on Investments, Net — 
(1)


       Net Change in Unrealized Appreciation



         (Depreciation) on Investments — 
(4)

(9)
            Net Increase (Decrease) in Net Assets From Operations — 
(5)

(8)
 Contract Transactions-All Products



    Purchase Payments — 
— 
— 
— 
    Transfers Between Funds or (to) from General Account — 
— 
— 
— 
    Surrenders and Terminations — 
(16)
— 
(15)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
— 
— 
    Rider Charge — 
— 
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions — 
(16)
— 
(15)
             Increase (Decrease) in Net Assets — 
(21)

(23)
 Net Assets at Beginning of Period — 
21 
27 
50 
 Net Assets at End of Period $ — 
$ — 
$ 31 
$ 27 
 Changes in Units



      Issued — 
— 
— 
— 
      Redeemed — 
(1)
— 
(1)
      Net Increase (Decrease) — 
(1)
— 
(1)
















Fidelity VIP Strategic Income Portfolio Franklin Rising Dividends VIP Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $
$
$ (90)
$ (105)
       Realized Gains (Losses) on Investments, Net — 
(6)
1,979 
2,640 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments
(9)
(401)
(4,852)
            Net Increase (Decrease) in Net Assets From Operations
(13)
1,488 
(2,317)
 Contract Transactions-All Products



    Purchase Payments — 
— 
— 

    Transfers Between Funds or (to) from General Account 18 
— 

(253)
    Surrenders and Terminations — 
(47)
(1,910)
(1,604)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
(4)
(4)
    Rider Charge — 
— 
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions 18 
(47)
(1,911)
(1,860)
             Increase (Decrease) in Net Assets 24 
(60)
(423)
(4,177)
 Net Assets at Beginning of Period 56 
116 
15,356 
19,533 
 Net Assets at End of Period $ 80 
$ 56 
$ 14,933 
$ 15,356 
 Changes in Units



      Issued — 
— 
— 
— 
      Redeemed — 
(2)
(17)
(16)
      Net Increase (Decrease) — 
(2)
(17)
(16)
See accompanying notes to financial statements
Page 33 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















Franklin U.S. Government Securities VIP Fund Invesco Oppenheimer V.I. International Growth Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 157 
$ 128 
$ — 
$ — 
       Realized Gains (Losses) on Investments, Net (552)
(605)
— 
(6)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 783 
(1,656)

(1)
            Net Increase (Decrease) in Net Assets From Operations 388 
(2,133)

(7)
 Contract Transactions-All Products



    Purchase Payments

— 
— 
    Transfers Between Funds or (to) from General Account 656 
107 
— 
— 
    Surrenders and Terminations (2,065)
(2,743)
— 
(16)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge (4)
(4)
— 
— 
    Rider Charge (163)
(181)
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (1,572)
(2,817)
— 
(16)
             Increase (Decrease) in Net Assets (1,184)
(4,950)

(23)
 Net Assets at Beginning of Period 15,455 
20,405 

27 
 Net Assets at End of Period $ 14,271 
$ 15,455 
$
$
 Changes in Units



      Issued 26 

— 
— 
      Redeemed (91)
(114)
— 
(1)
      Net Increase (Decrease) (65)
(109)
— 
(1)
















Invesco V.I. American Value Fund Invesco V.I. Global Strategic Income Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ — 
$ — 
$ (2)
$ (2)
       Realized Gains (Losses) on Investments, Net

(3)
(3)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments (1)
(4)
12 
(11)
            Net Increase (Decrease) in Net Assets From Operations
(2)

(16)
 Contract Transactions-All Products



    Purchase Payments — 
— 
— 
— 
    Transfers Between Funds or (to) from General Account — 
11 
— 
— 
    Surrenders and Terminations (2)
(20)
(10)
(8)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
— 
— 
    Rider Charge — 
— 
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (2)
(9)
(10)
(8)
             Increase (Decrease) in Net Assets
(11)
(3)
(24)
 Net Assets at Beginning of Period 22 
33 
102 
126 
 Net Assets at End of Period $ 24 
$ 22 
$ 99 
$ 102 
 Changes in Units



      Issued — 
— 
— 
— 
      Redeemed — 
(1)
— 
(1)
      Net Increase (Decrease) — 
(1)
— 
(1)
See accompanying notes to financial statements
Page 34 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















JPMorgan Insurance Trust Core Bond Portfolio LVIP JPMorgan Core Bond Fund

2023 (A) 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 22 
$
$
$ — 
       Realized Gains (Losses) on Investments, Net (255)
(35)
(10)
— 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 294 
(285)

— 
            Net Increase (Decrease) in Net Assets From Operations 61 
(315)
(1)
— 
 Contract Transactions-All Products



    Purchase Payments
10 
— 
— 
    Transfers Between Funds or (to) from General Account (291)
169 
1,681 
— 
    Surrenders and Terminations (1,633)
(288)
(205)
— 
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
— 
— 
    Rider Charge (7)
(29)
(18)
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (1,930)
(138)
1,458 
— 
             Increase (Decrease) in Net Assets (1,869)
(453)
1,457 
— 
 Net Assets at Beginning of Period 1,869 
2,322 
— 
— 
 Net Assets at End of Period $ — 
$ 1,869 
$ 1,457 
$ — 
 Changes in Units



      Issued — 
14 
132 
— 
      Redeemed (151)
(26)
(18)
— 
      Net Increase (Decrease) (151)
(12)
114 
— 
















MFS International Intrinsic Value Portfolio MFS VIT Total Return Bond Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ — 
$ — 
$ 77 
$ 56 
       Realized Gains (Losses) on Investments, Net
— 
(209)
(32)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments
(10)
387 
(1,009)
            Net Increase (Decrease) in Net Assets From Operations
(10)
255 
(985)
 Contract Transactions-All Products



    Purchase Payments — 
— 
14 
16 
    Transfers Between Funds or (to) from General Account — 
22 
360 
284 
    Surrenders and Terminations (3)
(17)
(1,066)
(532)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 


    Contract Maintenance Charge — 
— 
(1)
(1)
    Rider Charge — 
— 
(70)
(72)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (3)

(762)
(304)
             Increase (Decrease) in Net Assets
(5)
(507)
(1,289)
 Net Assets at Beginning of Period 33 
38 
5,239 
6,528 
 Net Assets at End of Period $ 36 
$ 33 
$ 4,732 
$ 5,239 
 Changes in Units



      Issued — 

22 
18 
      Redeemed (1)
— 
(66)
(35)
      Net Increase (Decrease) (1)

(44)
(17)
See accompanying notes to financial statements
Page 35 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















MFS VIT Utilities Portfolio PIMCO VIT Balanced Allocation Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ — 
$ — 
$ 243 
$ (129)
       Realized Gains (Losses) on Investments, Net — 
— 
(472)
1,845 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments (1)
— 
2,713 
(6,153)
            Net Increase (Decrease) in Net Assets From Operations (1)
— 
2,484 
(4,437)
 Contract Transactions-All Products



    Purchase Payments — 
— 
15 
27 
    Transfers Between Funds or (to) from General Account
— 
(394)
217 
    Surrenders and Terminations — 
— 
(1,865)
(1,468)
    Rescissions — 
— 
— 
(1)
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
(3)
(3)
    Rider Charge — 
— 
(428)
(415)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions
— 
(2,675)
(1,643)
             Increase (Decrease) in Net Assets — 
— 
(191)
(6,080)
 Net Assets at Beginning of Period

19,943 
26,023 
 Net Assets at End of Period $
$
$ 19,752 
$ 19,943 
 Changes in Units



      Issued — 
— 

21 
      Redeemed — 
— 
(216)
(154)
      Net Increase (Decrease) — 
— 
(215)
(133)
















PIMCO VIT CommodityRealReturn Strategy Portfolio PIMCO VIT Emerging Markets Bond Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 194 
$ 322 
$ 199 
$ 170 
       Realized Gains (Losses) on Investments, Net (130)
(4)
(190)
(133)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments (208)
(148)
429 
(1,129)
            Net Increase (Decrease) in Net Assets From Operations (144)
170 
438 
(1,092)
 Contract Transactions-All Products



    Purchase Payments — 
— 
— 
— 
    Transfers Between Funds or (to) from General Account 139 
(304)
(87)
248 
    Surrenders and Terminations (203)
(131)
(356)
(409)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
(1)
(1)
    Rider Charge (2)
(2)
(75)
(76)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (66)
(437)
(519)
(238)
             Increase (Decrease) in Net Assets (210)
(267)
(81)
(1,330)
 Net Assets at Beginning of Period 1,473 
1,740 
5,111 
6,441 
 Net Assets at End of Period $ 1,263 
$ 1,473 
$ 5,030 
$ 5,111 
 Changes in Units



      Issued 21 
— 
— 
14 
      Redeemed (31)
(53)
(31)
(29)
      Net Increase (Decrease) (10)
(53)
(31)
(15)
See accompanying notes to financial statements
Page 36 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















PIMCO VIT Global Core Bond (Hedged) Portfolio PIMCO VIT High Yield Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 58 
$ (4)
$ 1,801 
$ 1,782 
       Realized Gains (Losses) on Investments, Net (251)
(123)
(1,707)
(1,005)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 718 
(1,330)
4,180 
(7,669)
                Net Increase (Decrease) in Net Assets From Operations 525 
(1,457)
4,274 
(6,892)
 Contract Transactions-All Products



    Purchase Payments 10 

18 
17 
    Transfers Between Funds or (to) from General Account 444 
564 
1,901 
2,393 
    Surrenders and Terminations (1,369)
(1,704)
(12,327)
(7,791)
    Rescissions — 
(1)
— 
(1)
    Bonus (Recapture) — 
— 
— 

    Contract Maintenance Charge (2)
(2)
(9)
(9)
    Rider Charge (118)
(130)
(584)
(676)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (1,035)
(1,268)
(11,001)
(6,066)
             Increase (Decrease) in Net Assets (510)
(2,725)
(6,727)
(12,958)
 Net Assets at Beginning of Period 9,135 
11,860 
47,773 
60,731 
 Net Assets at End of Period $ 8,625 
$ 9,135 
$ 41,046 
$ 47,773 
 Changes in Units



      Issued 49 
61 
81 
103 
      Redeemed (161)
(192)
(550)
(356)
      Net Increase (Decrease) (112)
(131)
(469)
(253)
















PIMCO VIT Long-Term U.S. Government Portfolio PIMCO VIT Low Duration Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $
$
$
$
       Realized Gains (Losses) on Investments, Net (14)
(18)
— 
(2)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 23 
(98)

(5)
                Net Increase (Decrease) in Net Assets From Operations 12 
(114)

(5)
 Contract Transactions-All Products



    Purchase Payments
— 
— 
— 
    Transfers Between Funds or (to) from General Account 65 
14 
— 
83 
    Surrenders and Terminations (24)
(16)
— 
— 
    Rescissions — 
— 
— 
— 
    Bonus (Recapture) — 
— 
— 
— 
    Contract Maintenance Charge — 
— 
— 
— 
    Rider Charge (1)
(1)
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions 41 
(3)
— 
83 
             Increase (Decrease) in Net Assets 53 
(117)

78 
 Net Assets at Beginning of Period 257 
374 
162 
84 
 Net Assets at End of Period $ 310 
$ 257 
$ 169 
$ 162 
 Changes in Units



      Issued
— 
— 

      Redeemed (1)
— 
— 
— 
      Net Increase (Decrease)
— 
— 

See accompanying notes to financial statements
Page 37 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















PIMCO VIT Real Return Portfolio PIMCO VIT StocksPLUS Global Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 272 
$ 1,266 
$ 63 
$ (63)
       Realized Gains (Losses) on Investments, Net (667)
(156)
(298)
1,567 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 775 
(4,611)
1,634 
(3,508)
                Net Increase (Decrease) in Net Assets From Operations 380 
(3,501)
1,399 
(2,004)
 Contract Transactions-All Products



    Purchase Payments 29 
40 
— 

    Transfers Between Funds or (to) from General Account 1,400 
894 
(115)
62 
    Surrenders and Terminations (4,623)
(2,384)
(746)
(829)
    Rescissions — 
— 
— 
— 
    Bonus (Recapture)

— 
— 
    Contract Maintenance Charge (4)
(4)
(1)
(1)
    Rider Charge (302)
(322)
(2)
(4)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (3,499)
(1,775)
(864)
(771)
             Increase (Decrease) in Net Assets (3,119)
(5,276)
535 
(2,775)
 Net Assets at Beginning of Period 22,254 
27,530 
7,236 
10,011 
 Net Assets at End of Period $ 19,135 
$ 22,254 
$ 7,771 
$ 7,236 
 Changes in Units



      Issued 94 
63 
— 

      Redeemed (332)
(170)
(51)
(52)
      Net Increase (Decrease) (238)
(107)
(51)
(48)
















PIMCO VIT Total Return Portfolio T. Rowe Price Blue Chip Growth Portfolio

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $ 1,319 
$ 772 
$ — 
$ — 
       Realized Gains (Losses) on Investments, Net (3,212)
(1,786)

— 
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments 4,599 
(12,957)

(1)
                Net Increase (Decrease) in Net Assets From Operations 2,706 
(13,971)

(1)
 Contract Transactions-All Products



    Purchase Payments 79 
69 
— 
— 
    Transfers Between Funds or (to) from General Account 4,380 
4,157 
— 

    Surrenders and Terminations (13,810)
(9,237)
(8)
— 
    Rescissions — 
(4)
— 
— 
    Bonus (Recapture)

— 
— 
    Contract Maintenance Charge (13)
(14)
— 
— 
    Rider Charge (994)
(1,090)
— 
— 
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (10,357)
(6,117)
(8)

             Increase (Decrease) in Net Assets (7,651)
(20,088)
(6)

 Net Assets at Beginning of Period 72,272 
92,360 

— 
 Net Assets at End of Period $ 64,621 
$ 72,272 
$ — 
$
 Changes in Units



      Issued 239 
228 
— 
— 
      Redeemed (825)
(530)
— 
— 
      Net Increase (Decrease) (586)
(302)
— 
— 
See accompanying notes to financial statements
Page 38 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)

















T. Rowe Price Equity Income Portfolio Templeton Global Bond VIP Fund

2023 2022 2023 2022
 Increase (Decrease) in Net Assets:



    Operations:



       Investment Income (Loss), Net $
$
$ (622)
$ (720)
       Realized Gains (Losses) on Investments, Net

(2,355)
(3,115)
       Net Change in Unrealized Appreciation



         (Depreciation) on Investments
(9)
3,374 
751 
                Net Increase (Decrease) in Net Assets From Operations
(2)
397 
(3,084)
 Contract Transactions-All Products



    Purchase Payments — 
— 

49 
    Transfers Between Funds or (to) from General Account — 
43 
2,646 
367 
    Surrenders and Terminations (10)
— 
(6,929)
(6,820)
    Rescissions — 
— 
— 
(1)
    Bonus (Recapture) — 
— 
— 

    Contract Maintenance Charge — 
— 
(11)
(10)
    Rider Charge — 
— 
(571)
(614)
       Net Increase (Decrease) in Net Assets Resulting



         From Contract Transactions (10)
43 
(4,862)
(7,028)
             Increase (Decrease) in Net Assets (2)
41 
(4,465)
(10,112)
 Net Assets at Beginning of Period 106 
65 
41,861 
51,973 
 Net Assets at End of Period $ 104 
$ 106 
$ 37,396 
$ 41,861 
 Changes in Units



      Issued — 

73 
14 
      Redeemed (1)
— 
(209)
(192)
      Net Increase (Decrease) (1)

(136)
(178)










Total All Funds

2023 2022
 Increase (Decrease) in Net Assets:

    Operations:

       Investment Income (Loss), Net $ 25,061 
$ 14,839 
       Realized Gains (Losses) on Investments, Net (34,346)
102,793 
       Net Change in Unrealized Appreciation

         (Depreciation) on Investments 192,783 
(433,174)
                Net Increase (Decrease) in Net Assets From Operations 183,498 
(315,542)
 Contract Transactions-All Products

    Purchase Payments 253,001 
193,690 
    Transfers Between Funds or (to) from General Account (236,983)
(173,029)
    Surrenders and Terminations (204,729)
(165,611)
    Rescissions (735)
(572)
    Bonus (Recapture) 18 
63 
    Contract Maintenance Charge (242)
(250)
    Rider Charge (24,023)
(25,185)
       Net Increase (Decrease) in Net Assets Resulting

         From Contract Transactions (213,693)
(170,894)
             Increase (Decrease) in Net Assets (30,195)
(486,436)
 Net Assets at Beginning of Period 1,621,763 
2,108,199 
 Net Assets at End of Period $ 1,591,568 
$ 1,621,763 
 Changes in Units

      Issued 43,017 
15,477 
      Redeemed (51,573)
(24,643)
      Net Increase (Decrease) (8,556)
(9,166)

See accompanying notes to financial statements
Page 39 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statements of Changes in Net Assets
For the years or periods ended December 31, 2023 and 2022
(In thousands)







(A) Fund terminated in 2023. See Footnote 1 for further details.
(B) Fund terminated in 2022. See Footnote 1 for further details.

The following open/available funds had no activity for the years or periods ended December 31, 2023 and 2022, and therefore, were not listed in the Statements of Changes in Net Assets:






BlackRock Equity Dividend V.I. Fund
Delaware Ivy VIP Asset Strategy Portfolio
Delaware Ivy VIP Energy Portfolio
Delaware Ivy VIP Science and Technology Portfolio
Eaton Vance VT Floating-Rate Income Fund
Franklin Multi-Asset Dynamic Multi-Strategy VIT Portfolio (B)
Invesco V.I. Balanced-Risk Allocation Fund
Lazard Retirement International Equity Portfolio
Lazard Retirement U.S. Small-Mid Cap Equity Portfolio
T. Rowe Price Health Sciences Portfolio










See accompanying notes to financial statements
Page 40 of 59


ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements


(1) Organization
Allianz Life of NY Variable Account C (Variable Account) is a segregated investment account of Allianz Life Insurance Company of New York (Allianz Life of New York) and is registered with the Securities and Exchange Commission as a unit investment trust pursuant to the provisions of the Investment Company Act of 1940 (1940 Act), as amended. Allianz Life of New York applies the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) guidance of Topic 946, Financial Services - Investment Companies. The Variable Account was established by Allianz Life of New York on February 26, 1988, and commenced operations September 6, 1991. Accordingly, it is an accounting entity wherein all segregated account transactions are reflected.

The Variable Account's assets are the property of Allianz Life of New York and are held for the benefit of the owners and other persons entitled to payments under variable annuity contracts issued through the Variable Account and underwritten by Allianz Life of New York. The assets of the Variable Account are equal to the reserves and other liabilities of the Variable Account. These assets are not chargeable with liabilities that arise from any other business Allianz Life of New York may conduct. Allianz Life of New York products offered under the Variable Account are listed below. The only product actively being marketed is Allianz Index Advantage New York.

Allianz Advantage
Allianz Charter II New York
Allianz High Five New York
Allianz Index Advantage New York
Allianz Opportunity
Valuemark II New York
Allianz Valuemark IV New York
Allianz Vision New York
Allianz Retirement Advantage New York
Allianz Retirement Pro New York

The Variable Account's subaccounts are invested, at net asset values, in one or more of the funds (investment options) in accordance with the selection made by the contractholder. The contractholder may have the option to invest in the fixed account or other index options in the General Account, based on the product features. The liabilities of the fixed account are included in the General Account, which is not registered as an investment company under the 1940 Act. Not all funds listed are available for all products. Some funds have been closed to accepting new money. Each multiple-class fund is presented on an aggregate basis, however, when mergers occur, the fund will be presented separately by class, to disclose which class received additional money. The funds and investment advisers are:









Fund
Investment Adviser
AZL Balanced Index Strategy Fund †
Allianz Investment Management, LLC
AZL DFA Multi-Strategy Fund †
Allianz Investment Management, LLC
AZL Enhanced Bond Index Fund *†
Allianz Investment Management, LLC
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 1 †
Allianz Investment Management, LLC
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 2 *†
Allianz Investment Management, LLC
AZL Fidelity Institutional Asset Management Total Bond Fund Class 1 †
Allianz Investment Management, LLC
AZL Fidelity Institutional Asset Management Total Bond Fund Class 2 *†
Allianz Investment Management, LLC
AZL Government Money Market Fund *†
Allianz Investment Management, LLC
AZL International Index Fund Class 1 †
Allianz Investment Management, LLC
AZL International Index Fund Class 2 *†
Allianz Investment Management, LLC
AZL Mid Cap Index Fund Class 1 †
Allianz Investment Management, LLC
AZL Mid Cap Index Fund Class 2 *†
Allianz Investment Management, LLC
AZL Moderate Index Strategy Fund †
Allianz Investment Management, LLC
AZL MSCI Global Equity Index Fund Class 1 †
Allianz Investment Management, LLC
AZL MSCI Global Equity Index Fund Class 2 *†
Allianz Investment Management, LLC
AZL MVP Balanced Index Strategy Fund †
Allianz Investment Management, LLC
AZL MVP DFA Multi-Strategy Fund †
Allianz Investment Management, LLC
AZL MVP Fidelity Institutional Asset Management Multi-Strategy Fund †
Allianz Investment Management, LLC
AZL MVP Global Balanced Index Strategy Fund †
Allianz Investment Management, LLC
Page 41 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements











Fund
Investment Adviser
AZL MVP Growth Index Strategy Fund †
Allianz Investment Management, LLC
AZL MVP Moderate Index Strategy Fund †
Allianz Investment Management, LLC
AZL MVP T. Rowe Price Capital Appreciation Plus Fund †
Allianz Investment Management, LLC
AZL Russell 1000 Growth Index Fund Class 1 †
Allianz Investment Management, LLC
AZL Russell 1000 Growth Index Fund Class 2 *†
Allianz Investment Management, LLC
AZL Russell 1000 Value Index Fund Class 1 †
Allianz Investment Management, LLC
AZL Russell 1000 Value Index Fund Class 2 *†
Allianz Investment Management, LLC
AZL S&P 500 Index Fund *†
Allianz Investment Management, LLC
AZL Small Cap Stock Index Fund Class 1 †
Allianz Investment Management, LLC
AZL Small Cap Stock Index Fund Class 2 *†
Allianz Investment Management, LLC
AZL T. Rowe Price Capital Appreciation Fund *†
Allianz Investment Management, LLC
BlackRock Equity Dividend V.I. Fund *
BlackRock Advisors, LLC
ClearBridge Variable Aggressive Growth Portfolio
Franklin Advisers, Inc.
Columbia Variable Portfolio – Seligman Global Technology Fund
Columbia Management Investment Advisors, LLC
Davis VA Financial Portfolio
Davis Selected Advisers, L.P.
Delaware Ivy VIP Asset Strategy Portfolio *
Macquarie Asset Management
Delaware Ivy VIP Energy Portfolio *
Macquarie Asset Management
Delaware Ivy VIP Growth Portfolio *
Macquarie Asset Management
Delaware Ivy VIP Mid Cap Growth Portfolio *
Macquarie Asset Management
Delaware Ivy VIP Natural Resources Portfolio *
Macquarie Asset Management
Delaware Ivy VIP Science and Technology Portfolio *
Macquarie Asset Management
Eaton Vance VT Floating-Rate Income Fund *
Morgan Stanley Investment Management
Fidelity VIP Emerging Markets Portfolio
Fidelity Management & Research Company
Fidelity VIP Mid Cap Portfolio
Fidelity Management & Research Company
Fidelity VIP Strategic Income Portfolio
Fidelity Management & Research Company
Franklin Rising Dividends VIP Fund *
Franklin Advisers, Inc.
Franklin U.S. Government Securities VIP Fund *
Franklin Advisers, Inc.
Invesco Oppenheimer V.I. International Growth Fund *
Invesco Advisors, Inc.
Invesco V.I. American Value Fund *
Invesco Advisors, Inc.
Invesco V.I. Balanced-Risk Allocation Fund *
Invesco Advisors, Inc.
Invesco V.I. Global Strategic Income Fund
Invesco Advisors, Inc.
Lazard Retirement International Equity Portfolio *
Lazard Asset Management, LLC
Lazard Retirement U.S. Small-Mid Cap Equity Portfolio *
Lazard Asset Management, LLC
LVIP JPMorgan Core Bond Fund *
Lincoln Financial Group
MFS International Intrinsic Value Portfolio *
Massachusetts Financial Services Company
MFS VIT Total Return Bond Portfolio *
Massachusetts Financial Services Company
MFS VIT Utilities Portfolio *
Massachusetts Financial Services Company
PIMCO VIT Balanced Allocation Portfolio †
Pacific Investment Management Company, LLC
PIMCO VIT CommodityRealReturn Strategy Portfolio †
Pacific Investment Management Company, LLC
PIMCO VIT Emerging Markets Bond Portfolio †
Pacific Investment Management Company, LLC
PIMCO VIT Global Core Bond (Hedged) Portfolio †
Pacific Investment Management Company, LLC
PIMCO VIT High Yield Portfolio †
Pacific Investment Management Company, LLC
Page 42 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements











Fund
Investment Adviser
PIMCO VIT Long-Term U.S. Government Portfolio †
Pacific Investment Management Company, LLC
PIMCO VIT Low Duration Portfolio †
Pacific Investment Management Company, LLC
PIMCO VIT Real Return Portfolio †
Pacific Investment Management Company, LLC
PIMCO VIT StocksPLUS Global Portfolio †
Pacific Investment Management Company, LLC
PIMCO VIT Total Return Portfolio †
Pacific Investment Management Company, LLC
T. Rowe Price Blue Chip Growth Portfolio *
T. Rowe Price Associates, Inc.
T. Rowe Price Equity Income Portfolio *
T. Rowe Price Associates, Inc.
T. Rowe Price Health Sciences Portfolio *
T. Rowe Price Associates, Inc.
Templeton Global Bond VIP Fund *
Franklin Advisers, Inc.
* Fund contains share classes which assess 12b-1 fees.
† The investment adviser of this fund is an affiliate of Allianz Life of New York and is paid an investment management fee by the fund.

During the years ended December 31, 2022 and 2023, there were no name changes.
During the years ended December 31, 2022 and 2023, the following funds were closed to new money:









Fund
Date Closed
Franklin Multi-Asset Dynamic Multi-Strategy VIT Portfolio
June 10, 2022
AZL DFA Five-Year Global Fixed Income Fund
March 10, 2023
AZL Gateway Fund
March 10, 2023
AZL MetWest Total Return Bond Fund
March 10, 2023
AZL MSCI Emerging Markets Equity Index Fund Class 1
March 10, 2023
AZL MSCI Emerging Markets Equity Index Fund Class 2
March 10, 2023
AZL MVP Fusion Balanced Fund
March 10, 2023
AZL MVP Fusion Conservative Fund
March 10, 2023
AZL MVP Fusion Moderate Fund
March 10, 2023
JPMorgan Insurance Trust Core Bond Portfolio
April 28, 2023

During the year ended December 31, 2023, the following fund was added as an available option. No new funds were added in 2022.









Fund
Date Opened
LVIP JPMorgan Core Bond Fund
April 28, 2023
During the years ended December 31, 2022 and 2023, the following funds were merged or replaced:















Closed Fund
Receiving Fund
Date Merged
Franklin Multi-Asset Dynamic Multi-Strategy VIT Portfolio
AZL MVP Fusion Moderate Fund
June 10, 2022
AZL DFA Five-Year Global Fixed Income Fund
AZL Enhanced Bond Index Fund
March 10, 2023
AZL Gateway Fund
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 2
March 10, 2023
AZL MetWest Total Return Bond Fund
AZL Fidelity Institutional Asset Management Total Bond Fund Class 2
March 10, 2023
Page 43 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements

















Closed Fund
Receiving Fund
Date Merged
AZL MSCI Emerging Markets Equity Index Fund Class 1
AZL International Index Fund Class 1
March 10, 2023
AZL MSCI Emerging Markets Equity Index Fund Class 2
AZL International Index Fund Class 2
March 10, 2023
AZL MVP Fusion Balanced Fund
AZL MVP Balanced Index Strategy Fund
March 10, 2023
AZL MVP Fusion Conservative Fund
AZL MVP Fidelity Institutional Asset Management Multi-Strategy Fund
March 10, 2023
AZL MVP Fusion Moderate Fund
AZL MVP DFA Multi-Strategy Fund
March 10, 2023
JPMorgan Insurance Trust Core Bond Portfolio
LVIP JPMorgan Core Bond Fund
April 28, 2023
Effective December 8, 2023, a 13:1 reverse split occurred for the AZL Mid Cap Index Fund Class 1. The effect of this transaction was to divide the number of outstanding shares of the fund by the split ratio, resulting in a corresponding increase in the net asset value per share. The shares presented in the Statements of Assets and Liabilities reflect this reverse split. There were no changes in the net assets, results of operations or total return as a result of this transaction.
Page 44 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements


(2) Significant Accounting Policies
Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Investments

Investment transactions are recorded by the Variable Account on the trade date. Investments of the Variable Account are valued each day the markets are open at fair value using net asset values provided by the investment advisers of the funds after the 4 PM Eastern Standard Time market close.

The Fair Value Measurement Topic of the FASB ASC establishes a fair value hierarchy that prioritizes the inputs used in the valuation techniques to measure fair value.

Level 1 -     Unadjusted quoted prices for identical assets or liabilities in active markets that the Variable Account has the ability to access at the measurement date.

Level 2 –     Valuations derived from techniques that utilize observable inputs, other than quoted prices included in Level 1, which are observable for the asset or liability either directly or indirectly, such as:

(a)    Quoted prices for similar assets or liabilities in active markets.
(b)    Quoted prices for identical or similar assets or liabilities in markets that are not active.
(c)    Inputs other than quoted prices that are observable.
(d)    Inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 -    Valuations derived from techniques in which the significant inputs are unobservable. Level 3 fair values reflect the Variable Account’s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. As of December 31, 2023, all of the Variable Account’s investments are in funds for which quoted prices are available in an active market which the Variable Account has the ability to access. Therefore, all investments have been categorized as Level 1. The characterization of the underlying securities held by the funds are accounted for on a trade-date basis and are in accordance with the Fair Value Measurements and Disclosures topic of the FASB ASC.

Realized gains on investments include realized gain distributions received from the respective funds and gains on the sale of fund shares as determined by the average cost method. Realized gain distributions are reinvested in the respective funds. Dividend distributions received from the funds are reinvested in additional shares of the funds and are recorded as income to the Variable Account on the ex-dividend date.

The cost of investments sold and the corresponding capital gains and losses are determined on a specific identification basis. Net investment income (loss) and net realized gains (losses) and unrealized appreciation (depreciation) on investments are allocated to the contracts on each valuation date based on each contract's pro rata share of the assets of the fund as of the beginning of the valuation date.

Transfers between subaccounts, including the fixed account (net), include transfers of all or part of the contractholders' interest to or from another eligible subaccount, or from or to the fixed account option of the general account of Allianz Life of New York.

Contracts in Annuity Payment Period

Net assets allocated to contracts in the payout period are periodically compared to annuity reserves computed for currently payable contracts according to the 1983 and 2000 Individual Annuity Mortality Tables using an assumed investment return (AIR) equal to the AIR of the specific contracts, either 3%, 4.5% or 5%. The mortality risk is fully borne by Allianz Life of New York and may result in additional amounts reimbursed to Allianz Life of New York if the reserves required are less than originally estimated. If additional reserves are required, Allianz Life of New York reimburses the Variable Account.
Page 45 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements


(3) Related Party Charges, Expenses and Fees
Under the terms of the contracts, certain charges, expenses and fees are incurred by the contractholders to cover Allianz Life of New York's expenses in connection with the issuance and administration of the contracts. Following is a summary of these charges, expenses and fees for the period ended December 31, 2023:

Mortality and Expense Risk Charges
Allianz Life of New York assumes mortality and expense risks related to the operations of the Variable Account. These charges range from 0.35% to 3.55% annually during the accumulation phase, or from 1.25% to 1.90% annually during the annuity phase for variable annuity payments. These charges are deducted on a daily basis and assessed against the daily net asset value of each fund. These charges are assessed either through a reduction in subaccount accumulation unit values during the accumulation phase, or a reduction in subaccount annuity unit values during the annuity phase for contractholders that selected variable annuity payments.

Administrative Charges
A charge to cover administrative expenses of the Variable Account may be deducted from the Variable Account, depending on the contract. This annual charge of 0.15% is calculated and assessed daily as a percentage of each fund’s net asset value. This charge is assessed through a reduction in subaccount accumulation unit values during the accumulation phase, or a reduction in subaccount annuity unit values during the annuity phase for contractholders that selected variable annuity payments.

Contract Maintenance Charges
For certain contracts, an annual contract maintenance charge of $30 to $50 may be deducted to cover ongoing administrative expenses. These charges are assessed through the redemption of subaccount accumulation units during the accumulation phase, or a redemption in subaccount annuity unit values during the annuity phase if variable annuity payments are selected or a reduction in fixed annuity payments.

Withdrawal Charges
For certain contracts, a withdrawal charge (sometimes called a contingent deferred sales charge) is imposed as a percentage, with a range of 1.0% to 8.5%, of each purchase payment if the contract is surrendered or a partial withdrawal is taken during the withdrawal charge period. For certain contracts, a withdrawal charge may also apply during the annuity phase if there are liquidations of variable annuity payments under certain annuity options. These withdrawal charges are imposed as a percentage, with a range of 2.0% to 6.0% of the amount liquidated. These charges are assessed through the redemption of subaccount accumulation units during the accumulation phase, or a redemption in subaccount annuity units during the annuity phase.

Rider Charges
For certain contracts, optional benefit riders may be available for an additional charge to the contractholder. The rider charges for Investment Protector, Income Protector and Income Focus are deducted from the contract value.

Investment Protector: 1.05% to 1.30%
Income Protector: 1.00% to 1.70%
Income Focus: 1.30%

Transfer Fee
A charge for transfers between funds may be imposed at a rate of up to $25 per transfer. These charges are deducted from the contract value.

Other Contract Charges
For certain contracts there are additional fees, as described below.
Account Fee - ranges from 0.85% to 1.05% and are imposed as a percentage of the account’s guaranteed value and are assessed through the redemption of subaccount accumulation units during the accumulation phase.
Product Fee - is 1.25% annually and is accrued on a daily basis as a percentage of the prior quarterly contract anniversary contract value adjusted for subsequent purchase payments and withdrawals. The fee is deducted from the contract value during the accumulation phase through the redemption of accumulation units.

Additional details on charges and fees can be found in the respective product prospectus.
Page 46 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements


(4) Federal Income Taxes
Operations of the Variable Account form a part of Allianz Life of New York, which is taxed as a life insurance company under the Internal Revenue Code (the Code). Under current law, no federal income taxes are payable with respect to the Variable Account. Under the principles set forth in Internal Revenue Service Ruling 81-225 and Section 817(h) of the Code and regulations thereunder, Allianz Life of New York understands that it will be treated as owner of the assets invested in the Variable Account for federal income tax purposes, with the result that earnings and gains, if any, derived from those assets will not be included in an annuitant's gross income until amounts are received pursuant to an annuity.

(5) Purchases and Sales of Investments (In thousands)
The cost of purchases and proceeds from sales of investments for the year or period ended December 31, 2023, are as follows:













 Cost of Purchases
 Proceeds from Sales
AZL Balanced Index Strategy Fund $ 2,858 

$ 3,761 
AZL DFA Five-Year Global Fixed Income Fund 173 

1,034 
AZL DFA Multi-Strategy Fund 8,176 

8,875 
AZL Enhanced Bond Index Fund 1,431 

842 
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 1 184 

827 
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 2 10,454 

20,627 
AZL Fidelity Institutional Asset Management Total Bond Fund Class 1 71 

366 
AZL Fidelity Institutional Asset Management Total Bond Fund Class 2 4,723 

3,123 
AZL Gateway Fund 3,698 

6,857 
AZL Government Money Market Fund 175,735 

180,004 
AZL International Index Fund Class 1 633 

521 
AZL International Index Fund Class 2 3,976 

3,597 
AZL MetWest Total Return Bond Fund 99 

2,465 
AZL Mid Cap Index Fund Class 1 765 

264 
AZL Mid Cap Index Fund Class 2 1,649 

5,075 
AZL Moderate Index Strategy Fund 9,605 

15,877 
AZL MSCI Emerging Markets Equity Index Class 1 115 

425 
AZL MSCI Emerging Markets Equity Index Class 2 805 

3,050 
AZL MSCI Global Equity Index Fund Class 1 55 

420 
AZL MSCI Global Equity Index Fund Class 2 353 

1,252 
AZL MVP Balanced Index Strategy Fund 57,424 

14,571 
AZL MVP DFA Multi-Strategy Fund 142,081 

16,600 
AZL MVP Fidelity Institutional Asset Management Multi-Strategy Fund 16,049 

6,947 
AZL MVP Fusion Balanced Fund 5,245 

55,612 
AZL MVP Fusion Conservative Fund 1,230 

14,391 
AZL MVP Fusion Moderate Fund 15,687 

145,614 
AZL MVP Global Balanced Index Strategy Fund 2,888 

9,509 
AZL MVP Growth Index Strategy Fund 14,701 

36,375 
AZL MVP Moderate Index Strategy Fund 2,097 

7,879 
AZL MVP T. Rowe Price Capital Appreciation Plus Fund 17,801 

25,002 
AZL Russell 1000 Growth Index Fund Class 1 504 

470 
AZL Russell 1000 Growth Index Fund Class 2 1,885 

5,808 
Page 47 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements















 Cost of Purchases
 Proceeds from Sales
AZL Russell 1000 Value Index Fund Class 1 $ 1,644 

$ 1,610 
AZL Russell 1000 Value Index Fund Class 2 2,294 

4,452 
AZL S&P 500 Index Fund 2,469 

9,631 
AZL Small Cap Stock Index Fund Class 1 51 

216 
AZL Small Cap Stock Index Fund Class 2 1,588 

2,383 
AZL T. Rowe Price Capital Appreciation Fund 3,896 

4,912 
BlackRock Equity Dividend V.I. Fund — 

— 
ClearBridge Variable Aggressive Growth Portfolio

— 
Columbia Variable Portfolio – Seligman Global Technology Fund


Davis VA Financial Portfolio 92 

111 
Delaware Ivy VIP Asset Strategy Portfolio — 

— 
Delaware Ivy VIP Energy Portfolio — 

— 
Delaware Ivy VIP Growth Portfolio

— 
Delaware Ivy VIP Mid Cap Growth Portfolio

— 
Delaware Ivy VIP Natural Resources Portfolio — 


Delaware Ivy VIP Science and Technology Portfolio — 

— 
Eaton Vance VT Floating-Rate Income Fund — 

— 
Fidelity VIP Emerging Markets Portfolio — 

— 
Fidelity VIP Mid Cap Portfolio

— 
Fidelity VIP Strategic Income Portfolio 21 

— 
Franklin Rising Dividends VIP Fund 1,778 

2,237 
Franklin U.S. Government Securities VIP Fund 1,424 

2,839 
Invesco Oppenheimer V.I. International Growth Fund — 

— 
Invesco V.I. American Value Fund


Invesco V.I. Balanced-Risk Allocation Fund — 

— 
Invesco V.I. Global Strategic Income Fund — 

11 
JPMorgan Insurance Trust Core Bond Portfolio 36 

1,944 
Lazard Retirement International Equity Portfolio — 

— 
Lazard Retirement U.S. Small-Mid Cap Equity Portfolio — 

— 
LVIP JPMorgan Core Bond Fund 1,782 

320 
MFS International Intrinsic Value Portfolio


MFS VIT Total Return Bond Portfolio 539 

1,224 
MFS VIT Utilities Portfolio

— 
PIMCO VIT Balanced Allocation Portfolio 753 

3,185 
PIMCO VIT CommodityRealReturn Strategy Portfolio 419 

291 
PIMCO VIT Emerging Markets Bond Portfolio 397 

717 
PIMCO VIT Global Core Bond (Hedged) Portfolio 997 

1,973 
PIMCO VIT High Yield Portfolio 5,725 

14,925 
PIMCO VIT Long-Term U.S. Government Portfolio 71 

27 
PIMCO VIT Low Duration Portfolio


PIMCO VIT Real Return Portfolio 2,251 

5,478 
Page 48 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements















 Cost of Purchases
 Proceeds from Sales
PIMCO VIT StocksPLUS Global Portfolio $ 361 

$ 1,162 
PIMCO VIT Total Return Portfolio 6,922 

15,960 
T. Rowe Price Blue Chip Growth Portfolio — 


T. Rowe Price Equity Income Portfolio

11 
T. Rowe Price Health Sciences Portfolio — 

— 
Templeton Global Bond VIP Fund 2,507 

7,991 


Page 49 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements


(6) Financial Highlights
A summary of units outstanding (in thousands), unit values, net assets (in thousands), ratios, and total returns for variable annuity contracts is as follows:











































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
AZL Balanced Index Strategy Fund







2023 1,248 
$ 15.36 
to $ 19.57 
$ 23,130 

1.81  % 1.15  % to 3.55  % 9.44  % to 11.65  %
2022 1,380 
$ 13.90 
to $ 17.53 
$ 22,982 

2.28  % 1.15  % to 3.55  % (17.93) % to (16.27) %
2021 1,458 
$ 16.89 
to $ 20.93 
$ 29,132 

1.78  % 1.15  % to 3.55  % 6.36  % to 8.52  %
2020 1,549 
$ 15.84 
to $ 19.60 
$ 28,639 

1.99  % 1.15  % to 3.55  % 8.48  % to 10.85  %
2019 1,585 
$ 14.57 
to $ 17.68 
$ 26,578 

2.24  % 1.15  % to 3.55  % 13.32  % to 15.78  %
AZL DFA Multi-Strategy Fund







2023 2,923 
$ 17.76 
to $ 23.76 
$ 65,648 

2.84  % 1.15  % to 3.55  % 9.45  % to 11.82  %
2022 3,269 
$ 16.21 
to $ 21.25 
$ 65,986 

1.12  % 1.15  % to 3.55  % (14.37) % to (12.51) %
2021 3,672 
$ 18.91 
to $ 24.29 
$ 85,039 

1.53  % 1.15  % to 3.55  % 10.01  % to 12.40  %
2020 4,248 
$ 17.17 
to $ 21.61 
$ 87,949 

3.12  % 1.15  % to 3.55  % 6.93  % to 9.26  %
2019 4,765 
$ 16.04 
to $ 19.77 
$ 90,599 

1.06  % 1.15  % to 3.55  % 12.68  % to 15.13  %
AZL Enhanced Bond Index Fund







2023 470 
$ 8.94 
to $ 10.99 
$ 5,022 

1.69  % —  % to 3.55  % 3.10  % to 4.94  %
2022 414 
$ 9.38 
to $ 10.46 
$ 4,262 

1.51  % 1.15  % to 2.20  % (15.56) % to (14.87) %
2021 407 
$ 11.11 
to $ 12.29 
$ 4,927 

0.77  % 1.15  % to 2.20  % (4.08) % to (3.30) %
2020 411 
$ 11.58 
to $ 12.71 
$ 5,142 

2.34  % 1.15  % to 2.20  % 5.19  % to 6.05  %
2019 409 
$ 11.01 
to $ 11.98 
$ 4,837 

2.60  % 1.15  % to 2.20  % 6.02  % to 6.88  %
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 1




2023 525 
$ 9.98 
to $ 10.01 
$ 5,290 

2.95  % 1.40  % to 1.49  % 12.55  % to 12.66  %
2022 600 
$ 8.87 
to $ 8.88 
$ 5,374 

1.45  % 1.40  % to 1.49  % (15.66) % to (15.58) %
2021¹ 675 
$ 10.52 
to $ 10.52 
$ 7,168 

0.80  % 1.40  % to 1.49  % 5.18  % to 5.23  %
AZL Fidelity Institutional Asset Management Multi-Strategy Fund Class 2





2023 6,159 
$ 15.20 
to $ 24.00 
$ 118,803 

1.60  % —  % to 3.55  % 10.07  % to 13.47  %
2022 6,711 
$ 13.80 
to $ 21.76 
$ 115,499 

0.94  % 0.35  % to 3.55  % (17.53) % to (14.86) %
2021 7,354 
$ 16.69 
to $ 26.30 
$ 150,623 

0.83  % 0.35  % to 3.55  % 4.27  % to 11.26  %
2020 1,369 
$ 15.45 
to $ 24.32 
$ 25,460 

2.48  % 0.35  % to 3.55  % 9.67  % to 13.07  %
2019 1,518 
$ 14.07 
to $ 22.13 
$ 25,311 

2.37  % 0.35  % to 3.55  % 13.35  % to 16.86  %
AZL Fidelity Institutional Asset Management Total Bond Fund Class 1





2023 97 
$ 10.23 
to $ 10.30 
$ 1,004 

6.20  % 1.40  % to 1.49  % 5.34  % to 5.44  %
2022 133 
$ 9.71 
to $ 9.77 
$ 1,295 

2.91  % 1.40  % to 1.49  % (14.48) % to (14.40) %
2021 143 
$ 11.35 
to $ 11.41 
$ 1,635 

2.84  % 1.40  % to 1.49  % (0.89) % to (0.81) %
2020 151 
$ 11.46 
to $ 11.50 
$ 1,739 

3.67  % 1.40  % to 1.49  % 7.50  % to 7.60  %
2019 175 
$ 10.66 
to $ 10.69 
$ 1,878 

3.35  % 1.40  % to 1.49  % 8.93  % to 9.03  %
AZL Fidelity Institutional Asset Management Total Bond Fund Class 2





2023 1,593 
$ 8.31 
to $ 12.43 
$ 16,392 

6.05  % —  % to 3.55  % 2.97  % to 6.68  %
2022 1,511 
$ 8.07 
to $ 11.65 
$ 14,776 

2.45  % —  % to 3.55  % (16.38) % to (13.37) %
2021 1,683 
$ 9.65 
to $ 13.45 
$ 19,373 

2.55  % —  % to 3.55  % (3.19) % to 0.31  %
2020 1,655 
$ 9.97 
to $ 13.41 
$ 19,319 

3.13  % —  % to 3.55  % 5.04  % to 8.84  %
Page 50 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements













































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
2019 1,876 
$ 9.49 
to $ 12.01 
$ 20,470 

3.00  % —  % to 3.55  % 6.43  % to 9.89  %
AZL Government Money Market Fund





2023 4,517 
$ 5.88 
to $ 13.76 
$ 44,998 

4.18  % —  % to 3.55  % 0.65  % to 4.27  %
2022 4,517 
$ 5.84 
to $ 13.20 
$ 49,267 

0.79  % —  % to 3.55  % (2.74) % to 0.77  %
2021 4,258 
$ 6.21 
to $ 13.10 
$ 46,026 

—  % —  % to 3.55  % (3.34) % to —  %
2020 4,388 
$ 6.23 
to $ 13.10 
$ 45,883 

0.16  % —  % to 3.55  % (3.30) % to 0.21  %
2019 3,184 
$ 6.95 
to $ 13.07 
$ 32,267 

1.38  % —  % to 3.55  % (1.70) % to 1.39  %
AZL International Index Fund Class 1







2023 355 
$ 13.03 
to $ 14.36 
$ 5,079 

4.21  % 1.40  % to 2.75  % 14.37  % to 15.92  %
2022 355 
$ 11.39 
to $ 12.39 
$ 4,392 

4.60  % 1.40  % to 2.75  % (16.57) % to (15.44) %
2021 376 
$ 13.66 
to $ 14.65 
$ 5,506 

2.54  % 1.40  % to 2.75  % 7.79  % to 9.26  %
2020 403 
$ 12.67 
to $ 13.41 
$ 5,410 

5.07  % 1.40  % to 2.75  % 4.74  % to 6.16  %
2019 438 
$ 12.09 
to $ 12.63 
$ 5,550 

3.69  % 1.40  % to 2.75  % 18.37  % to 19.98  %
AZL International Index Fund Class 2







2023 1,138 
$ 11.81 
to $ 24.37 
$ 15,448 

2.46  % —  % to 3.55  % 13.25  % to 16.93  %
2022 1,090 
$ 10.40 
to $ 20.84 
$ 13,047 

2.65  % —  % to 3.55  % (17.49) % to (14.82) %
2021 1,322 
$ 12.57 
to $ 24.47 
$ 19,119 

1.46  % —  % to 3.55  % 6.69  % to 10.16  %
2020 1,579 
$ 11.76 
to $ 22.21 
$ 21,214 

3.11  % —  % to 3.55  % 3.65  % to 7.03  %
2019 1,801 
$ 11.31 
to $ 20.75 
$ 23,105 

2.26  % —  % to 3.55  % 17.21  % to 21.02  %
AZL Mid Cap Index Fund Class 1







2023 118 
$ 18.19 
to $ 18.31 
$ 2,186 

8.51  % 1.40  % to 1.49  % 14.45  % to 14.55  %
2022 132 
$ 15.89 
to $ 15.98 
$ 2,127 

3.23  % 1.40  % to 1.49  % (14.62) % to (14.54) %
2021 149 
$ 18.61 
to $ 18.70 
$ 2,804 

2.59  % 1.40  % to 1.49  % 22.19  % to 22.30  %
2020 167 
$ 15.23 
to $ 15.29 
$ 2,577 

3.98  % 1.40  % to 1.49  % 13.12  % to 13.22  %
2019 176 
$ 13.47 
to $ 13.51 
$ 2,401 

3.09  % 1.40  % to 1.49  % 23.62  % to 23.73  %
AZL Mid Cap Index Fund Class 2







2023 485 
$ 24.67 
to $ 54.63 
$ 14,165 

0.70  % —  % to 3.55  % 11.85  % to 15.48  %
2022 617 
$ 21.97 
to $ 47.30 
$ 16,019 

0.68  % —  % to 3.55  % (16.56) % to (13.85) %
2021 758 
$ 26.23 
to $ 54.91 
$ 23,389 

0.68  % —  % to 3.55  % 19.35  % to 23.23  %
2020 978 
$ 21.89 
to $ 44.56 
$ 25,166 

1.15  % —  % to 3.55  % 10.52  % to 14.13  %
2019 1,171 
$ 19.72 
to $ 39.04 
$ 26,961 

1.02  % —  % to 3.55  % 20.91  % to 24.84  %
AZL Moderate Index Strategy Fund







2023 3,581 
$ 18.26 
to $ 32.63 
$ 88,662 

1.91  % —  % to 3.55  % 10.99  % to 14.42  %
2022 4,135 
$ 16.44 
to $ 28.52 
$ 90,713 

2.19  % —  % to 3.55  % (18.19) % to (15.67) %
2021 4,591 
$ 20.07 
to $ 33.81 
$ 121,206 

0.88  % —  % to 3.55  % 8.31  % to 11.67  %
2020 1,447 
$ 18.51 
to $ 30.28 
$ 34,602 

1.99  % 0.35  % to 3.55  % 9.06  % to 12.44  %
2019 1,579 
$ 16.96 
to $ 26.93 
$ 34,102 

2.37  % 0.35  % to 3.55  % 15.34  % to 18.91  %
AZL MSCI Global Equity Index Fund Class 1







2023 173 
$ 10.73 
to $ 10.75 
$ 1,864 

2.62  % 1.40  % to 1.49  % 21.84  % to 21.95  %
2022 214 
$ 8.81 
to $ 8.82 
$ 1,883 

1.74  % 1.40  % to 1.49  % (19.29) % to (19.22) %
2021¹ 246 
$ 10.91 
to $ 10.92 
$ 2,690 

1.20  % 1.40  % to 1.49  % 9.12  % to 9.17  %
AZL MSCI Global Equity Index Fund Class 2







2023 185 
$ 17.93 
to $ 28.25 
$ 3,943 

1.24  % 0.35  % to 3.55  % 19.26  % to 22.94  %
2022 228 
$ 14.73 
to $ 22.98 
$ 4,058 

1.07  % 0.35  % to 3.55  % (21.08) % to (18.52) %
Page 51 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements













































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
2021 274 
$ 18.67 
to $ 28.20 
$ 6,101 

1.31  % 0.35  % to 3.55  % 6.16  % to 20.76  %
2020 16 
$ 18.72 
to $ 23.35 
$ 324 

0.72  % 0.35  % to 2.20  % 12.87  % to 14.95  %
2019 27 
$ 16.59 
to $ 20.31 
$ 495 

1.61  % 0.35  % to 2.20  % 24.52  % to 26.81  %
AZL MVP Balanced Index Strategy Fund







2023 5,202 
$ 12.79 
to $ 19.22 
$ 82,872 

0.61  % —  % to 3.55  % 9.09  % to 12.85  %
2022 2,193 
$ 12.18 
to $ 17.03 
$ 32,062 

2.15  % —  % to 3.55  % (17.42) % to (14.87) %
2021 2,475 
$ 14.75 
to $ 20.00 
$ 43,028 

1.75  % —  % to 3.55  % 6.72  % to 10.02  %
2020 2,636 
$ 14.39 
to $ 18.18 
$ 42,195 

1.99  % —  % to 3.55  % 3.25  % to 5.98  %
2019 2,773 
$ 13.94 
to $ 17.15 
$ 42,359 

2.07  % —  % to 3.55  % 13.92  % to 16.92  %
AZL MVP DFA Multi-Strategy Fund







2023 11,465 
$ 11.45 
to $ 13.58 
$ 149,649 

0.19  % 0.35  % to 3.55  % 10.79  % to 12.13  %
2022 684 
$ 11.14 
to $ 11.85 
$ 8,031 

0.97  % 1.15  % to 2.20  % (13.67) % to (12.97) %
2021 744 
$ 12.90 
to $ 13.62 
$ 10,052 

1.25  % 1.15  % to 2.20  % 11.27  % to 12.17  %
2020 791 
$ 11.60 
to $ 12.14 
$ 9,557 

3.01  % 1.15  % to 2.20  % 1.51  % to 2.34  %
2019 824 
$ 11.42 
to $ 11.86 
$ 9,738 

0.97  % 1.15  % to 2.20  % 13.29  % to 14.21  %
AZL MVP Fidelity Institutional Asset Management Multi-Strategy Fund







2023 2,507 
$ 9.77 
to $ 15.10 
$ 37,088 

1.58  % 0.35  % to 3.55  % 10.18  % to 11.38  %
2022 1,810 
$ 12.47 
to $ 13.59 
$ 24,250 

0.69  % 1.15  % to 2.20  % (15.68) % to (15.00) %
2021 2,029 
$ 14.79 
to $ 15.99 
$ 32,008 

2.49  % 1.15  % to 2.20  % 8.66  % to 9.54  %
2020 2,295 
$ 13.61 
to $ 14.60 
$ 33,097 

2.74  % 1.15  % to 2.20  % 4.83  % to 5.68  %
2019 2,473 
$ 12.98 
to $ 13.81 
$ 33,814 

3.99  % 1.15  % to 2.20  % 13.72  % to 14.64  %
AZL MVP Global Balanced Index Strategy Fund







2023 4,452 
$ 13.20 
to $ 14.54 
$ 63,849 

3.99  % 1.15  % to 2.20  % 11.38  % to 12.28  %
2022 5,060 
$ 11.85 
to $ 12.95 
$ 64,732 

2.87  % 1.15  % to 2.20  % (17.92) % to (17.25) %
2021 5,525 
$ 14.44 
to $ 15.65 
$ 85,510 

1.47  % 1.15  % to 2.20  % 5.70  % to 6.56  %
2020 6,071 
$ 13.66 
to $ 14.69 
$ 88,279 

9.17  % 1.15  % to 2.20  % 5.45  % to 6.31  %
2019 6,816 
$ 12.95 
to $ 13.82 
$ 93,339 

1.72  % 1.15  % to 2.20  % 13.67  % to 14.59  %
AZL MVP Growth Index Strategy Fund







2023 14,248 
$ 15.63 
to $ 23.91 
$ 283,305 

1.97  % —  % to 3.55  % 12.75  % to 16.81  %
2022 15,769 
$ 13.86 
to $ 20.47 
$ 272,658 

1.72  % —  % to 3.55  % (18.05) % to (15.10) %
2021 16,939 
$ 16.92 
to $ 24.11 
$ 350,178 

1.72  % —  % to 3.55  % 12.34  % to 16.40  %
2020 18,004 
$ 15.06 
to $ 20.71 
$ 324,506 

1.88  % —  % to 3.55  % 1.07  % to 4.73  %
2019 18,956 
$ 14.90 
to $ 19.78 
$ 330,885 

2.26  % —  % to 3.55  % 16.32  % to 20.52  %
AZL MVP Moderate Index Strategy Fund







2023 2,741 
$ 16.94 
to $ 18.66 
$ 50,205 

1.92  % 1.15  % to 2.20  % 12.10  % to 13.01  %
2022 3,127 
$ 15.11 
to $ 16.51 
$ 50,798 

1.98  % 1.15  % to 2.20  % (17.22) % to (16.55) %
2021 3,348 
$ 18.25 
to $ 19.79 
$ 65,293 

1.80  % 1.15  % to 2.20  % 10.01  % to 10.91  %
2020 3,762 
$ 16.59 
to $ 17.84 
$ 66,231 

1.92  % 1.15  % to 2.20  % 4.12  % to 4.97  %
2019 3,679 
$ 15.93 
to $ 17.00 
$ 61,833 

2.12  % 1.15  % to 2.20  % 16.06  % to 17.00  %
AZL MVP T. Rowe Price Capital Appreciation Plus Fund







2023 8,611 
$ 17.47 
to $ 18.94 
$ 160,903 

7.98  % 1.15  % to 2.20  % 14.81  % to 15.74  %
2022 9,610 
$ 15.21 
to $ 16.36 
$ 155,416 

7.35  % 1.15  % to 2.20  % (15.58) % to (14.90) %
Page 52 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements













































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
2021 10,359 
$ 18.02 
to $ 19.22 
$ 197,069 

3.51  % 1.15  % to 2.20  % 14.49  % to 15.42  %
2020 10,944 
$ 15.74 
to $ 16.66 
$ 180,567 

2.83  % 1.15  % to 2.20  % 5.66  % to 6.53  %
2019 11,175 
$ 14.90 
to $ 15.64 
$ 173,290 

1.89  % 1.15  % to 2.20  % 18.75  % to 19.71  %
AZL Russell 1000 Growth Index Fund Class 1







2023 137 
$ 28.30 
to $ 28.48 
$ 3,928 

1.44  % 1.40  % to 1.49  % 40.94  % to 41.07  %
2022 154 
$ 20.08 
to $ 20.19 
$ 3,113 

0.61  % 1.40  % to 1.49  % (30.49) % to (30.43) %
2021 174 
$ 28.89 
to $ 29.02 
$ 5,082 

0.70  % 1.40  % to 1.49  % 25.26  % to 25.37  %
2020 185 
$ 23.06 
to $ 23.15 
$ 4,288 

1.17  % 1.40  % to 1.49  % 36.97  % to 37.10  %
2019 194 
$ 16.84 
to $ 16.89 
$ 3,289 

1.37  % 1.40  % to 1.49  % 33.53  % to 33.65  %
AZL Russell 1000 Growth Index Fund Class 2







2023 381 
$ 36.45 
to $ 60.85 
$ 17,366 

0.36  % —  % to 3.55  % 37.73  % to 42.20  %
2022 498 
$ 26.47 
to $ 42.80 
$ 16,409 

0.06  % —  % to 3.55  % (32.04) % to (29.84) %
2021 575 
$ 38.95 
to $ 61.00 
$ 27,769 

0.25  % —  % to 3.55  % 22.45  % to 26.43  %
2020 714 
$ 31.81 
to $ 48.25 
$ 27,959 

0.54  % —  % to 3.55  % 33.74  % to 38.10  %
2019 936 
$ 23.78 
to $ 34.94 
$ 27,265 

0.74  % —  % to 3.55  % 30.56  % to 34.81  %
AZL Russell 1000 Value Index Fund Class 1







2023 833 
$ 15.17 
to $ 16.72 
$ 14,032 

3.62  % 1.40  % to 2.75  % 8.67  % to 10.14  %
2022 919 
$ 13.96 
to $ 15.18 
$ 14,049 

2.11  % 1.40  % to 2.75  % (10.37) % to (9.16) %
2021 1,009 
$ 15.58 
to $ 16.71 
$ 16,976 

2.06  % 1.40  % to 2.75  % 21.17  % to 22.82  %
2020 866 
$ 12.85 
to $ 13.61 
$ 11,950 

3.08  % 1.40  % to 2.75  % (0.53) % to 0.83  %
2019 935 
$ 12.92 
to $ 13.50 
$ 12,802 

2.88  % 1.40  % to 2.75  % 22.71  % to 24.37  %
AZL Russell 1000 Value Index Fund Class 2







2023 701 
$ 20.10 
to $ 32.24 
$ 16,914 

1.98  % —  % to 3.55  % 7.95  % to 11.17  %
2022 826 
$ 17.95 
to $ 29.00 
$ 18,457 

1.20  % —  % to 3.55  % (11.37) % to (8.50) %
2021 1,011 
$ 20.25 
to $ 31.69 
$ 25,384 

1.42  % —  % to 3.55  % 19.92  % to 23.82  %
2020 742 
$ 17.55 
to $ 25.60 
$ 15,543 

1.98  % —  % to 3.55  % (1.26) % to 1.65  %
2019 847 
$ 17.77 
to $ 25.18 
$ 17,797 

1.93  % —  % to 3.55  % 21.84  % to 25.42  %
AZL S&P 500 Index Fund







2023 1,002 
$ 23.59 
to $ 41.32 
$ 28,593 

1.18  % —  % to 3.55  % 21.31  % to 25.24  %
2022 1,301 
$ 19.40 
to $ 33.00 
$ 30,433 

1.03  % —  % to 3.55  % (21.34) % to (18.79) %
2021 1,505 
$ 24.60 
to $ 40.63 
$ 44,338 

0.99  % —  % to 3.55  % 23.65  % to 27.67  %
2020 1,930 
$ 19.85 
to $ 31.83 
$ 45,615 

1.62  % —  % to 3.55  % 13.39  % to 17.09  %
2019 2,187 
$ 17.46 
to $ 27.18 
$ 45,078 

1.48  % 0.35  % to 3.55  % 26.32  % to 30.43  %
AZL Small Cap Stock Index Fund Class 1







2023 26 
$ 15.98 
to $ 17.62 
$ 443 

1.95  % 1.40  % to 2.75  % 12.51  % to 14.04  %
2022 39 
$ 14.20 
to $ 15.45 
$ 594 

1.58  % 1.40  % to 2.75  % (18.71) % to (17.61) %
2021 42 
$ 17.47 
to $ 18.75 
$ 767 

1.16  % 1.40  % to 2.75  % 22.94  % to 24.62  %
2020 45 
$ 14.21 
to $ 15.05 
$ 674 

1.94  % 1.40  % to 2.75  % 7.96  % to 9.43  %
2019 51 
$ 13.16 
to $ 13.75 
$ 691 

1.60  % 1.40  % to 2.75  % 19.10  % to 20.71  %
AZL Small Cap Stock Index Fund Class 2







2023 503 
$ 20.84 
to $ 34.09 
$ 12,390 

1.01  % —  % to 3.55  % 11.35  % to 14.96  %
2022 561 
$ 18.67 
to $ 29.65 
$ 12,251 

0.77  % —  % to 3.55  % (19.55) % to (16.94) %
2021 613 
$ 23.15 
to $ 35.70 
$ 16,461 

0.64  % —  % to 3.55  % 21.65  % to 25.60  %
2020 726 
$ 18.98 
to $ 28.42 
$ 15,859 

1.10  % —  % to 3.55  % 6.84  % to 10.32  %
2019 799 
$ 17.72 
to $ 25.76 
$ 16,165 

0.92  % —  % to 3.55  % 17.93  % to 21.77  %
Page 53 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements













































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
AZL T. Rowe Price Capital Appreciation Fund







2023 571 
$ 22.97 
to $ 44.17 
$ 16,486 

1.33  % 0.35  % to 3.55  % 14.35  % to 18.06  %
2022 674 
$ 20.04 
to $ 37.42 
$ 17,021 

0.65  % 0.35  % to 3.55  % (15.15) % to (12.40) %
2021 840 
$ 23.55 
to $ 42.71 
$ 24,966 

0.96  % 0.35  % to 3.55  % 14.00  % to 17.71  %
2020 920 
$ 20.61 
to $ 36.28 
$ 23,850 

1.36  % 0.35  % to 3.55  % 13.37  % to 17.07  %
2019 1,071 
$ 18.13 
to $ 30.99 
$ 24,132 

2.07  % 0.35  % to 3.55  % 20.04  % to 23.95  %
ClearBridge Variable Aggressive Growth Portfolio







2023
$ 30.79 
to $ 30.79 
$ 27 

0.07  % 0.35  % to 0.35  % 23.70  % to 23.70  %
2022
$ 24.89 
to $ 24.89 
$ 22 

—  % 0.35  % to 0.35  % (26.84) % to (26.84) %
2021
$ 34.03 
to $ 34.03 
$ 37 

0.18  % 0.35  % to 0.35  % 9.66  % to 9.66  %
2020
$ 31.03 
to $ 31.03 
$ 57 

0.45  % 0.35  % to 0.35  % 17.32  % to 17.32  %
2019
$ 26.45 
to $ 26.45 
$ 81 

0.77  % 0.35  % to 0.35  % 24.31  % to 24.31  %
Columbia Variable Portfolio – Seligman Global Technology Fund







2023
$ 55.25 
to $ 55.25 
$ 55 

—  % 1.49  % to 1.49  % 43.14  % to 43.14  %
2022
$ 38.60 
to $ 38.60 
$ 38 

—  % 1.49  % to 1.49  % (32.73) % to (32.73) %
2021
$ 57.38 
to $ 57.38 
$ 57 

0.40  % 1.49  % to 1.49  % 36.97  % to 36.97  %
2020
$ 41.89 
to $ 41.89 
$ 42 

—  % 1.49  % to 1.49  % 44.02  % to 44.02  %
2019
$ 29.09 
to $ 29.09 
$ 29 

—  % 1.49  % to 1.49  % 53.02  % to 53.02  %
Davis VA Financial Portfolio







2023 35 
$ 20.46 
to $ 35.51 
$ 899 

2.14  % 1.15  % to 3.55  % 11.45  % to 13.69  %
2022 37 
$ 18.24 
to $ 31.23 
$ 848 

1.77  % 1.15  % to 3.55  % (11.58) % to (9.80) %
2021 42 
$ 20.50 
to $ 34.62 
$ 1,048 

1.39  % 1.15  % to 3.55  % 26.17  % to 28.72  %
2020 46 
$ 16.14 
to $ 26.90 
$ 906 

1.53  % 1.15  % to 3.55  % (9.14) % to (7.30) %
2019 48 
$ 17.65 
to $ 29.02 
$ 1,020 

1.34  % 1.15  % to 3.55  % 21.65  % to 24.11  %
Delaware Ivy VIP Growth Portfolio







2023 — 
$ 488.86 
to $ 488.86 
$ 10 

—  % 0.35  % to 0.35  % 37.44  % to 37.44  %
2022 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2021 — 
$ 490.22 
to $ 490.22 
$ 33 

—  % 0.35  % to 0.35  % 29.57  % to 29.57  %
2020 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2019 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
Delaware Ivy VIP Mid Cap Growth Portfolio







2023 — 
$ 68.43 
to $ 68.43 
$ 10 

—  % 0.35  % to 0.35  % 19.20  % to 19.20  %
2022 — 
$ 57.41 
to $ 57.41 
$

—  % 0.35  % to 0.35  % (31.03) % to (31.03) %
2021 — 
$ 83.24 
to $ 83.24 
$ 13 

—  % 0.35  % to 0.35  % 15.95  % to 15.95  %
2020 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2019 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
Delaware Ivy VIP Natural Resources Portfolio







2023
$ 13.97 
to $ 13.97 
$ 13 

2.53  % 0.35  % to 0.35  % 1.23  % to 1.23  %
2022
$ 13.80 
to $ 13.80 
$ 13 

1.63  % 0.35  % to 0.35  % 17.36  % to 17.36  %
2021
$ 11.76 
to $ 11.76 
$ 12 

1.60  % 0.35  % to 0.35  % 26.24  % to 26.24  %
2020
$ 9.31 
to $ 9.31 
$

—  % 0.35  % to 0.35  % (12.30) % to (12.30) %
2019 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
Eaton Vance VT Floating-Rate Income Fund







Page 54 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements













































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
2023 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2022 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2021 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2020 — 
$ — 
to $ — 
$ — 

5.61  % 0.35  % to 0.35  % —  % to —  %
2019 14 
$ 17.52 
to $ 17.52 
$ 238 

4.31  % 0.35  % to 0.35  % 6.71  % to 6.71  %
Fidelity VIP Emerging Markets Portfolio







2023 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2022 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2021
$ 16.80 
to $ 16.80 
$ 21 

1.80  % 0.35  % to 0.35  % (2.75) % to (2.75) %
2020
$ 17.27 
to $ 17.27 
$ 23 

0.61  % 0.35  % to 0.35  % 30.42  % to 30.42  %
2019
$ 13.24 
to $ 13.24 
$ 23 

1.27  % 0.35  % to 0.35  % 28.74  % to 28.74  %
Fidelity VIP Mid Cap Portfolio







2023 — 
$ 93.12 
to $ 93.12 
$ 31 

0.40  % 0.35  % to 0.35  % 14.40  % to 14.40  %
2022 — 
$ 81.40 
to $ 81.40 
$ 27 

0.19  % 0.35  % to 0.35  % (15.26) % to (15.26) %
2021
$ 96.06 
to $ 96.06 
$ 50 

0.25  % 0.35  % to 0.35  % 24.87  % to 24.87  %
2020
$ 76.93 
to $ 76.93 
$ 63 

0.43  % 0.35  % to 0.35  % 17.45  % to 17.45  %
2019
$ 65.50 
to $ 65.50 
$ 46 

0.69  % 0.35  % to 0.35  % 22.74  % to 22.74  %
Fidelity VIP Strategic Income Portfolio







2023
$ 23.35 
to $ 23.35 
$ 80 

5.34  % 0.35  % to 0.35  % 8.80  % to 8.80  %
2022
$ 21.46 
to $ 21.46 
$ 56 

2.45  % 0.35  % to 0.35  % (11.83) % to (11.83) %
2021
$ 24.34 
to $ 24.34 
$ 116 

3.83  % 0.35  % to 0.35  % 3.17  % to 3.17  %
2020
$ 23.59 
to $ 23.59 
$ 62 

3.14  % 0.35  % to 0.35  % 6.78  % to 6.78  %
2019
$ 22.09 
to $ 22.09 
$ 58 

3.24  % 0.35  % to 0.35  % 10.27  % to 10.27  %
Franklin Rising Dividends VIP Fund







2023 126 
$ 81.08 
to $ 185.04 
$ 14,933 

1.05  % 0.35  % to 2.75  % 9.04  % to 11.68  %
2022 143 
$ 74.36 
to $ 165.69 
$ 15,356 

0.99  % 0.35  % to 2.75  % (12.99) % to (10.88) %
2021 159 
$ 85.46 
to $ 185.92 
$ 19,533 

0.98  % 0.35  % to 2.75  % 23.35  % to 26.35  %
2020 172 
$ 69.28 
to $ 147.15 
$ 16,902 

1.40  % 0.35  % to 2.75  % 12.82  % to 15.56  %
2019 192 
$ 61.41 
to $ 127.33 
$ 16,450 

1.42  % 0.35  % to 2.75  % 25.73  % to 28.78  %
Franklin U.S. Government Securities VIP Fund







2023 571 
$ 14.28 
to $ 38.84 
$ 14,271 

2.73  % —  % to 3.55  % 1.08  % to 4.10  %
2022 636 
$ 14.13 
to $ 37.31 
$ 15,455 

2.41  % —  % to 3.55  % (12.67) % to (10.07) %
2021 745 
$ 16.18 
to $ 41.48 
$ 20,405 

2.47  % —  % to 3.55  % (5.01) % to (2.17) %
2020 830 
$ 17.12 
to $ 42.40 
$ 23,452 

3.41  % —  % to 3.55  % 0.55  % to 3.47  %
2019 889 
$ 17.03 
to $ 40.98 
$ 24,617 

2.94  % —  % to 3.55  % 1.92  % to 4.86  %
Invesco Oppenheimer V.I. International Growth Fund







2023 — 
$ 32.20 
to $ 32.20 
$

0.31  % 0.35  % to 0.35  % 20.22  % to 20.22  %
2022 — 
$ 26.79 
to $ 26.79 
$

—  % 0.35  % to 0.35  % (27.42) % to (27.42) %
2021
$ 36.91 
to $ 36.91 
$ 27 

—  % 0.35  % to 0.35  % 9.74  % to 9.74  %
2020 — 
$ 33.63 
to $ 33.63 
$

0.66  % 0.35  % to 0.35  % 20.62  % to 20.62  %
2019 — 
$ 27.89 
to $ 27.89 
$

0.34  % 0.35  % to 0.35  % 27.50  % to 27.50  %
Invesco V.I. American Value Fund







2023 — 
$ 59.27 
to $ 59.27 
$ 24 

0.38  % 0.35  % to 0.35  % 14.89  % to 14.89  %
2022 — 
$ 51.59 
to $ 51.59 
$ 22 

0.37  % 0.35  % to 0.35  % (3.20) % to (3.20) %
Page 55 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements













































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
2021
$ 53.29 
to $ 53.29 
$ 33 

0.36  % 0.35  % to 0.35  % 27.18  % to 27.18  %
2020 — 
$ 41.90 
to $ 41.90 
$ 15 

0.43  % 0.35  % to 0.35  % 0.50  % to 0.50  %
2019
$ 41.69 
to $ 41.69 
$ 26 

0.43  % 0.35  % to 0.35  % 24.27  % to 24.27  %
Invesco V.I. Global Strategic Income Fund







2023
$ 17.91 
to $ 26.37 
$ 99 

—  % 1.25  % to 2.75  % 5.94  % to 7.28  %
2022
$ 16.91 
to $ 24.58 
$ 102 

—  % 1.25  % to 2.75  % (13.86) % to (12.77) %
2021
$ 19.63 
to $ 28.18 
$ 126 

4.61  % 1.25  % to 2.75  % (6.03) % to (4.84) %
2020
$ 20.89 
to $ 29.61 
$ 141 

5.80  % 1.25  % to 2.75  % 0.59  % to 1.87  %
2019
$ 20.77 
to $ 29.07 
$ 149 

3.74  % 1.25  % to 2.75  % 7.80  % to 9.16  %
LVIP JPMorgan Core Bond Fund







2023² 114 
$ 11.57 
to $ 13.28 
$ 1,457 

1.25  % 0.35  % to 2.20  % 0.19  % to 0.72  %
MFS International Intrinsic Value Portfolio







2023
$ 24.55 
to $ 24.55 
$ 36 

0.49  % 0.35  % to 0.35  % 16.96  % to 16.96  %
2022
$ 20.99 
to $ 20.99 
$ 33 

0.56  % 0.35  % to 0.35  % (24.02) % to (24.02) %
2021
$ 27.62 
to $ 27.62 
$ 38 

0.11  % 0.35  % to 0.35  % 9.89  % to 9.89  %
2020
$ 25.14 
to $ 25.14 
$ 14 

0.80  % 0.35  % to 0.35  % 19.79  % to 19.79  %
2019
$ 20.98 
to $ 20.98 
$ 12 

1.49  % 0.35  % to 0.35  % 25.21  % to 25.21  %
MFS VIT Total Return Bond Portfolio







2023 272 
$ 14.92 
to $ 18.01 
$ 4,732 

3.00  % 0.35  % to 2.20  % 4.83  % to 5.65  %
2022 316 
$ 14.23 
to $ 17.04 
$ 5,239 

2.50  % 0.35  % to 2.20  % (16.03) % to (15.37) %
2021 333 
$ 16.95 
to $ 25.29 
$ 6,528 

2.52  % 0.35  % to 2.20  % (3.20) % to (1.41) %
2020 353 
$ 17.48 
to $ 25.65 
$ 7,134 

3.32  % 0.35  % to 2.20  % 5.81  % to 7.79  %
2019 353 
$ 16.54 
to $ 23.80 
$ 6,711 

3.26  % 0.35  % to 2.20  % 7.55  % to 9.54  %
MFS VIT Utilities Portfolio







2023 — 
$ 43.38 
to $ 43.38 
$

3.36  % 0.35  % to 0.35  % (2.67) % to (2.67) %
2022 — 
$ 44.58 
to $ 44.58 
$

2.23  % 0.35  % to 0.35  % 0.13  % to 0.13  %
2021 — 
$ 44.52 
to $ 44.52 
$

1.54  % 0.35  % to 0.35  % 13.43  % to 13.43  %
2020 — 
$ 39.25 
to $ 39.25 
$

2.25  % 0.35  % to 0.35  % 5.25  % to 5.25  %
2019 — 
$ 37.29 
to $ 37.29 
$

3.83  % 0.35  % to 0.35  % 24.37  % to 24.37  %
PIMCO VIT Balanced Allocation Portfolio







2023 1,495 
$ 11.05 
to $ 13.49 
$ 19,752 

2.79  % —  % to 3.55  % 11.59  % to 13.51  %
2022 1,710 
$ 9.91 
to $ 11.88 
$ 19,943 

0.97  % —  % to 3.55  % (18.68) % to (17.28) %
2021 1,843 
$ 12.18 
to $ 14.37 
$ 26,023 

0.09  % —  % to 3.55  % 2.61  % to 9.43  %
2020 948 
$ 12.26 
to $ 13.13 
$ 12,288 

1.00  % 1.15  % to 2.20  % 8.72  % to 9.58  %
2019 1,054 
$ 11.26 
to $ 11.98 
$ 12,484 

2.16  % 1.15  % to 2.20  % 16.41  % to 17.36  %
PIMCO VIT CommodityRealReturn Strategy Portfolio







2023 194 
$ 5.46 
to $ 10.75 
$ 1,263 

16.25  % —  % to 3.55  % (10.93) % to (8.17) %
2022 204 
$ 6.12 
to $ 11.70 
$ 1,473 

21.48  % —  % to 3.55  % 4.99  % to 8.24  %
2021 257 
$ 5.82 
to $ 10.81 
$ 1,740 

4.20  % —  % to 3.55  % 28.88  % to 32.88  %
2020 326 
$ 4.51 
to $ 8.14 
$ 1,706 

6.53  % —  % to 3.55  % (1.95) % to 1.00  %
2019 364 
$ 4.60 
to $ 8.06 
$ 1,933 

4.51  % —  % to 3.55  % 7.81  % to 11.04  %
PIMCO VIT Emerging Markets Bond Portfolio







2023 282 
$ 13.22 
to $ 19.61 
$ 5,030 

5.70  % —  % to 3.55  % 7.28  % to 9.77  %
2022 313 
$ 12.30 
to $ 18.28 
$ 5,111 

4.83  % —  % to 3.55  % (18.66) % to (16.78) %
2021 328 
$ 15.08 
to $ 22.47 
$ 6,441 

4.47  % —  % to 3.55  % (5.97) % to (3.78) %
Page 56 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements













































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
2020 387 
$ 16.00 
to $ 23.90 
$ 7,924 

4.60  % —  % to 3.55  % 2.97  % to 5.38  %
2019 421 
$ 15.50 
to $ 24.44 
$ 8,216 

4.43  % —  % to 3.55  % 10.79  % to 13.37  %
PIMCO VIT Global Core Bond (Hedged) Portfolio







2023 904 
$ 7.50 
to $ 9.86 
$ 8,625 

2.30  % —  % to 3.55  % 4.22  % to 6.49  %
2022 1,016 
$ 7.20 
to $ 9.26 
$ 9,135 

1.60  % —  % to 3.55  % (14.62) % to (12.76) %
2021 1,147 
$ 8.43 
to $ 10.62 
$ 11,860 

2.10  % —  % to 3.55  % (4.95) % to (1.01) %
2020 848 
$ 9.00 
to $ 10.93 
$ 9,149 

6.11  % 1.15  % to 3.55  % 4.49  % to 6.61  %
2019 955 
$ 8.61 
to $ 10.25 
$ 9,668 

2.22  % 1.15  % to 3.55  % 4.28  % to 6.39  %
PIMCO VIT High Yield Portfolio







2023 1,639 
$ 16.04 
to $ 26.39 
$ 41,046 

5.68  % —  % to 3.55  % 8.51  % to 10.86  %
2022 2,108 
$ 14.79 
to $ 31.40 
$ 47,773 

5.05  % —  % to 3.55  % (13.29) % to (10.61) %
2021 2,361 
$ 17.05 
to $ 35.13 
$ 60,731 

4.44  % —  % to 3.55  % 0.17  % to 3.27  %
2020 2,719 
$ 17.02 
to $ 34.02 
$ 68,447 

4.84  % —  % to 3.55  % 2.21  % to 5.39  %
2019 3,153 
$ 16.66 
to $ 32.28 
$ 76,529 

4.96  % —  % to 3.55  % 10.92  % to 14.35  %
PIMCO VIT Long-Term U.S. Government Portfolio







2023 13 
$ 19.53 
to $ 33.61 
$ 310 

2.37  % —  % to 2.75  % 1.73  % to 3.99  %
2022 11 
$ 19.20 
to $ 32.33 
$ 257 

2.04  % —  % to 2.75  % (30.43) % to (28.89) %
2021 11 
$ 27.59 
to $ 45.46 
$ 374 

1.59  % —  % to 2.75  % (6.85) % to (4.78) %
2020 17 
$ 29.62 
to $ 47.74 
$ 590 

1.68  % —  % to 2.75  % 14.85  % to 17.41  %
2019 11 
$ 25.79 
to $ 30.44 
$ 311 

1.99  % —  % to 2.75  % 10.88  % to 11.77  %
PIMCO VIT Low Duration Portfolio







2023
$ 19.02 
to $ 19.02 
$ 169 

3.60  % 0.35  % to 0.35  % 4.61  % to 4.61  %
2022
$ 18.18 
to $ 18.18 
$ 162 

1.98  % 0.35  % to 0.35  % (6.07) % to (6.07) %
2021
$ 19.36 
to $ 19.36 
$ 84 

0.52  % 0.35  % to 0.35  % (1.27) % to (1.27) %
2020
$ 19.61 
to $ 19.61 
$ 105 

1.14  % 0.35  % to 0.35  % 2.63  % to 2.63  %
2019
$ 19.11 
to $ 19.11 
$ 47 

2.79  % 0.35  % to 0.35  % 3.67  % to 3.67  %
PIMCO VIT Real Return Portfolio







2023 1,255 
$ 10.90 
to $ 29.96 
$ 19,135 

2.98  % —  % to 3.55  % 0.31  % to 3.31  %
2022 1,493 
$ 10.87 
to $ 29.00 
$ 22,254 

6.98  % —  % to 3.55  % (14.76) % to (12.22) %
2021 1,600 
$ 12.75 
to $ 33.03 
$ 27,530 

4.94  % —  % to 3.55  % 2.18  % to 5.24  %
2020 1,775 
$ 12.48 
to $ 31.39 
$ 29,506 

1.41  % —  % to 3.55  % 8.08  % to 11.33  %
2019 2,063 
$ 11.55 
to $ 28.19 
$ 31,244 

1.66  % —  % to 3.55  % 4.92  % to 8.07  %
PIMCO VIT StocksPLUS Global Portfolio







2023 417 
$ 15.02 
to $ 20.58 
$ 7,771 

2.81  % 0.35  % to 3.55  % 18.74  % to 21.32  %
2022 468 
$ 12.64 
to $ 16.97 
$ 7,236 

1.18  % 0.35  % to 3.55  % (21.49) % to (19.65) %
2021 516 
$ 16.11 
to $ 21.12 
$ 10,011 

0.12  % 0.35  % to 3.55  % 15.34  % to 17.85  %
2020 578 
$ 13.96 
to $ 17.92 
$ 9,602 

1.16  % 0.35  % to 3.55  % 9.25  % to 11.89  %
2019 675 
$ 12.78 
to $ 16.01 
$ 10,093 

1.56  % 0.35  % to 3.55  % 23.26  % to 26.09  %
PIMCO VIT Total Return Portfolio







2023 3,388 
$ 12.04 
to $ 27.92 
$ 64,621 

3.56  % —  % to 3.55  % 2.41  % to 5.94  %
2022 3,974 
$ 11.74 
to $ 26.45 
$ 72,272 

2.61  % —  % to 3.55  % (17.17) % to (14.31) %
2021 4,276 
$ 14.16 
to $ 30.97 
$ 92,360 

1.82  % —  % to 3.55  % (4.57) % to (1.27) %
2020 3,696 
$ 14.82 
to $ 31.48 
$ 81,796 

2.14  % —  % to 3.55  % 5.02  % to 8.66  %
2019 4,085 
$ 14.10 
to $ 29.07 
$ 84,759 

3.02  % —  % to 3.55  % 4.75  % to 7.99  %
T. Rowe Price Blue Chip Growth Portfolio







Page 57 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements













































At December 31
For the years or periods ended December 31

 Units Outstanding **** Unit Fair Value lowest to highest  Net Assets ****
Investment Income Ratio* Expense Ratio
lowest to highest**
Total Return
lowest to highest***
2023 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2022 — 
$ 47.30 
to $ 47.30 
$

—  % 0.35  % to 0.35  % (38.88) % to (38.88) %
2021 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2020
$ 66.19 
to $ 66.19 
$ 71 

—  % 0.35  % to 0.35  % 33.45  % to 33.45  %
2019
$ 49.60 
to $ 49.60 
$ 53 

—  % 0.35  % to 0.35  % 29.12  % to 29.12  %
T. Rowe Price Equity Income Portfolio







2023
$ 41.91 
to $ 41.91 
$ 104 

1.90  % 0.35  % to 0.35  % 8.93  % to 8.93  %
2022
$ 38.48 
to $ 38.48 
$ 106 

1.77  % 0.35  % to 0.35  % (3.92) % to (3.92) %
2021
$ 40.05 
to $ 40.05 
$ 65 

1.39  % 0.35  % to 0.35  % 24.78  % to 24.78  %
2020
$ 32.10 
to $ 32.10 
$ 52 

2.11  % 0.35  % to 0.35  % 0.60  % to 0.60  %
2019
$ 31.90 
to $ 31.90 
$ 52 

2.08  % 0.35  % to 0.35  % 25.60  % to 25.60  %
T. Rowe Price Health Sciences Portfolio







2023 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2022 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2021 — 
$ — 
to $ — 
$ — 

—  % 0.35  % to 0.35  % —  % to —  %
2020 — 
$ 116.87 
to $ 116.87 
$ 16 

—  % 0.35  % to 0.35  % 28.82  % to 28.82  %
2019 — 
$ 90.72 
to $ 90.72 
$ 12 

—  % 0.35  % to 0.35  % 28.18  % to 28.18  %
Templeton Global Bond VIP Fund







2023 1,000 
$ 20.76 
to $ 57.33 
$ 37,396 

—  % —  % to 3.55  % (0.45) % to 2.53  %
2022 1,136 
$ 20.84 
to $ 55.92 
$ 41,861 

—  % —  % to 3.55  % (8.03) % to (5.28) %
2021 1,314 
$ 22.65 
to $ 59.04 
$ 51,973 

—  % —  % to 3.55  % (8.08) % to (5.32) %
2020 1,371 
$ 24.63 
to $ 62.36 
$ 58,232 

8.33  % —  % to 3.55  % (8.36) % to (5.61) %
2019 1,459 
$ 26.86 
to $ 66.07 
$ 66,699 

7.06  % —  % to 3.55  % (1.30) % to 1.66  %



 1 Period from June 18, 2021 (fund commencement) to December 31, 2021
 2 Period from April 28, 2023 (fund commencement) to December 31, 2023

* These amounts represent the dividends, excluding distributions of capital gains, received by the subaccount from the underlying fund, net of management fees assessed by the fund manager, divided by the average daily net assets. These ratios exclude those expenses, such as mortality and expense risk and administrative charges, that result in direct reductions in the unit values. The recognition of investment income by the subaccount is affected by the timing of the declaration of dividends by the underlying fund in which the subaccounts invest.
** These ratios represent the annualized contract expenses of the Variable Account, consisting primarily of mortality and expense risk and administrative charges, for each period indicated, based on the products available to the contractholders. The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to contractholder accounts through the redemption of units such as the contract maintenance charges and rider charges for the optional benefits, and expenses of the underlying funds are excluded. Mortality and expense risk and administrative charges for all funds in annuitized contracts are excluded from the expense ratio.
*** These amounts represent the total return for the periods indicated, including changes in the value of the underlying fund, and reflect contract expenses of the Variable Account for products held at the time by contractholders. The total return does not include any expenses assessed through the redemption of units. Inclusion of these expenses in the calculation would result in a reduction in the total return presented. Funds with a date notation, as shown above, indicate the effective date of that fund in the Variable Account. The total return is calculated for the period indicated or from the effective date through the end of the reporting period. The total return is presented as a range of minimum to maximum values. Based on the product grouping representing the minimum and maximum expense ratio amounts, some individual contract returns are not within the ranges presented and are not annualized.
**** Units Outstanding excludes units for annuitized contracts. Total Net Assets includes the net assets of the annuitized contracts. Total net assets of annuitized contracts at December 31, 2023, 2022, 2021, 2020 and 2019, are $463, $460, $492, $660, and $698, respectively.
Page 58 of 59



ALLIANZ LIFE OF NY VARIABLE ACCOUNT C
OF ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Financial Statements



The following open/available funds had no activity for the years or periods ended December 31, 2023, 2022, 2021, 2020 and, 2019, and therefore, were not listed in the Financial Highlights:



BlackRock Equity Dividend V.I. Fund
Delaware Ivy VIP Asset Strategy Portfolio
Delaware Ivy VIP Energy Portfolio
Delaware Ivy VIP Science and Technology Portfolio
Invesco V.I. Balanced-Risk Allocation Fund
Lazard Retirement International Equity Portfolio
Lazard Retirement U.S. Small-Mid Cap Equity Portfolio

(7) Subsequent Events

No material subsequent events have occurred since December 31, 2023 through April 8, 2024, the date at which the financial statements were issued, that would require adjustment to the financial statements.





Page 59 of 59





ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Financial Statements
December 31, 2023 and 2022
(With Report of Independent Auditors Thereon)


Statutory Financial Statements for the year ended December 31, 2023





Report of Independent Auditors

To the Board of Directors of Allianz Life Insurance Company of New York

Opinions

We have audited the accompanying statutory financial statements of Allianz Life Insurance Company of New York (the "Company"), which comprise the statutory statements of admitted assets, liabilities and capital and surplus as of December 31, 2023 and 2022, and the related statutory statements of operations, of capital and surplus, and of cash flow for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the "financial statements").

Unmodified Opinion on Statutory Basis of Accounting

In our opinion, the accompanying financial statements present fairly, in all material respects, the admitted assets, liabilities and capital and surplus of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in accordance with the accounting practices prescribed or permitted by the New York State Department of Financial Services described in Note 2.

Adverse Opinion on U.S. Generally Accepted Accounting Principles

In our opinion, because of the significance of the matter discussed in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles section of our report, the accompanying financial statements do not present fairly, in accordance with accounting principles generally accepted in the United States of America, the financial position of the Company as of December 31, 2023 and 2022, or the results of its operations or its cash flows for each of the three years in the period ended December 31, 2023.

Basis for Opinions

We conducted our audit in accordance with auditing standards generally accepted in the United States of America (US GAAS). Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles

As described in Note 2 to the financial statements, the financial statements are prepared by the Company on the basis of the accounting practices prescribed or permitted by the New York State Department of Financial Services, which is a basis of accounting other than accounting principles generally accepted in the United States of America.

The effects on the financial statements of the variances between the statutory basis of accounting described in Note 2 and accounting principles generally accepted in the United States of America, although not reasonably determinable, are presumed to be material.

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with the accounting practices prescribed or permitted by the New York State Department of Financial Services. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the financial statements are available to be issued.
Statutory Financial Statements for the year ended December 31, 2023










1 of 42

    






Auditors' Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with US GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with US GAAS, we:

Exercise professional judgment and maintain professional skepticism throughout the audit.
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.
Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.
Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/PricewaterhouseCoopers LLP

Minneapolis, Minnesota
April 8, 2024




















Statutory Financial Statements for the year ended December 31, 2023










2 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus
(Dollars in thousands, except share data)
















Admitted Assets
2023
2022
Cash and invested assets:



Bonds
$ 618,672 

647,422 
Cash and cash equivalents
31,012 

22,009 
Policy loans
193 

185 
Derivative assets
26 

— 
Receivables for securities
860 

1,456 
Total cash and invested assets
650,763 

671,072 
Investment income due and accrued
5,071 

4,719 
Deferred tax asset, net
10,221 

8,439 
Current federal and foreign income tax recoverable
2,157 

— 
Admitted disallowed interest maintenance reserve
11,618 

— 
Other assets
435 

475 
Admitted assets, exclusive of separate account assets
680,265 

684,705 
Separate account assets
5,399,495 

4,347,526 
Total admitted assets
$ 6,079,760 

5,032,231 

Statutory Financial Statements for the year ended December 31, 2023










3 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus
(Dollars in thousands, except share data)
















Liabilities and Capital and Surplus 2023
2022
Policyholder liabilities:



Life policies and annuity contracts
$ 423,911 

459,725 
Accident and health policies
86,028 

83,151 
Deposit-type contracts
6,478 

6,735 
Life policy and contract claims
14 

21 
Accident and health policy and contract claims
369 

433 
Other policyholder funds
13,568 

4,000 
Total policyholder liabilities
530,368 

554,065 
General expenses due and accrued
2,610 

1,108 
Due from separate accounts
(65,902)

(64,853)
Payable to parent and affiliates
7,052 

5,176 
Current income taxes
— 

3,548 
Asset valuation reserve
19,896 

12,862 
Other liabilities
1,041 

1,235 
Liabilities, exclusive of separate account liabilities
495,065 

513,141 
Separate account liabilities
5,399,495 

4,347,526 
Total liabilities
5,894,560 

4,860,667 
Capital and surplus:



Common stock, $10 par value. Authorized, issued, and outstanding 200,000 shares at December 31, 2023 and 2022
2,000 

2,000 
Additional paid-in capital
132,500 

102,500 
Special surplus funds - admitted disallowed interest maintenance reserve
11,618 

— 
Unassigned surplus
39,082 

67,064 
Total capital and surplus
185,200 

171,564 
Total liabilities and capital and surplus
$ 6,079,760 

5,032,231 





See accompanying notes to statutory financial statements.




Statutory Financial Statements for the year ended December 31, 2023










4 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Operations
Years ended December 31, 2023, 2022, and 2021
(Dollars in thousands)
























2023
2022
2021
Income:





Premiums and annuity considerations
$ 970,465 

656,597 

688,560 
Consideration for supplementary contracts
2,308 

2,242 

1,042 
Net investment income
20,031 

18,100 

16,177 
Commissions and expense allowances on reinsurance ceded
1,791 

1,146 

578 
Fees from separate accounts
54,306 

58,894 

66,792 
Total income
1,048,901 

736,979 

773,149 
Benefits and other expenses:





Policyholder benefits
57,890 

43,865 

40,707 
Surrenders
491,471 

230,201 

240,826 
Change in aggregate reserves and deposit funds
(32,581)

76,056 

(17,165)
Commissions and other agent compensation
62,988 

46,104 

47,602 
General and administrative expenses
45,032 

36,832 

30,752 
Net transfers to separate accounts
396,569 

351,286 

358,538 
Total benefits and other expenses
1,021,369 

784,344 

701,260 
Income from operations before income taxes and net realized capital gain
27,532 

(47,365)

71,889 
Income tax (benefit) expense
(1,665)

3,586 

6,319 
Net income (loss) from operations before net realized capital gain
29,197 

(50,951)

65,570 
Net realized capital (loss) gain, net of taxes and interest maintenance reserve
(41,157)

22,638 

(59,957)
Net (loss) income
$ (11,960)

(28,313)

5,613 







See accompanying notes to statutory financial statements.






Statutory Financial Statements for the year ended December 31, 2023










5 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Capital and Surplus
Years ended December 31, 2023, 2022, and 2021
(Dollars in thousands)
























2023
2022
2021
Capital and surplus at beginning of year
$ 171,564 

163,010 

155,969 
Correction of errors, net of tax (Note 3)
(2,198)

— 

— 
Adjusted balance at beginning of year
169,366 

163,010 

155,969 
Net (loss) income
(11,960)

(28,313)

5,613 
Change in unrealized capital gain (loss)
(7,720)

4,843 

1,534 
Change in net deferred income tax
880 

8,856 

3,807 
Change in nonadmitted assets
(42)

(4,124)

(1,308)
Capital contribution from parent
30,000 

30,000 

— 
Other changes in capital and surplus
(6,942)

(2,708)

(2,605)
Change in admitted disallowed IMR
11,618 

— 

— 
Capital and surplus at end of year
$ 185,200 

171,564 

163,010 







See accompanying notes to statutory financial statements.






Statutory Financial Statements for the year ended December 31, 2023










6 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Statutory Statements of Cash Flow
Years ended December 31, 2023, 2022, and 2021
(Dollars in thousands)
























2023
2022
2021
Cash flows from operating activities:





Revenues:





Premiums and annuity considerations, net
$ 801,076 

658,838 

689,603 
Net investment income
22,280 

20,141 

19,340 
Other income
56,100 

60,035 

67,367 
Total cash provided by operating activities
879,456 

739,014 

776,310 
Benefits and expenses paid:





Benefit and loss-related payments
377,129 

272,409 

279,458 
Commissions, expenses paid, and aggregate write-ins for deductions
106,560 

82,323 

78,441 
Net transfers to separate accounts
399,816 

377,329 

337,054 
Income tax paid, net
3,590 

6,004 

2,310 
Total cash used in operating activities
887,095 

738,065 

697,263 
Net cash (used in) provided by operating activities
(7,639)

949 

79,047 
Cash flows from investing activities:





Proceeds from investments sold, matured, or repaid:





Bonds
89,218 

97,922 

82,882 
Derivatives
— 

29,969 

— 
Miscellaneous proceeds
596 

— 

36 
Total cash provided by investing activities
89,814 

127,891 

82,918 
Cost of investments acquired:





Bonds
62,148 

166,219 

91,367 
Derivatives
51,189 

— 

58,296 
Miscellaneous applications
190 

1,284 

574 
Total cash used in investing activities
113,527 

167,503 

150,237 
Net cash used in investing activities
(23,713)

(39,612)

(67,319)
Cash flows from financing and miscellaneous activities:





Capital Contribution
30,000 

30,000 

— 
Change in payable to parent and affiliates
1,876 

383 

891 
Other
8,479 

1,242 

(209)
Net cash provided by financing and miscellaneous activities
40,355 

31,625 

682 
Net increase (decrease) in cash and cash equivalents
9,003 

(7,038)

12,410 
Cash and cash equivalents:





Beginning of year
22,009 

29,047 

16,637 
End of year
$ 31,012 

22,009 

29,047 







See accompanying notes to statutory financial statements.





Statutory Financial Statements for the year ended December 31, 2023










7 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(1)Organization and Nature of Operations
Allianz Life Insurance Company of New York (the Company) is a wholly-owned subsidiary of Allianz Life Insurance Company of North America (Allianz Life), which is a wholly-owned subsidiary of Allianz of America, Inc. (AZOA). AZOA is a wholly-owned subsidiary of Allianz Europe, B.V., which is a wholly-owned subsidiary of Allianz SE. Allianz SE is a European company registered in Munich, Germany, and is the Company's ultimate parent.
The Company is a life insurance company licensed to sell annuity, group and individual life, group and individual accident and health policies in six states and the District of Columbia. Based on statutory net premium written, the Company's business is predominately annuity. The annuity business consists of variable-indexed annuities and closed blocks of variable, fixed and fixed-indexed annuities. The life business includes term life policies and closed blocks of universal life policies. Accident and health business is primarily comprised of closed blocks of long-term care (LTC) insurance. The Company's primary distribution channel is through broker-dealers.
After evaluating the Company’s ability to continue as a going concern, management is not aware of any conditions or events which raise substantial doubt concerning the Company’s ability to continue as a going concern as of the date of filing these Statutory Financial Statements.
(2)    Summary of Significant Accounting Policies
(a)    Basis of Presentation
The Statutory Financial Statements have been prepared in accordance with accounting practices prescribed or permitted by the New York State Department of Financial Services (the Department). The Department recognizes statutory accounting practices prescribed or permitted by the state of New York for determining and reporting the financial condition and results of operations of an insurance company and its solvency under New York insurance law. The state of New York has adopted the National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures Manual as its prescribed basis of statutory accounting principles (SAP). The state of New York has also adopted certain prescribed accounting practices that differ from those found in NAIC SAP. The Company has no material statutory accounting practices that differ from those of the Department or NAIC SAP. These practices differ in some respects from accounting principles generally accepted in the United States of America (U.S. GAAP). The effects of these differences, while not quantified, are presumed to be material to the Statutory Financial Statements. The more significant of these differences are as follows:
(1)    Acquisition costs, such as commissions and other costs incurred in connection with acquiring new and renewal business, are charged to current operations as incurred. Under U.S. GAAP, acquisition costs that are directly related to the successful acquisition of insurance contracts are capitalized and charged to operations on a straight-line basis over the expected term of the related contracts.
(2)    Aggregate reserves for life policies and annuity contracts, excluding variable annuities, are based on statutory mortality and interest assumptions without consideration for lapses or withdrawals. Under U.S. GAAP, aggregate reserves consider lapses and withdrawals.
(3)    Ceded reinsurance recoverable are netted against their related reserves within Policyholder liabilities, Life policies and annuity contracts and Life policy and contract claims, on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. Under U.S. GAAP, these ceded reserves are presented on a gross basis as an asset.
(4)    Bonds are carried at values prescribed by the NAIC, generally amortized cost, except for those with an NAIC rating of 6, which are reported at the lower of amortized cost or fair value. Under U.S. GAAP, bonds classified as “available-for-sale” are carried at fair value, with unrealized gains and losses recorded in stockholder’s equity.
(5)    Changes in deferred income taxes are recorded directly to Unassigned surplus. Under U.S. GAAP, these items are generally recorded as an item of income tax benefit or expense in operations. Moreover, under NAIC SAP, a valuation allowance may be recorded against the deferred tax asset (DTA) and admittance
Statutory Financial Statements for the year ended December 31, 2023










8 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



testing may result in an additional charge to capital and surplus for nonadmitted portions of DTAs. Under U.S. GAAP, a valuation allowance may be recorded against the DTA and reflected as an expense.
(6)    The Company is required to establish an asset valuation reserve (AVR) liability and an interest maintenance reserve (IMR) liability. The AVR provides for a standardized statutory investment valuation reserve for certain invested assets. Changes in this reserve are recorded as direct charges or credits to Unassigned surplus. The IMR is designed to defer net realized capital gains and losses, net of tax, resulting from changes in the level of prevailing market interest rates and amortize them into income within the Statutory Statements of Operations over the remaining life of the investment sold. The IMR represents the unamortized portion of applicable investment gains and losses as of the balance sheet date. There is no such concept under U.S. GAAP.
(7)    Certain assets designated as “nonadmitted assets” are not recognized and are charged directly to Unassigned surplus within the Statutory Statements of Capital and Surplus. These include, but are not limited to, furniture and fixtures, prepaid expenses, receivables outstanding greater than 90 days, negative IMR, and portions of DTAs. There is no such concept under U.S. GAAP.
(8)    A provision is made for amounts ceded to unauthorized reinsurers in excess of collateral in the form of a trust or letter of credit through a direct charge to Unassigned surplus within the Statutory Statements of Capital and Surplus. There is no such requirement under U.S. GAAP.
(9)    Revenues for universal life policies and annuity contracts, excluding deposit-type contracts, are recognized as revenue when received within the Statutory Statements of Operations. Under U.S. GAAP, policy and contract fees charged for the cost of insurance, policy administrative charges, amortization of policy initiation fees, and surrender contract charges are recorded as revenues when earned.
(10)    Benefits for universal life policies and annuity contracts within the Statutory Statements of Operations, excluding deposit-type contracts, consist of payments made to policyholders. Under U.S. GAAP, benefits represent interest credited, and claims and benefits incurred in excess of the policyholder’s contract balance.
(11)    Changes in the fair value of derivatives are recorded as direct adjustments to Unassigned surplus as a component of Change in unrealized capital gains (losses) within the Statutory Statements of Capital and Surplus. Under U.S. GAAP, changes in the fair value of derivatives are recorded in derivative income (loss) as part of operating income.
(12)    Commissions allowed by reinsurers on business ceded are reported as income when received within the Statutory Statements of Operations. Under U.S. GAAP, such commissions are deferred and amortized as a component of deferred acquisition costs to the extent recoverable.
(13)    The Statutory Financial Statements do not include a statement of comprehensive income as required under U.S. GAAP.
(14)    The Statutory Statements of Cash Flow do not classify cash flows consistent with U.S. GAAP and a reconciliation of net income to net cash provided from operating activities is not provided.
(15)    The calculation of reserves and transfers in the separate account statement requires the use of a Commissioners Annuity Reserve Valuation Method (CARVM) allowance on annuities for NAIC SAP. There is no such requirement under U.S. GAAP.
(16)    Sales inducements and premium bonuses are included in Life policies and annuity contracts in the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus, and are charged to current operations as incurred. Under U.S. GAAP, deferred sales inducements and premium bonuses are similarly reserved; however, the costs are capitalized as assets and charged to operations as future profits are recognized in a manner similar to acquisition costs.
Statutory Financial Statements for the year ended December 31, 2023










9 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(17)    Negative cash balances are presented as a negative asset within the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. These balances are presented as a liability under U.S. GAAP.
(18)    Embedded derivatives are not separated from the host contract and accounted for separately as a derivative instrument. Under U.S. GAAP, entities must separate the embedded derivative from the host contracts and separately account for those embedded derivatives at fair value.
(19)    For variable-indexed annuities, the Department requires the Company to maintain a separate asset portfolio to back related reserves. These assets and liabilities are required to be included as part of the Separate account assets and Separate account liabilities presented on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. Under U.S. GAAP, there is no such requirement.
(b)    Permitted and Prescribed Statutory Accounting Practices
The Company is required to file annual statements with insurance regulatory authorities, which are prepared on an accounting basis permitted or prescribed by such authorities. Prescribed statutory accounting practices include state laws, regulations, and general administrative rules, as well as a variety of publications of the NAIC. Permitted statutory accounting practices encompass all accounting practices that are not prescribed; such practices differ from state to state, may differ from company to company within a state, and may change in the future. The Company has no permitted or prescribed practices that differ from NAIC SAP that had an impact on net income or surplus as of December 31, 2023, 2022, and 2021.
(c)    Use of Estimates
The preparation of Statutory Financial Statements in conformity with NAIC SAP requires management to make certain estimates and assumptions that affect reported amounts of admitted assets and liabilities, including reporting or disclosure of contingent assets and liabilities as of December 31, 2023 and 2022, and the reported amounts of revenues and expenses during the reporting period. Future events, including changes in mortality, morbidity, interest rates, capital markets, and asset valuations could cause actual results to differ from the estimates used within the Statutory Financial Statements. Such changes in estimates are recorded in the period they are determined.
(d)    Premiums and Annuity Considerations
Life premiums are recognized as income over the premium paying period of the related policies. Nondeposit-type annuity considerations are recognized as revenue when received. Accident and health premiums are earned ratably over the terms of the related insurance and reinsurance contracts or policies.
(e)    Aggregate Reserves for Life Policies and Annuity Contracts
Reserves are principally calculated as the minimum reserves permitted by the state where the contract is issued for the year in which the contract is issued.
For the Company’s fixed annuity product lines, reserves are calculated using CARVM. The Company uses both issue year for fixed-indexed and change in fund basis for deferred fixed-interest annuities for the calculation method, on a continuous basis, using the maximum allowable interest rate. Deferred fixed-indexed and fixed-interest annuities only have a single-tier structure, which may include bonuses.
For the Company’s variable and variable-indexed annuity product lines, reserves are calculated using NY Regulation 213, for guaranteed benefits with adequacy confirmed using stochastic scenario testing. Variable deferred annuities include a wide range of guaranteed minimum death benefits and living benefits (income, accumulation, and withdrawal).
Aggregate reserves for life insurance policies are principally calculated using the Commissioners Reserve Valuation Method (CRVM) or VM-20, Requirements for Principle-Based Reserves for Life Products, depending on the policy's issue date. Additional reserves are held for supplemental benefits and for contracts with secondary guarantees, consistent with prescribed regulations and actuarial guidelines.
Statutory Financial Statements for the year ended December 31, 2023










10 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



The Company performs an annual asset adequacy analysis as required by regulation covering substantially all of its reserves. These tests are not only performed under the required interest rate scenarios, but also under additional stochastically generated interest and equity growth scenarios. Sensitivity tests, including policy lapse, annuitization, maintenance expenses, and investment return, are performed to evaluate potential insufficiencies in reserve adequacy. The results of these tests and analysis resulted in additional adequacy reserves recorded of $57,000 at December 31, 2023 and 2022. For the universal life business, the Department’s Regulation 147 – Valuation of Life Insurance Reserves stand-alone asset adequacy analysis was performed, which resulted in establishing additional reserves of $100 as of December 31, 2023 and 2022.
(f)    Aggregate Reserves for Accident and Health Policies
For accident and health business, reserves consist of active life reserves (mainly reserves for unearned premiums and reserves for contingent benefits on individual LTC business) and claim reserves (the present value of amounts not yet due). Claim reserves represent incurred but unpaid claims under group policies. For the LTC business, the Department’s Regulation 56 – Minimum Reserves for Individual Accident and Health Insurance Policies stand‑alone asset adequacy analysis was performed through a gross premium valuation. The testing under the “sound value” requirements resulted in recorded reserves of $36,504 as of December 31, 2023 and 2022.
(g)    Deposit-type Contracts
Deposit-type contracts represent liabilities to policyholders in a payout status, who have chosen a fixed payout option without life contingencies. The premiums and claims related to deposit-type contracts are not reflected in the Statutory Statements of Operations as they do not have insurance risk. The Company accounts for the contract as a deposit-type contract in the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(h)    Policy and Contract Claims
Policy and contract claims include the liability for claims reported but not yet paid, claims incurred but not yet reported (IBNR), and claim settlement expenses on the Company’s accident and health business. Actuarial reserve development methods are generally used in the determination of IBNR liabilities. In cases of limited experience or lack of credible claims data, loss ratios are used to determine an appropriate IBNR liability. Claim and IBNR liabilities of a short-term nature are not discounted, but those claim liabilities resulting from disability income or LTC benefits include interest and mortality discounting.
(i)    Reinsurance
The Company cedes business to other insurers. Reinsurance premium and benefits paid or provided are accounted for in a manner consistent with the basis used in accounting for original policies issued and the terms of the reinsurance contracts. Amounts recoverable from reinsurers represent account balances and unpaid claims covered under reinsurance contracts. Amounts paid or deemed to have been paid for claims covered by reinsurance contracts are recorded as a reinsurance recoverable and are included in Other assets on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(j)    Investments
Investment values are determined in accordance with methods prescribed by the NAIC.
Bonds
The Securities Valuation Office (SVO) of the NAIC evaluates the credit quality of the Company’s bond investments. Bonds rated at “1” (highest quality), “2” (high quality), “3” (medium quality), “4” (low quality), or “5” (lower quality) are reported at cost adjusted for the amortization of premiums, accretion of discounts, and any impairment. Bonds rated at “6” (lowest quality) are carried at the lower of amortized cost or fair value with any adjustments to fair value recorded to Unassigned surplus within the Statutory Statements of Capital and Surplus.
Statutory Financial Statements for the year ended December 31, 2023










11 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



In accordance with its investment policy, the Company invests primarily in high-grade marketable securities. Dividends are accrued on the date declared and interest is accrued as earned. Premiums or discounts on bonds are amortized using the constant-yield method.
Loan-backed securities and structured securities are amortized using anticipated prepayments, in addition to other less significant factors. Prepayment assumptions for loan-backed and structured securities are obtained from various external sources or internal estimates. The Company believes these assumptions are consistent with those a market participant would use. The Company recognizes income using the modified scientific method based on prepayment assumptions and the estimated economic life of the securities. For structured securities, except impaired bonds, when actual prepayments differ significantly from anticipated prepayments, the effective yield is recalculated to reflect actual payments to date and anticipated future payments retrospectively. Any resulting adjustment is included in Net investment income on the Statutory Statements of Operations. For impaired bonds, when adjustments are made for anticipated prepayments and other expected changes in future cash flows, the effective yield is recalculated using the prospective method as required by Statement of Statutory Accounting Principles (SSAP) No. 43R – Loan Backed and Structured Securities (SSAP No. 43R).
Hybrid securities are investments structured to have characteristics of both stocks and bonds. The Company records these securities within Bonds on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
Gross realized gains and losses are computed based on the average amortized cost of all lots held for a particular CUSIP.
The fair value of bonds is obtained from third-party pricing sources whenever possible. Management completes its own independent price verification (IPV) process, which ensures security pricing is obtained from a third-party source other than the sources used by the Company's internal and external investment managers. The IPV process supports the reasonableness of price overrides and challenges by the internal and external investment managers and reviews pricing for appropriateness. Results of the IPV process are reviewed by the Company’s Pricing Committee.
Allianz Life reviews its entire combined investment portfolio, including the investment portfolios of the Company and all other subsidiaries, in aggregate each quarter to determine if declines in fair value are other than temporary.
For bonds for which the fair value is less than amortized cost, the Company evaluates whether a credit loss exists by considering primarily the following factors: (a) the length of time and extent to which the fair value has been less than the amortized cost of the security; (b) changes in the financial condition, credit rating, and near-term prospects of the issuer; (c) whether the issuer is current on contractually obligated interest and principal payments; (d) changes in the financial condition of the security’s underlying collateral, if any; and (e) the payment structure of the security. For loan-backed securities, the Company must allocate other-than-temporary impairments (OTTI) between interest and noninterest-related declines in fair value. Interest-related impairments are considered other than temporary when the Company has the intent to sell the investment prior to recovery of the cost of the investment. The Company maintains a prohibited disposal list that restricts the ability of the investment managers to sell securities in a significant unrealized loss position and requires formal attestations from investment managers regarding their lack of intent to sell certain securities.
Impairments considered to be other-than-temporary are recorded as a reduction of the cost of the security, and a corresponding realized loss is recognized on the Statutory Statements of Operations in the period in which the impairment is determined. Recognition of the realized loss is subject to potential offset by AVR and IMR.
Cash and Cash Equivalents
Cash and cash equivalents may include cash on hand, demand deposits, money market funds, and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the carrying value is deemed to approximate fair value.
Statutory Financial Statements for the year ended December 31, 2023










12 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)




Policy Loans
Policy loans are supported by the underlying cash value of the policies. Policy loans are carried at unpaid principal balances plus accrued interest income on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. The unpaid principal balances are not in excess of the cash surrender values of the related policies.
Receivables for Securities
Receivables and payables for securities are carried at fair value on the trade date and represent a timing difference on securities that are traded at the balance sheet date but not settled until subsequent to the balance sheet date. Receivables and payables for securities are included in Receivables for securities and Other liabilities, respectively, on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(k)    Derivatives
The Company utilizes derivatives within certain actively managed investment portfolios for hedging purposes.
Futures and Options Contracts
The Company provides benefits through certain annuity products which are linked to the fluctuation of various market indices, and certain variable annuity contracts that provide minimum guaranteed benefits. The Company has analyzed the characteristics of these benefits and has entered into over-the-counter (OTC) option contracts and exchange-traded futures contracts tied to an underlying index with similar characteristics with the objective to economically hedge these benefits. Management monitors in-force amounts as well as option and futures contract values to ensure satisfactory matching and to identify unsatisfactory mismatches. If actual persistency deviated, management would purchase or sell option and futures contracts as deemed appropriate or take other actions.
The OTC option contracts are reported at fair value in Derivative assets and Derivative liabilities on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. The fair value of the OTC options is derived internally and deemed by management to be reasonable via performing an IPV process. The process of deriving internal derivative prices requires the Company to calibrate Monte Carlo scenarios to actual market information. The calibrated scenarios are applied to derivative cash flow models to calculate fair value prices for the derivatives. Incremental gains and losses from expiring options are included in Net realized capital gain (loss) on the Statutory Statements of Operations. The liability for the related policyholder benefits is reported in Life policies and annuity contracts on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. The unrealized gain or loss on open OTC option contracts is recognized as a direct adjustment to Unassigned surplus within the Statutory Statements of Capital and Surplus. Any unrealized gains or losses on open OTC option contracts are recognized as realized when the contracts mature (see Note 5 for further discussion).
Futures contracts do not require an initial cash outlay, and the Company has agreed to daily net settlement based on movements of the representative index. Therefore, no asset or liability is recorded as of the end of the reporting period. A derivative asset or liability and an offsetting variation margin payable or receivable is recorded in Derivative assets or Derivative liabilities in the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus for the outstanding unpaid variation margin representing market movements on the last trading day of the year.
Gains and losses are not considered realized until the termination or expiration of the futures contract. Unrealized gains and losses on futures contracts are reflected in the Statutory Statements of Capital and Surplus in Unassigned surplus, within Change in unrealized capital gains (loss). Realized gains and losses on futures contracts are included in the Statutory Statements of Operations, Net realized capital gain (loss), net of taxes and interest maintenance reserve.

Statutory Financial Statements for the year ended December 31, 2023










13 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)




(l)    Income Taxes
The Company files a consolidated federal income tax return with AZOA. The consolidated tax allocation agreement stipulates that each company participating in the return will bear its share of the tax liability pursuant to certain tax allocation elections under the Internal Revenue Code (IRC) and its related regulations and reimbursement will be in accordance with an intercompany tax reimbursement arrangement. The Company generally will be paid for the tax benefit of any of their tax attributes used by any member of the consolidated group.
The Company provides for federal income taxes based on amounts the Company believes it ultimately will owe. Inherent in the provision for federal income taxes are estimates regarding the deductibility of certain items and the realization of certain tax credits. In the event the ultimate deductibility of certain items or the realization of certain tax credits differs from estimates, the Company may be required to significantly change the provision for federal income taxes recorded in the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. Any such change could significantly affect the amounts reported in the Statutory Statements of Operations. Management uses best estimates to establish reserves based on current facts and circumstances regarding tax exposure items where the ultimate deductibility is open to interpretation. Quarterly, management evaluates the appropriateness of such reserves based on any new developments specific to their fact patterns. Information considered includes results of completed tax examinations, Technical Advice Memorandums, and other rulings issued by the Internal Revenue Service or the tax courts.
The Company utilizes the asset and liability method of accounting for income taxes. DTAs and deferred tax liabilities (DTLs), net of the nonadmitted portion are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Gross DTAs and DTLs are measured using enacted tax rates and are considered for admitted tax asset status according to the admissibility test as set forth by the state of New York. Changes in DTAs and DTLs, including changes attributable to changes in tax rates, are recognized as a component of Unassigned surplus on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(m)    Separate Accounts
Separate account assets and liabilities are primarily funds held for the exclusive benefit of variable and variable-indexed annuity contract holders. Separate account assets are reported at fair value in accordance with SSAP No. 56 – Separate Accounts (SSAP No. 56), with the exception of certain bonds, cash, cash equivalents, and investment income due and accrued. Certain assets that are allocated to the index options for the Allianz Index Advantage New York Variable Annuity (VIA), as listed above, are carried at amortized cost in accordance with the product filing requirements in the state of New York.
Amounts due from separate accounts primarily represent the difference between the surrender value of the contracts and the Separate account liability as disclosed on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. This receivable represents the surrender fee that would be paid to the Company upon the surrender of the policy or contract by the policyholder or contract holder as of December 31. Amounts charged to the contract holders for mortality and contract maintenance, and other administrative services fees are included in income within Fees from separate accounts on the Statutory Statements of Operations. These fees have been earned and assessed against contract holders on a daily or monthly basis throughout the contract period and are recognized as revenue when assessed and earned. Transfers to separate accounts within the Statutory Statements of Operations primarily includes transfers for new premium and annuity considerations, benefit payments, surrender charge wear-off, realized and unrealized investment gains/losses, investment income, and other contractholder behavior.
Statutory Financial Statements for the year ended December 31, 2023










14 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(n)    Receivables
Receivable balances approximate estimated fair values. This is based on pertinent information available to management as of year-end, including the financial condition and creditworthiness of the parties underlying the receivables. Any balances outstanding more than 90 days are nonadmitted on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
(o)    Reclassifications
On the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus, there were policyholder suspense items within Other liabilities that were material enough to warrant their own line item, and therefore, were reclassified to Other policyholder funds. The prior year balance was reclassified to conform to the current year presentation.
(3)    Accounting Changes and Corrections of Errors
Accounting Changes
During 2023, the Company changed its accounting policy for internal exchanges, which are 1035 tax-free exchanges initiated by the policyholder to transition from an existing annuity contract to a new like kind annuity contract. Historically, the transaction was recorded net, with no financial statement impact. The Company has concluded that the transaction should be accounted for as a surrender of the existing contract within Surrenders on the Statement of Operations and a subsequent application of premium on the new contract within Premiums and annuity considerations on the Statement of Operations. This change in accounting policy was effective January 1, 2023. As the increase in both Premium and annuity considerations and Surrenders net to zero, there is no change to net income or surplus for the year ended December 31, 2022.
Recently Issued Accounting Standards – Adopted in 2023
In March 2020, the NAIC adopted NS 2020-12, Reference Rate Reform, which provides optional guidance for a limited period of time to ease the potential burden on accounting for reference rate reform. The expedients outlined in the amendment are for modifications solely related to reference rate reform and optionally suspend assessments for re-measuring a contract. The Company adopted these amendments effective March 12, 2020. In August 2023, the NAIC adopted NS 2023-05, whereby the sunset date for relief afforded by NS 2020-12, was deferred until December 31, 2024. The Company has evaluated the impact of the new guidance and has identified financial assets which have terms related to reference rates that are expected to be discontinued. As of December 31, 2023, the Company has utilized the optional expedient to account for all modifications to financial assets occurring as a result of reference rate reform as a continuation of the existing financial asset. There was no impact on net income or surplus during the year-ended December 31, 2023, as a result of adopting the revisions.
In August 2023, the NAIC adopted INT 23-01 Negative IMR. The temporary relief, which is optional for all companies required to maintain an AVR and IMR, allows for those entities to admit a limited amount of a net negative IMR balance as an admitted asset on a reporting entity's balance sheet. The revisions are effective as of August 13, 2023, and will be automatically nullified on January 1, 2026. The Company has adopted and implemented this INT for the purposes of December 31, 2023 reporting. Financial impacts associated with the implementation of this adoption are contained within Note 5(i), per the disclosure requirements associated with INT 23-01.
Recently Issued Accounting Standards – Adopted in 2022
Not applicable.
Recently Issued Accounting Standards – Adopted in 2021
In 2021, the NAIC extended the following interpretations (INT) in response to the COVID-19 pandemic:
INT 20-03, Troubled Debt Restructuring due to COVID-19. This INT followed the interagency COVID-19 guidance issued by federal and state prudential banking regulators (and concurred by the FASB) and the Coronavirus Aid, Relief, and Economic Security (CARES) Act. Specifically, a modification of a mortgage loan or bank loan terms did not result in troubled debt restructurings as long as
Statutory Financial Statements for the year ended December 31, 2023










15 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



the modification was in response to COVID-19, the borrower was current at the time of the modification, and the modification was short-term. In addition, insurers were not required to designate mortgage loans or bank loans with deferrals granted due to COVID-19 as past due or report them as nonaccrual loans. This INT was effective for the period beginning March 1, 2020 and originally expired on December 31, 2020. In January 2021, the provisions in this INT were extended updating the effective period to be the earlier of January 1, 2022 or the date that is 60 days after the date on which the national emergency declared by the President terminates. This INT did not impact the Company.
INT 20-07, Troubled Debt Restructuring of Certain Debt Investments Due to COVID-19. This INT provided temporary guidance by allowing practical expedients when assessing whether modifications made to debt securities (under SSAP No. 26R and SSAP No. 43R) due to COVID-19 are insignificant. Specifically, the guidance proposed restructurings in response to COVID-19 are considered to be insignificant if the restructuring resulted in a 10% or less shortfall amount in the contractual amount due and did not extend the maturity of the investment by more than 3 years. This INT was effective for the period beginning March 1, 2020 and originally expired on December 31, 2020. In January 2021, the provisions in this INT were extended updating the effective period to be the earlier of January 1, 2022 or the date that is 60 days after the date on which the national emergency declared by the President terminates. This INT did not impact the Company.
In 2016, the NAIC adopted revisions to SSAP No. 51R, Life Contracts and SSAP No. 54, Individual and Group Accident and Health Contracts, Issue Paper No. 154, Implementation of Principles-Based Reserving. These revisions relate to the adoption of the Valuation Manual and provides for principles based reserving for Life and Heath contracts. The Valuation Manual is part of the Department Regulation 213. Final adoption of the First Amendment to Regulation 213 was published February 2020 and provides the following revisions: 1) VM-20, Requirements for Principle-Based Reserves for Life Products, is effective January 1, 2020. However, an insurer could request a one-year delay in adopting this standard. The Company adopted Regulation 213 for life products as of January 1, 2021 for new business issued January 1, 2021 and later, in accordance with its agreement with the Department. The adoption resulted in an immaterial impact. 2) VM-21, Requirements for Principle-Based Reserves for Variable Annuities was adopted in 2020. 3) VM-22, Statutory Maximum Valuation Interest Rates for Income Annuities, VM-25, Health Insurance Reserves Minimum Requirements, and VM-26, Credit Life and Disability Reserve Requirements, are not applicable as the Company does not issue these contracts
Recently Issued Accounting Standards – To Be Adopted
In August 2023, the NAIC adopted revisions to SSAP No. 26R and SSAP No. 43R, and updated references for various SSAPs to accommodate the two newly revised and adopted standards. Both revised SSAPs as well as the updated references were adopted as part of SAPWG's Principles Based Bond Definition project, and represent the first step towards implementing the new bond definition. The revised standards will be effective starting January 1, 2025. The Company is currently assessing the impacts of the amendments.
In December 2023, the NAIC adopted revisions to the Annual Statement Instructions through Ref #2023-15: IMR/AVR Specific Allocations. The revisions clarify the treatment of realized gains or losses in the context of allocating those gains and losses to either AVR or IMR. While the amendment reflects a SAP Clarification, the amendment addresses a new concept in basing the allocation of realized gains or losses on an "Acute Credit Event." The amendment is effective beginning January 1, 2024, and the Company plans to adopt these revisions as of that date. As this amendment applies to future transactions, there will be no impact to net income or surplus upon adoption.
Corrections of Errors
The Company records corrections of errors in accordance with SSAP No. 3 – Accounting Changes and Correction of Errors (SSAP No. 3). SSAP No. 3 prescribes that the correction of errors in previously issued Statutory Financial Statements will be reported as an adjustment to capital and surplus in the period the error is detected. These errors are shown within Correction of errors, net of tax, on the Statutory Statements of Capital and Surplus.
Statutory Financial Statements for the year ended December 31, 2023










16 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



During 2023, an error was identified related to the non-admittance of negative IMR that resulted from separate account assets. As of December 31, 2022, the Company had produced a negative IMR in both the general account and the separate account, and therefore, should have non-admitted all negative IMR. The negative IMR in the general account was appropriately being fully non-admitted, however, the impacts from the non-admitted IMR in the separate account were not being reflected appropriately in the general account. The error resulted in a $2,198 overstatement of Due from the separate accounts and a corresponding $2,198 overstatement of Total capital and surplus within the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus as of December 31, 2022. The Statutory Statements of Capital and Surplus was adjusted in 2023 to correct for the prior period impact.
During the years ended December 31, 2022 and 2021 there were no corrections of errors recorded on the Statutory Statements of Capital and Surplus.
(4)    Risk Disclosures
The following is a description of the significant risks facing the Company and how it attempts to mitigate those risks:
(a)    Credit Risk
Credit risk is the risk that issuers of fixed-income securities, or other parties with whom the Company has transactions, such as reinsurers and derivative counterparties, default on their contractual obligations, resulting in unexpected credit losses.
The Company mitigates this risk by adhering to investment policies and limits that provide portfolio diversification on an asset class, asset quality, creditor, and geographical basis, and by complying with investment limitations from applicable state insurance laws and regulations. The Company considers all relevant objective information available in estimating the cash flows related to structured securities. The Company actively monitors and manages exposures, and determines whether any securities are impaired. The aggregate credit risk is influenced by management’s risk/return preferences, the economic and credit environment, and the ability to manage this risk through liability portfolio management.
For derivative counterparties, the Company mitigates credit risk by tracking and limiting exposure to each counterparty through limits that are reported regularly and, once breached, restricts further trades; establishing relationships with counterparties rated BBB+ and higher; and monitoring the credit default swaps (CDS) of each counterparty as an early warning signal to cease trading when credit default swap spreads imply severe impairment in credit quality.
The Company executes Credit Support Annexes (CSA) with all active and new counterparties which further limits credit risk by requiring counterparties to post collateral to a segregated account to cover any counterparty exposure. Additionally most transactions are cleared through a clearinghouse thereby transferring counterparty risk from the bank to the clearinghouse that tends to have stronger credit. This often leads to increased collateralization and lower counterparty risk for the Company.
(b)    Credit Concentration Risk
Credit concentration risk is the risk of increased exposure to significant asset defaults (of a single security issuer); economic conditions (if business is concentrated in a certain industry sector or geographic area); or adverse regulatory or court decisions (if concentrated in a single jurisdiction) affecting credit.
The Company’s Finance Committee, responsible for asset/liability management (ALM) issues, recommends an investment policy to the Company’s Board of Directors (BOD) and approves the strategic asset allocation and accompanying investment mandates for an asset manager with respect to asset class. The investment policy and accompanying investment mandates specify asset allocation among major asset classes and the degree of asset manager flexibility for each asset class. The investment policy complies, at a minimum, with state statutes. Compliance with the policy is monitored by the Finance Committee who is responsible for implementing internal controls and procedures. Deviations from the policy are monitored and addressed. The Finance Committee and, subsequently, the BOD review the investment policy at least annually.
Statutory Financial Statements for the year ended December 31, 2023










17 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



To further mitigate this risk, internal concentration limits based on credit rating and sector are established and are monitored regularly by Allianz Life on a consolidated basis. Any ultimate obligor group exceeding these limits is placed on a restricted list to prevent further purchases, and the excess exposure may be actively sold down to comply with concentration limit guidelines. Any exceptions require Chief Risk Officer approval and monitoring by the Risk Committee. Further, the Company performs a quarterly concentration risk calculation to ensure compliance with the State of New York basket clause.
(c)    Liquidity Risk
Liquidity risk is the risk that unexpected timing or amounts of cash needed will require liquidation of assets in a market that will result in a realized loss or an inability to sell certain classes of assets such that an insurer will be unable to meet its obligations and contractual guarantees. Liquidity risk also includes the risk that in the event of a company liquidity crisis, refinancing is only possible at higher interest rates. Liquidity risk can be affected by the maturity of liabilities, the presence of withdrawal penalties, the breadth of funding sources, and terms of funding sources. It can also be affected by counterparty collateral triggers as well as whether anticipated liquidity sources, such as credit agreements, are cancelable.
The Company manages liquidity within four specific domains: (1) monitoring product development, product management, business operations, and the investment portfolio; (2) setting ALM strategies; (3) managing the cash requirements stemming from the Company’s derivative dynamic economic hedging activities; and (4) establishing a liquidity facility with Allianz Life to provide additional liquidity. The Company has established liquidity risk limits, which are approved by the Company’s Risk Committee, and the Company monitors its liquidity risk regularly.
(d)    Interest Rate Risk
Interest rate risk is the risk that movements in interest rates or interest rate volatility will cause a decrease in the value of an insurer’s assets relative to the value of its liabilities and/or an unfavorable change in prepayment activity resulting in compressed interest margins.
The Company has an ALM strategy to align cash flows and duration of the investment portfolio with policyholder liability cash flows and duration. Allianz Life monitors the economic and accounting impacts of interest rate sensitivities on assets and liabilities on a consolidated basis regularly and on the Company's specific basis periodically.
(e)    Equity Market Risk
Equity market risk is the risk that movements in equity prices or equity volatility will cause a decrease in the value of an insurer’s assets relative to the value of its liabilities.
Variable annuity products guarantee minimum payments regardless of market movements. The Company has adopted an economic hedging program to manage the equity risk of these products.
Allianz Life monitors the impacts of equity sensitivities on assets and liabilities on a consolidated basis regularly and on the Company’s specific basis periodically.
Basis risk is the risk that variable annuity hedge asset values change unexpectedly relative to the value of the underlying separate account funds of the variable annuity contracts. Basis risk may arise from the Company’s inability to directly hedge the underlying investment options of the variable annuity contracts. The Company regularly reviews and synchronizes fund mappings, product design features, hedge design, and manages funds line-up.
(f)    Operational Risk
Operational risk is the risk of loss resulting from inadequate or failed internal processes and systems, from human misbehavior or error, or from external events. Operational risk is comprised of the following seven risk categories: (1) external fraud; (2) internal fraud; (3) employment practices and workplace safety; (4) clients/third-party, products and business practices; (5) damage to physical assets; (6) business disruption and system
Statutory Financial Statements for the year ended December 31, 2023










18 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



failure; and (7) execution, delivery, and process management. Operational risk is comprehensively managed through a combination of core qualitative and quantitative activities.
The Operational Risk Management framework includes the following key activities: (1) an Operational Risk Capital Model covering all material types of operational risks, under which the Company quantifies and regularly monitors operational risk; (2) a loss data capture policy to create transparency and gather information about losses that meet a designated threshold, requiring business owners to identify and resolve the root cause of operational loss events; and (3) a bottom-up risk assessment process for significant operational risk scenarios to proactively manage significant operational risk scenarios throughout the organization.
(g)    Regulatory Change Risk
Regulatory change risk is the risk that regulatory changes and imposed regulation may materially impact the Company's business model, sales levels, company financials and ability to effectively comply with regulations.
The Company actively monitors all regulatory changes and participates in national and international discussions relating to legal, regulatory, and accounting changes. The Company maintains active membership with various professional and industry trade organizations. A formal process exists to review, analyze, and implement new legislation as it is enacted.
(h)    Rating Agency Risk
Rating agency risk is the risk that rating agencies change their outlook or rating of the Company. The rating agencies generally utilize proprietary capital adequacy models in the process of establishing ratings for the Company. The Company is at risk of changes in these models and the impact that changes in the underlying business that it is engaged in can have on such models. To mitigate this risk, the Company maintains regular communications with the rating agencies and evaluates the impact of significant transactions on such capital adequacy models and considers the same in the design of transactions to minimize the adverse impact of this risk. Rating agency risk is also addressed in the TRA process and on an ad hoc basis as necessary.
(i)    Mortality/Longevity Risk
Mortality/longevity risk is the risk that mortality experience is different than the life expectancy assumptions used by the Company to price its products.
The Company mitigates mortality risk primarily through reinsurance, whereby the Company cedes a significant portion of its mortality risk to third parties. The Company also manages mortality risk through the underwriting process. Both mortality and longevity risks are managed through the review of life expectancy assumptions and experience in conjunction with active product management.
(j)    Lapse Risk
Lapse risk is the risk that actual lapse experience evolves differently than the assumptions used for pricing and valuation exercises leading to a significant loss in Company value and/or income.
The Company mitigates this risk by performing sensitivity analysis at the time of pricing to affect product design, adding Market Value Adjustments and surrender charges when appropriate, regular ALM analysis, and exercising management levers at issue, as well as post-issue as experience evolves. Policyholder experience is monitored regularly.
(k)    Cyber Security Risk
Cyber security risk is the risk of losses due to external and/or internal attacks impacting the confidentiality, integrity, and/or availability of key systems, data, and processes reliant on digital technology. The Company has implemented preventative, detective, response, and recovery measures including firewalls, intrusion detection and prevention, advanced malware detection, spyware and anti-virus software, email protection, network and laptop encryption, web content filtering, web application firewalls, and regular scanning of all servers and network devices to identify vulnerabilities. Controls are implemented to prevent and review unauthorized access.
Statutory Financial Statements for the year ended December 31, 2023










19 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(l)    Reinsurance Risk
Reinsurance risk is the risk that reinsurance companies default on their obligation where the Company has ceded a portion of its insurance risk. The Company uses reinsurance to limit its risk exposure to certain business lines and to enable better capital management.
Reinsurance contracts do not relieve the Company from its obligations to policyholders. Failure of reinsurers to honor their obligations could result in losses to the Company.
The Company mitigates this risk by requiring certain counterparties to post collateral to cover the exposure and to meet thresholds related to the counterparty’s credit rating, exposure, or other factors. For counterparties that are not initially required to post collateral, if the thresholds are not met by those counterparties, they are required to establish a trust or letter of credit backed by assets meeting certain quality criteria. All arrangements are regularly monitored to determine whether trusts or letters of credit are sufficient to support the ceded liabilities and that their terms are being met. In addition, the Company reviews the financial standings and ratings of its reinsurance counterparties and monitors concentrations of credit risk to minimize its exposure to significant losses from reinsurer insolvencies regularly.
(5)    Investments
(a)    Bonds and Other Assets Receiving Bond Treatment
At December 31, the amortized cost, gross unrealized gains, gross unrealized losses, and fair values of investments are shown below:     





























2023


Amortized cost
Gross unrealized gains
Gross unrealized losses
Fair value
Bonds:







U.S. government
$ 142,582 

— 

8,161 

134,421 
States and political subdivisions
8,623 

38 

677 

7,984 
Corporate securities
364,970 

6,390 

27,399 

343,961 
Mortgage-backed securities
102,497 

63 

8,638 

93,922 
Total
$ 618,672 

6,491 

44,875 

580,288 





























2022


Amortized cost
Gross unrealized gains
Gross unrealized losses
Fair value
Bonds:







U.S. government
$ 192,732 

— 

12,000 

180,732 
States and political subdivisions
6,788 

22 

776 

6,034 
Corporate securities
340,514 

2,477 

37,920 

305,071 
Mortgage-backed securities
107,388 



10,707 

96,690 
Total
$ 647,422 

2,507 

61,403 

588,527 
At December 31, 2023 and 2022, the Company did not have NAIC-6 rated bonds.
At December 31, 2023 and 2022, the Company did not have any hybrid securities.
As of December 31, 2023 and 2022, investments with an amortized cost of $1,662 and $1,651, respectively were held on deposit as required by statutory regulations.
Statutory Financial Statements for the year ended December 31, 2023










20 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



The amortized cost and fair value of bonds and other assets receiving bond treatment reported in the statutory Annual Statement Schedule D Part 1A at December 31, 2023, by contractual maturity, are shown below:

















Amortized cost
Fair value
Due in 1 year or less
$ 13,653 

13,445 
Due after 1 year through 5 years
174,094 

168,850 
Due after 5 years through 10 years
71,238 

70,607 
Due after 10 years through 20 years
202,492 

180,523 
Due after 20 years
54,698 

52,941 
Loan-backed and other structured securities
102,497 

93,922 
       Total bonds and other assets receiving bond treatment
$ 618,672 

580,288 
Expected maturities will differ from contractual maturities, because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
Proceeds from sales of bonds includes sales, maturities, paydowns, and other redemptions of bonds and other assets receiving bond treatment. Proceeds from sales of bonds for the years ended December 31 are shown below:























2023
2022
2021
Proceeds from sales
$ 89,218 

97,922 

82,882 
Gross gains
181 

152 

82 
Gross losses
1,837 

335 

80 
For the years ended December 31, 2023 and 2022, there were 1 and 13 CUSIPs sold, disposed, or otherwise redeemed as a result of a callable feature, respectively. The aggregate amount of investment income generated as a result of these transactions was $0 and $642 for 2023 and 2022, respectively.
The Company’s bond portfolio includes mortgage-backed securities. Due to the high quality of these investments and the lack of subprime loans within the securities, the Company does not have a material exposure to subprime mortgages.
(b)    Unrealized Investment Losses
To determine whether or not declines in fair value are other than temporary, Allianz Life performs a quarterly review of its entire combined investment portfolio, including the Company as their subsidiary, using quoted market prices by third-party sources. For further discussion, see Notes 2 and 6.
Unrealized losses and the related fair value of investments held by the Company for the years ended December 31 are shown below:





































2023

12 months or less
Greater than 12 months
Total

Fair value
Unrealized losses
Fair value
Unrealized losses
Fair value
Unrealized losses
Bonds:










U.S. government $ — 

— 

134,421 

8,161 

134,421 

8,161 
States and political subdivisions 1,881 

54 

5,220 

623 

7,101 

677 
Corporate securities 15,227 

360 

213,090 

27,040 

228,317 

27,400 
Mortgage-backed securities 606 



89,360 

8,632 

89,966 

8,637 
Total temporarily impaired securities $ 17,714 

419 

442,091 

44,456 

459,805 

44,875 
Statutory Financial Statements for the year ended December 31, 2023










21 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)








































2022

12 months or less
Greater than 12 months
Total

Fair value
Unrealized losses
Fair value
Unrealized losses
Fair value
Unrealized losses
Bonds:










U.S. government $ 149,836 

7,654 

30,896 

4,346 

180,732 

12,000 
States and political subdivisions 5,088 

776 

— 

— 

5,088 

776 
Corporate securities 197,026 

22,189 

56,543 

15,731 

253,569 

37,920 
Mortgage-backed securities 78,483 

5,516 

17,776 

5,191 

96,259 

10,707 
Total temporarily impaired securities $ 430,433 

36,135 

105,215 

25,268 

535,648 

61,403 
As of December 31, 2023 and 2022, the number of bonds that were in an unrealized loss position was 200 and 225, respectively.
As of December 31, 2023 and 2022, of the total amount of unrealized losses, $44,672, or 99.5%, and $61,245, or 99.7%, respectively, are related to unrealized losses on investment grade securities. Investment grade is defined as a security having an NAIC SVO credit rating of 1 or 2. Unrealized losses on securities are principally related to changes in interest rates or changes in sector spreads from the date of purchase. As contractual payments continue to be met, management continues to expect all contractual cash flows to be received and does not consider these investments to be other-than-temporarily impaired.
(c)    Realized Investment Gains (Losses)
Net realized capital gains (losses) for the years ended December 31 are shown below:























2023
2022
2021
Bonds
$ (1,912)

(722)


Derivatives
(41,041)

23,057 

(60,008)
Other


(25)

64 
Total realized capital (losses) gains
(42,948)

22,310 

(59,942)
Income tax benefit (expense) on net realized gains (losses)
450 

38 

(20)
Total realized capital (losses) gains, net of taxes
(42,498)

22,348 

(59,962)
Net (losses) gains transferred to IMR, net of taxes
(1,341)

(290)

(5)
Net realized (losses) gains, net of taxes and IMR
$ (41,157)

22,638 

(59,957)
(d)    Net Investment Income
Major categories of net investment income for the years ended December 31 are shown below:























2023
2022
2021
Interest:





Bonds
21,130 

20,464 

19,345 
Policy loans
11 




Cash, cash equivalents, and short-term investments
3,085 

553 


Derivatives
— 

— 

(1)
Other
96 

72 

119 
Gross investment income
24,322 

21,097 

19,472 
Investment expenses
(1,532)

(971)

(1,579)
Net investment income before amortization of IMR
22,790 

20,126 

17,893 
Amortization of IMR
(2,759)

(2,026)

(1,716)
Net investment income
$ 20,031 

18,100 

16,177 

Statutory Financial Statements for the year ended December 31, 2023










22 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



Interest income due and accrued for the years ended December 31 was as follows:













2023
2022
Gross $ 5,071 

4,719 
Nonadmitted — 

— 
Admitted $ 5,071 

4,719 
The Company had no aggregate deferred interest as of December 31, 2023 and 2022.
The Company had no cumulative amounts of paid-in-kind interest included in the current principal balance as of December 31, 2023 and 2022.
(e)    Loan-Backed Securities
SSAP No. 43R requires the bifurcation of impairment losses on loan-backed or structured securities into interest and noninterest-related portions. The noninterest portion is the difference between the present value of cash flows expected to be collected from the security and the amortized cost basis of the security. The interest portion is the difference between the present value of cash flows expected to be collected from the security and its fair value at the balance sheet date.
The Company had no loan-backed securities with a recognized OTTI for the years ended December 31, 2023 and 2022.
(f)    Derivatives and Hedging Instruments
The Company does not have derivative contracts with financing premium. Derivatives held by the Company do not qualify for hedge accounting treatment.
Futures and Options Contracts
OTC options are cleared through the Options Clearing Corporation, which operates under the jurisdiction of both the Securities and Exchange Commission (SEC) and the Commodities Futures Trading Commission. The fair values of the collateral posted for futures and OTC options are discussed in the derivative collateral management section below.
The following table presents a summary of the aggregate notional amounts and fair values of the Company’s derivative instruments reported on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus as of December 31:









































2023
2022




Gross Fair Value


Gross Fair Value


Notional (1)

Assets
Liabilities
Notional (1)

Assets
Liabilities
OTC options
$ 111 

26 

— 

— 

— 

— 
Futures
336,455 

— 

— 

302,305 

— 

— 
Total derivative instruments


$ 26 

— 



— 

— 













(1) Notional amounts are presented on an absolute basis.
Derivative Collateral Management
The Company manages derivative collateral for the general account and separate account combined. Additionally, said derivative collateral is managed separately between exchange-traded and OTC derivatives. The total collateral posted for exchange-traded derivatives at December 31, 2023 and 2022, had a fair value of $45,086 and $26,302, respectively, and is included in Bonds on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus and recorded at amortized cost. The Company retains ownership of the exchange-traded collateral, but the collateral resides in an account designated by the exchange. The collateral is subject to specific exchange rules regarding rehypothecation.
Statutory Financial Statements for the year ended December 31, 2023










23 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(g)    Offsetting Assets and Liabilities
The Company elects to disclose derivative assets and liabilities eligible for offset under SSAP No. 64 – Offsetting and Netting of Assets and Liabilities on a gross basis on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus in accordance with the provisions set forth in SSAP No. 86. This treatment is consistent with the Company’s historical reporting presentation.
(h)    Restricted Assets
As of December 31, 2023, the Company had the following restricted assets, including assets pledged to others as collateral, recorded at book value:





















































Gross Restricted




Percentage


Total general account
Total separate account
Total current year
Total prior year
Increase (decrease)
Total current year admitted restricted
Gross restricted to total assets
Admitted restricted to total admitted assets
On deposit with states
$ 1,662 

— 

1,662 

1,651 

11 

1,662 

—  %
—  %
Derivative collateral
50,136 

— 

50,136 

48,894 

1,242 

50,136 

0.8 

0.8 
Total restricted assets
51,798 

— 

51,798 

50,545 

1,253 

51,798 

0.8  %
0.8  %
(i)    Negative IMR
Fixed income investments generating IMR losses comply with the the Company’s documented investment and liability management policies. IMR losses for fixed-income-related derivatives are all in accordance with prudent and documented risk management procedures, in accordance with the Company’s derivative use plans and reflect symmetry with historical treatment in which unrealized derivative gains were reversed to IMR and amortized in lieu of being recognized as realized gains upon derivative termination. Asset sales that generated admitted negative IMR were not compelled by liquidity pressures.
As of December 31, 2023, the Company had the following net negative IMR and admitted negative IMR balances:













2023

General Account Insulated Separate Account Non-Insulated Separate Account
Net Negative IMR $ (11,618)
— 
(4,669)
Admitted Negative IMR 11,618 
— 
4,290 
Calculated Adjusted Capital and Surplus 159,072
Percentage of Admitted Negative IMR to Adjusted Capital 7.3  % —  % 2.7  %
As of December 31, 2022, the Company had no admitted negative IMR balances.
As of December 31, 2023, the Company had the following unamortized balances in IMR from the allocation of gains/losses from derivatives that were reported at fair value prior to the termination of the derivative:













2023

General Account Insulated Separate Account Non-Insulated Separate Account
Unamortized gains $ 32,780 
— 
— 
Unamortized losses (19,718)
— 
— 
There were no unamortized balances in IMR as of December 31, 2022.
Statutory Financial Statements for the year ended December 31, 2023










24 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(6)    Fair Value Measurements
SSAP No. 100R – Fair Value establishes a fair value hierarchy that prioritizes the inputs used in the valuation techniques to measure fair value.
Level 1 –     Unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date.
Level 2 –     Valuations derived from techniques that utilize observable inputs, other than quoted prices included in Level 1, which are observable for the asset or liability either directly or indirectly, such as:
(a)    Quoted prices for similar assets or liabilities in active markets.
(b)    Quoted prices for identical or similar assets or liabilities in markets that are not active.
(c)    Inputs other than quoted prices that are observable.
(d)    Inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 –     Valuations derived from techniques in which the significant inputs are unobservable. Level 3 fair values reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).
The Company has analyzed the valuation techniques and related inputs, evaluated its assets and liabilities reported at fair value, and determined an appropriate fair value hierarchy level based upon trading activity and the observability of market inputs. Based on the results of this evaluation and investment class analysis, each financial asset and liability was classified into Level 1, 2, or 3.
The following presents the assets and liabilities measured at fair value on a recurring basis and their corresponding level in the fair value hierarchy at December 31:





























2023


Level 1
Level 2 (a)

Level 3
Total
Assets at fair value







Derivative assets
$ — 

26 

— 

26 
Separate account assets
$ 1,945,422 

459,996 

— 

2,405,418 
Total assets reported at fair value
1,945,422 

460,022 

— 

2,405,444 
Liabilities at fair value







Separate account derivative liabilities
— 

174,717 

— 

174,717 
Total liabilities reported at fair value
$ — 

174,717 

— 

174,717 









(a) The Company does not have any assets or liabilities measured at net asset value (NAV) that are included in Level 2 within this table.
Statutory Financial Statements for the year ended December 31, 2023










25 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)
































2022


Level 1
Level 2 (a)

Level 3
Total
Assets at fair value







Derivative assets
$ — 

— 

— 

— 
Separate account assets
1,958,660 

113,012 

— 

2,071,672 
Total assets reported at fair value
1,958,660 

113,012 

— 

2,071,672 
Liabilities at fair value







Separate account derivative liabilities
— 

122,296 

— 

122,296 
Total liabilities reported at fair value
$ — 

122,296 

— 

122,296 









(a) The Company does not have any assets or liabilities measured at NAV that are included in Level 2 within this table.
The following is a discussion of the methodologies used to determine fair values for the assets and liabilities listed in the above table. These fair values represent an exit price (i.e., what a buyer in the marketplace would pay for an asset in a current sale or charge to transfer a liability). The Company has not made changes to valuation techniques in 2023.
(a)    Valuation of Derivatives
The fair value of OTC option assets and liabilities are derived internally, by calculating their expected discounted cash flows, using a set of calibrated, risk-neutral stochastic scenarios, including a market data monitor, a market data model generator, a stochastic scenario calibrator, and the actual asset pricing calculator, because active markets do not exist. Options that are internally priced and IRS, foreign currency swaps, TBA securities, and CDS are included in Level 2, because they use market observable inputs. The fair values of exchange-traded options and futures contracts are based on quoted market prices in active markets and are included in Level 1.
Certain derivatives are priced using external third-party vendors. The Company has controls in place to monitor the valuations of these derivatives. These prices are also internally recalculated and reviewed for reasonableness at the position level on a monthly basis. The Company does not have insight into the specific inputs used by third-party vendors; however, the key unobservable input would generally include the spread.
(b)    Valuation of Separate Account Assets and Separate Account Derivative Liabilities
Separate account assets and Separate account derivative liabilities, with the exception of certain bonds, cash, cash equivalents and investment income due and accrued, are carried at fair value, which is based on the fair value of the underlying assets which are described throughout this note. Funds in the separate accounts are primarily invested in variable investment option funds with the following investment types: bond, domestic equity, international equity, or specialty. Variable investment option funds are included in Level 1 because their fair value is based on quoted prices in active, observable markets. The remaining investments are categorized similar to the investments held by the Company in the general account (e.g., if the separate account invested in bonds, short-term investments and derivatives, that portion could be classified within Level 2 or Level 3). Certain bonds, cash and cash equivalents, along with related accrued investment income and receivables, carried at amortized cost within the separate account have an amortized cost of $2,973,744 and $2,275,854 as of December 31, 2023 and 2022, respectively, and a fair value of $2,778,435 and $1,956,071 as of December 31, 2023 and 2022, respectively. Separate account assets carried at amortized cost are included in the table in section 6(f) below.

Statutory Financial Statements for the year ended December 31, 2023










26 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(c)    Level 3 Rollforward
The Company did not have any Level 3 assets or liabilities during the year ended December 31, 2023.
The following table provides a reconciliation of the beginning and ending balances for the Company’s Level 3 assets and liabilities measured at fair value on a recurring basis:

























January 1, 2022 Transfers into
Level 3
Transfers out
of Level 3
Total gains
and (losses)
included in
Net Income
Total gains
and (losses)
included in
Surplus
Purchases, issuances, sales and settlements December 31, 2022








TRS asset $ — 
— 
— 
— 
— 
— 
— 
Total Level 3 assets — 
— 
— 
— 
— 
— 
— 








TRS liability — 
— 
— 
(758)
— 
758 
— 
Total Level 3 liabilities $ — 
— 
— 
(758)
— 
758 
— 
(d)    Transfers
The Company reviews its fair value hierarchy classifications quarterly. Transfers between levels occur when there are changes in the observability of inputs and market activity.
For the years ended December 31, 2023 and 2022, the Company did not have any transfers into or out of Level 3.
(e)    Estimates
The Company has been able to estimate the fair value of all financial assets and liabilities.
(f)    Aggregate Fair Value of Financial Instruments
The following tables present the carrying amounts and fair values of all financial instruments at December 31 (b):



































2023






Fair Value


Aggregate Fair Value
Admitted Assets/
Carrying Value

Level 1
Level 2
Level 3
Financial Assets









Bonds
$ 580,288 

618,672 

134,421 

443,089 

2,778 
Cash equivalents
47,759 

47,759 

47,759 

— 

— 
Derivative assets
26 

26 

— 

26 

— 
Separate account assets
5,199,897 

5,399,495 

2,014,610 

3,171,611 

13,676 
Financial Liabilities









Deposit-type contracts
$ 6,651 

6,478 

— 

— 

6,651 
Other investment contracts
247,134 

397,007 

— 

— 

247,134 
Separate account liabilities
5,199,897 

5,399,495 

2,014,610 

3,171,611 

13,676 











(b) The Company does not have any assets or liabilities measured at NAV that are included in Level 2 in this table. In addition, the Company has no assets or liabilities for which it is not practicable to measure at fair value.
Statutory Financial Statements for the year ended December 31, 2023










27 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)






































2022






Fair Value


Aggregate Fair Value
Admitted Assets/
Carrying Value

Level 1
Level 2
Level 3
Financial Assets









Bonds
$ 588,527 

647,422
180,732
407,795
— 
Cash equivalents
26,558 

26,558 

26,558 

— 

— 
Separate account assets
4,027,744 

4,347,526
1,982,157
2,045,587
— 
Financial Liabilities









Deposit-type contracts
$ 6,815 

6,735
— 

— 

6,815 
Other investment contracts
384,701 

434,151
— 

— 

384,701 
Separate account liabilities
4,027,744 

4,347,526
1,982,157 

2,045,587 

— 











(b) The Company does not have any assets or liabilities measured at NAV that are included in Level 2 in this table. In addition, the Company has no assets or liabilities for which it is not practicable to measure at fair value.
A description of the Company’s valuation techniques for financial instruments not reported at fair value and categorized within the fair value hierarchy is shown below:
Valuation of Bonds
The fair value of bonds is based on quoted market prices in active markets when available. Based on the market data, the securities are categorized into asset class, and based on the asset class of the security, appropriate pricing applications, models and related methodology, and standard inputs are utilized to determine what a buyer in the marketplace would pay for the security in a current sale. When quoted prices are not readily available or in an inactive market, standard inputs used in the valuation models, listed in approximate order of priority, include, but are not limited to, benchmark yields, reported trades, Municipal Securities Rulemaking Board reported trades, Nationally Recognized Municipal Securities Information Repository material event notices, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and industry and economic events. In some cases, including private placement securities and certain difficult-to-price securities, internal pricing models may be used that are based on market proxies. Internal pricing models based on market spread and U.S. Treasury rates are used to value private placement holdings. The primarily unobservable input used in the discounted cash flow models for states and political subdivisions, foreign government, and corporate bonds is a corporate index option adjusted spread (OAS). CDO and certain mortgage-backed securities are priced by a third-party vendor and the Company internally reviews the valuation for reasonableness. The Company does not have insight into the specific inputs; however, the key unobservable inputs would generally include default rates.
Generally, U.S. Treasury securities and exchange-traded stocks are included in Level 1. Most bonds for which prices are provided by third-party pricing sources are included in Level 2, because the inputs used are market observable. Bonds for which prices were obtained from broker quotes, certain bonds without active trading markets and private placement securities that are internally priced are included in Level 3.
Valuation of Cash Equivalents
Cash equivalents are comprised of money market mutual funds. The fair value of money market mutual funds is based on quoted market prices in active markets and included in Level 1.
Valuation of Deposit-Type Contracts
Fair values of deposit-type contracts are based on discounted cash flows using internal inputs, including the discount rate and consideration of the Company’s own credit standing and a risk margin for actuarial inputs.
Valuation of Other Investment Contracts
Other investment contracts are included within Life policies and annuity contracts within the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. Other investment contracts include certain reserves related to deferred annuities and other payout annuities that may include life contingencies, but do not
Statutory Financial Statements for the year ended December 31, 2023










28 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



have significant mortality risk due to substantial periods certain. Fair values are based on discounted cash flows using internal inputs, including the discount rate and consideration of the Company’s own credit standing and a risk margin for market inputs.
Valuation of Separate Account Liabilities
The fair value of separate account liabilities approximates the fair value of separate account assets.
(7)    Income Taxes
(a)    Deferred Tax Assets and Liabilities
The components of the net DTA or net DTL are as follows:



















December 31, 2023

Ordinary
Capital
Total
Total gross deferred tax assets
$ 29,751 

756 

30,507 
Statutory valuation allowance adjustments
— 

— 

— 
Adjusted gross deferred tax assets
29,751 

756 

30,507 
Deferred tax assets nonadmitted
(19,096)



(19,096)
Subtotal net admitted deferred tax assets
10,655 

756 

11,411 
Deferred tax liabilities
(1,190)

— 

(1,190)
Net admitted deferred tax assets
$ 9,465 

756 

10,221 



















December 31, 2022

Ordinary
Capital
Total
Total gross deferred tax assets
$ 27,191 

814 

28,005 
Statutory valuation allowance adjustments
— 

— 

— 
Adjusted gross deferred tax assets
27,191 

814 

28,005 
Deferred tax assets nonadmitted
(17,639)

— 

(17,639)
Subtotal net admitted deferred tax assets
9,552 

814 

10,366 
Deferred tax liabilities
(1,927)

— 

(1,927)
Net admitted deferred tax assets
$ 7,625 

814 

8,439 



















Change

Ordinary
Capital
Total
Total gross deferred tax assets
$ 2,560 

(58)

2,502 
Statutory valuation allowance adjustments
— 

— 

— 
Adjusted gross deferred tax assets
2,560 

(58)

2,502 
Deferred tax assets nonadmitted
(1,457)

— 

(1,457)
Subtotal net admitted deferred tax assets
1,103 

(58)

1,045 
Deferred tax liabilities
737 

— 

737 
Net admitted deferred tax assets
$ 1,840 

(58)

1,782 

The amount of admitted adjusted gross DTAs allowed under each component of SSAP No. 101 – Income Taxes (SSAP No. 101) as of December 31 are as follows:
Statutory Financial Statements for the year ended December 31, 2023










29 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)






















December 31, 2023

Ordinary
Capital
Total
Federal income taxes paid in prior years recoverable through loss carrybacks (11.a) $ — 

— 

— 
Adjusted gross DTAs expected to be realized after application of the threshold limitations





Lesser of 11.b.i or 11.b.ii:





Adjusted gross DTAs expected to be realized following the balance sheet date (11.b.i.)
9,465 

756 

10,221 
Adjusted gross DTAs allowed per limitation threshold (11.b.ii)
N/A
N/A
24,504 
Lesser of 11.b.i or 11.b.ii
9,465 

756 

10,221 
Adjusted gross DTAs offset by gross DTLs (11.c)
1,190 

— 

1,190 
Deferred tax assets admitted
$ 10,655 

756 

11,411 



















December 31, 2022

Ordinary
Capital
Total
Federal income taxes paid in prior years recoverable through loss carrybacks (11.a) $ — 

718 

718 
Adjusted gross DTAs expected to be realized after application of the threshold limitations





Lesser of 11.b.i or 11.b.ii:





Adjusted gross DTAs expected to be realized following the balance sheet date (11.b.i.)
7,625 

96 

7,721 
Adjusted gross DTAs allowed per limitation threshold (11.b.ii)
N/A
N/A
24,469 
Lesser of 11.b.i or 11.b.ii
7,625 

96 

7,721 
Adjusted gross DTAs offset by gross DTLs (11.c)
1,927 

— 

1,927 
Deferred tax assets admitted
$ 9,552 

814 

10,366 



















Change

Ordinary
Capital
Total
Federal income taxes paid in prior years recoverable through loss carrybacks (11.a) $ — 

(718)

(718)
Adjusted gross DTAs expected to be realized after application of the threshold limitations





Lesser of 11.b.i or 11.b.ii:





Adjusted gross DTAs expected to be realized following the balance sheet date (11.b.i.)
1,840 

660 

2,500 
Adjusted gross DTAs allowed per limitation threshold (11.b.ii)
N/A
N/A
35 
Lesser of 11.b.i or 11.b.ii
1,840 

660 

2,500 
Adjusted gross DTAs offset by gross DTLs (11.c)
(737)

— 

(737)
Deferred tax assets admitted
$ 1,103 

(58)

1,045 

Ratios used for threshold limitation as of December 31 are as follows:



















December 31


2023
2022
Change
Ratio percentage used to determine recovery period and threshold limitation amount 552  %
589  %
(37) %
Amount of adjusted capital and surplus used to determine recovery period threshold limitation $ 163,362 

$ 163,125 

$ 237 
Statutory Financial Statements for the year ended December 31, 2023










30 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



Impact of tax planning strategies on the determination of net admitted adjusted gross DTAs is as follows:



















December 31, 2023

Ordinary
Capital
Total
Net admitted adjusted gross DTAs - (percentage of total net admitted adjusted gross DTAs)
—  %
100.0  %
100.0  %



















December 31, 2022

Ordinary
Capital
Total
Net admitted adjusted gross DTAs - (percentage of total net admitted adjusted gross DTAs)
—  %
11.8  %
11.8  %



















Change

Ordinary
Capital
Total
Net admitted adjusted gross DTAs - (percentage of total net admitted adjusted gross DTAs)
—  %
88.2  %
88.2  %
The Company’s tax planning strategies do not include the use of reinsurance.
(b)    Unrecognized Deferred Tax Liabilities
There are no temporary differences for which DTLs are not recognized.
(c)    Current and Deferred Income Taxes
The significant components of income taxes incurred (i.e. Current income tax expense) include:































December 31




2023
2022
2021
2023-2022 Change
2022-2021 Change
Current year federal tax expense (benefit) - ordinary income $ (1,665)

3,586 

6,319 

(5,251)

(2,733)
Current year foreign tax expense (benefit) - ordinary income — 

— 

— 

— 

— 
Subtotal (1,665)

3,586 

6,319 

(5,251)

(2,733)
Current year tax expense (benefit) - net realized capital gains (losses) (450)

(38)

19 

(412)

(57)
Federal and foreign income taxes incurred $ (2,115)

3,548 

6,338 

(5,663)

(2,790)
DTAs and DTLs consist of the following major components:























December 31

Deferred tax assets
2023
2022
Change
Ordinary:





Deferred acquisition costs
$ 5,054 

4,241 

813 
Policyholder reserves
22,957 

22,937 

20 
Expense accruals




(6)
Investments
1,732 

— 

1,732 
Nonadmitted assets





Subtotal
29,751 

27,191 

2,560 
Nonadmitted ordinary deferred tax assets
(19,096)

(17,639)

(1,457)
Admitted ordinary tax assets
10,655 

9,552 

1,103 






— 
Capital:




— 
Impaired assets
756 

814 

(58)
Subtotal
756 

814 

(58)
Admitted capital deferred tax assets
756 

814 

(58)
Admitted deferred tax assets
$ 11,411 

10,366 

1,045 
Statutory Financial Statements for the year ended December 31, 2023










31 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)


























December 31

Deferred tax liabilities
2023
2022
Change
Ordinary:





Investments
$ (563)

(989)

426 
Policyholder reserves
(621)

(931)

310 
Deferred and uncollected premiums
(6)

(7)


Subtotal
(1,190)

(1,927)

737 







Capital:





Other
— 

— 

— 
Subtotal
— 

— 

— 
Deferred tax liabilities
(1,190)

(1,927)

737 
Net deferred tax asset
$ 10,221 

8,439 

1,782 
The realization of the DTAs is dependent upon the Company’s ability to generate sufficient taxable income in future periods. Based on historical results and the prospects for future current operations, management anticipates that it is more likely than not that future taxable income will be sufficient for the realization of the remaining DTAs.
The Inflation Reduction Act was enacted on August 16, 2022. The Company has determined as of December 31, 2023 that it is an applicable corporation with respect to the Corporate Alternative Minimum Tax ("CAMT"), but that it will not incur a CAMT liability in 2023. The financial statements, therefore, do not include any impact related to CAMT. The Company has made an accounting election to disregard CAMT when evaluating the need for a Valuation Allowance for its non-CAMT DTAs.
In computing taxable income, life insurance companies are allowed a deduction attributable to their life insurance and accident and health reserves. The Tax Act of 2017 significantly changed the methodology by which these reserves are computed for tax purposes. The changes are effective for tax years beginning after 2017 and are subject to a transition rule that spreads the additional income tax liability over the subsequent eight years beginning in 2018.  Due to complexities in the new methodology and limited guidance from the Internal Revenue Service and U.S. Treasury, the Company has recorded provisional amounts for the deferred tax revaluation associated with the changes in the computation of life insurance tax reserves based on information available at December 31, 2017.  Pursuant to Interpretation of the SAP Working Group 18-01: Updated Tax Estimates under the Tax Cuts and Jobs Act, provisional tax computations related to these amounts were reasonably estimated as of December 31, 2017 and have been adjusted based on guidance received from Internal Revenue Service and U.S. Treasury. Adjusted amounts are reflected in the Company's results of operations for the years ended December 31, 2023, 2022, and 2021.
The Change in net deferred income tax is comprised of the following (this analysis is exclusive of the nonadmitted DTAs as the Change in nonadmitted assets is reported separately from the Change in net deferred income tax in the Unassigned surplus section of the Statutory Statements of Capital and Surplus):



















December 31


2023
2022
Change
Net deferred tax assets
$ 29,316 

26,078 

3,238 
Statutory valuation allowance adjustment
— 

— 

— 
Net deferred tax assets after statutory valuation allowance
29,316 

26,078 

3,238 
Tax effect of unrealized gains/(losses)
(1,732)

626 

(2,358)
Change in net deferred income tax




$ 880 
Statutory Financial Statements for the year ended December 31, 2023










32 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(d)    Reconciliation of Federal Income Tax Rate to Actual Effective Rate
The provision for federal income taxes incurred is different from that which would be obtained by applying the statutory federal income tax rate to income before income taxes. The significant items causing this difference are as follows:



















December 31, 2023
December 31, 2022
December 31, 2021
Federal income tax rate 21.0  %
21.0  %
21.0  %
Amortization of IMR 2.1 

(0.9)

0.5 
Dividends received deduction (1.6)

1.0 

(0.8)
Tax hedges 0.9 

— 

(0.2)
Tax hedge reclassification (31.3)

(10.3)

(17.5)
Non-deductible expenses 0.8 

— 

— 
Prior period adjustments 0.4 

— 

0.5 
Change in deferred tax impairments 0.2 

0.3 

— 
Realized capital gains tax (1.6)

0.1 

— 
Correction of error surplus (1.7)

— 

— 
Effective tax rate (10.8) %
11.2  %
3.5  %






Federal and foreign income taxes incurred (6.0) %
(7.6) %
8.8  %
Realized capital gains tax (1.6)

0.1 

— 
Change in net deferred income taxes (3.2)

18.7 

(5.3)
Effective tax rate (10.8) %
11.2  %
3.5  %
(e)    Carryforwards, Recoverable Taxes, and IRC Section 6603 Deposits
As of December 31, 2023, there are no operating losses or tax credit carryforwards available for tax purposes.
There are no Federal income taxes available for recoupment in the event of future net losses.
There are no aggregate deposits admitted under Section 6603 of the IRC.
The Company had no tax contingencies computed in accordance with SSAP No. 101 as of December 31, 2023 and 2022.
The Company recognizes interest and penalties accrued related to unrecognized tax benefits in federal income tax expense. During the years ended December 31, 2023 and 2022, the Company recognized no such expenses.
(f)    Consolidated Federal Income Tax Return
Statutory Financial Statements for the year ended December 31, 2023










33 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



The Company's federal income tax return is consolidated with its parent, Allianz Life Insurance Company of North America (Allianz Life) for consolidation with the tax return of Allianz of America (AZOA), the parent of Allianz Life. The method of allocation among companies is subject to a written agreement with AZOA, approved by the Board of Directors of AZOA, that provides for computation of federal income taxes primarily on a separate company basis with the Company receiving reimbursement by AZOA for the benefit of all tax attributes, including credits and losses, when such attributes are utilized in the AZOA consolidated federal income tax return. In 2023, the Company amended the agreement to include the corporate alternative minimum tax applying principles described above. Intercompany tax balances are settled annually after the consolidated return is filed.
The Company is included in the consolidated group for which AZOA files a federal income tax return on behalf of all group members. As a member of the AZOA consolidated group, the Company is no longer subject to U.S. Federal and non-U.S. income tax examinations for years prior to 2016, though examinations of combined returns filed by AZOA, which include the Company, by certain U.S. state and local tax authorities, may still be conducted for 2016 and subsequent years. The Internal Revenue Service (IRS) examination of AZOA for the 2016 and 2017 income tax returns has completed the exam phase and has been assigned to Appeals for an issue unrelated to the Company. A verbal agreement for the settlement of this hedging issue has been reached with the IRS. The settlement is subject to a final closing agreement. The IRS has also initiated an examination of AZOA's 2018-2020 income tax returns, which is expected to close by the end of 2024.
As of December 31, 2023, the companies included in the consolidated group for which AZOA files a federal income tax return are included below:






Members of Consolidated Tax Group
Allianz Life Insurance Company of New York Allianz Life Insurance Company of Missouri
Allianz Life Insurance Company of North America Allianz Underwriters Insurance Company
AZOA Services Corporation AGCS Marine Insurance Company
Allianz Global Risks US Insurance Company Allianz Reinsurance Management Services, Inc.
Allianz Reinsurance of America, Inc. Fireman’s Fund Insurance Company
Allianz Technology of America, Inc. Fireman’s Fund Indemnity Corporation
Allianz Renewable Energy Partners of America LLC National Surety Corporation
Allianz Renewable Energy Partners of America 2 LLC Chicago Insurance Company
PFP Holdings, LLC. Interstate Fire & Casualty Company
AZL PF Investments, Inc. American Automobile Insurance Company
Dresdner Kleinwort Pfandbriefe Investments II, Inc. The American Insurance Company
Allianz Fund Investments, Inc. Allianz Risk Transfer, Inc.
Yorktown Financial Companies, Inc. Allianz Risk Transfer (Bermuda), Ltd.
Questar Capital Corporation Questar Agency, Inc.

(8)    Accident and Health Claim Reserves
Accident and health claim reserves are based on estimates that are subject to uncertainty. Uncertainty regarding reserves of a given accident year is gradually reduced as new information emerges each succeeding year, thereby allowing more reliable reevaluations of such reserves. While management believes that reserves as of December 31, 2023, are appropriate, uncertainties in the reserving process could cause reserves to develop favorably or unfavorably in the near term as new or additional information emerges. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Movements in reserves could significantly impact the Company’s future reported earnings.
Statutory Financial Statements for the year ended December 31, 2023










34 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



Activity in the accident and health claim reserves is summarized as follows:























2023
2022
2021
Balance at January 1, net of reinsurance recoverables of $1,416, $1,137, and $1,079, respectively
$ 10,658 

8,074 

7,834 
Incurred related to:





Current year
3,845 

5,182 

2,613 
Prior years
16 

(113)

(433)
Total incurred
3,861 

5,069 

2,180 
Paid related to:





Current year
272 

361 

154 
Prior years
2,844 

2,124 

1,786 
Total paid
3,116 

2,485 

1,940 
Balance at December 31, net of reinsurance recoverables of $1,512, $1,416, and $1,137, respectively
$ 11,403 

10,658 

8,074 
Prior year incurred claim reserves for 2023 were unfavorable as a result of re-estimation of unpaid claims and claim adjustment expenses, principally on the individual LTC line of business. Prior year incurred claim reserves for 2022 and 2021 reflect favorable claim development principally on the individual LTC line of business.
(9)    Reinsurance
The Company primarily enters into reinsurance agreements to manage risk resulting from its life, annuity, and accident and health businesses, as well as businesses the Company has chosen to exit. In the normal course of business, the Company seeks to limit its exposure to loss on any single insured and to recover a portion of benefits paid by ceding risks under excess coverage and coinsurance contracts.
The Company monitors the financial exposure and financial strength of the reinsurers on an ongoing basis. The Company attempts to mitigate risk by securing recoverable balances with various forms of collateral, including arranging trust accounts and letters of credit with certain reinsurers.
The effect of reinsurance on reserves and claims, for amounts recoverable from other insurers, was as follows:

















For the years ended December 31,
Reduction in:
2023
2022
Aggregate reserves
$ 15,137 

11,183 
Policy and contract claims
147 

181 
Statutory Financial Statements for the year ended December 31, 2023










35 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



The Company assumed no business from other companies for the years ended December 31, 2023, 2022, and 2021. Life insurance, annuities, and accident and health business ceded to other companies are as follows:





















Year ended
Direct amount
Ceded to other companies
Net amount
December 31, 2023





Life insurance in force
$ 2,921,758 

2,627,567 

294,191 
Premiums:





Life
3,661 

3,321 

340 
Annuities
967,460 

— 

967,460 
Accident and health
3,058 

393 

2,665 
Total premiums
$ 974,179 

3,714 

970,465 







December 31, 2022





Life insurance in force
$ 1,837,298 

1,651,432 

185,866 
Premiums:





Life
2,286 

2,046 

240 
Annuities
653,562 

— 

653,562 
Accident and health
3,207 

412 

2,795 
Total premiums
$ 659,055 

2,458 

656,597 







December 31, 2021





Life insurance in force
$ 750,332 

673,079 

77,253 
Premiums:





Life
1,171 

1,035 

136 
Annuities
685,610 

— 

685,610 
Accident and health
3,245 

431 

2,814 
Total premiums
$ 690,026 

1,466 

688,560 
There are no nonaffiliated reinsurers owned in excess of 10% or controlled, either directly or indirectly, by the Company or by a representative, officer, trustee, or director of the Company.
There are no policies issued by the Company that have been reinsured with a company chartered in a country other than the United States that is owned in excess of 10% or controlled directly or indirectly by an insured, a beneficiary, a creditor, or any other person not primarily engaged in the insurance business.
The Company does not have any reinsurance agreements in effect under which the reinsurer may unilaterally cancel any reinsurance for reasons other than for nonpayment of premium or other similar credits.
The Company does not have reinsurance agreements in effect such that the amount of losses paid or accrued through the statement date may result in a payment to the reinsurer of amounts that, in aggregate and allowing for offset of mutual credits from other reinsurance agreements with the same reinsurer, exceed the total direct premium collected under the reinsured policies.
The Company did not write off any uncollectible recoverables during 2023, 2022, and 2021.
Statutory Financial Statements for the year ended December 31, 2023










36 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(10)    Annuity Actuarial Reserves and Deposit Liabilities by Withdrawal Characteristics
Information regarding the Company’s annuity actuarial reserves and deposit liabilities by withdrawal characteristics at December 31 is as follows:





























2023
Percentage of total
2022
Percentage of total
Subject to discretionary withdrawal:







With market value adjustment
$ 79,917 

%
$ 82,552 

%
At book value less current surrender charges of 5% or more
2,704,747 

49 

1,897,657 

41 
At market value
1,574,991 

29 

1,599,527 

35 
Total with adjustment or at market value
4,359,655 

79 

3,579,736 

78 
At book value without adjustment (minimal or no charge or adjustment)
1,044,473 

19 

873,856 

19 
Not subject to discretionary withdrawal
121,446 



114,825 


Total gross
5,525,574 

100  %
4,568,417 

100  %
Reinsurance ceded
— 



— 


Total net
$ 5,525,574 



$ 4,568,417 


Amount included in At book value less current charges of 5% or more that will move to At book value without adjustment in the year after the statement date:
$ 447,649 



$ 271,907 

















Reconciliation of total annuity actuarial reserves and deposit fund liabilities:
2023
2022
Life, Accident and Health Annual Statement:



Annuities, net (excluding supplementary contracts with life contingencies)
$ 340,007 

377,151 
Supplemental contracts with life contingencies, net
23,099 

21,956 
Deposit-type contracts
6,478 

6,735 
Subtotal
369,584 

405,842 
Separate Accounts Annual Statement:



Annuities, net (excluding supplementary contracts with life contingencies)
5,155,534 

4,162,122 
Supplemental contracts with life contingencies, net
456 

453 
Subtotal
5,155,990 

4,162,575 
Total annuity actuarial reserves and deposit fund liabilities
$ 5,525,574 

4,568,417 
Statutory Financial Statements for the year ended December 31, 2023










37 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(11)    Life Actuarial Reserves by Withdrawal Characteristics
Information regarding the Company’s life actuarial reserves by withdrawal characteristics at December 31 is as follows:













2023
General Account Account value Cash value Reserve
Subject to discretionary withdrawal, surrender values, or policy loans:


Universal life $ — 
— 
488 
Indexed life 1,709 
1,649 
1,707 
Other permanent cash value life insurance 250 
250 
250 
Miscellaneous reserves — 
— 
22,000 
Not subject to discretionary withdrawal or no cash values:


Term policies without cash value XXX XXX 3,344 
Miscellaneous reserves XXX XXX 41,114 
Total gross 1,959 
1,899 
68,903 
Reinsurance ceded — 
— 
8,099 
Total net (1)
$ 1,959 
1,899 
60,804 




(1) Balances reflected within this disclosure reside in the Company's general account; the Company's separate accounts do not contain Life business.





2022
General Account Account value Cash value Reserve
Subject to discretionary withdrawal, surrender values, or policy loans:


Universal life $

608 
Indexed life 1,816 
1,721 
1,794 
Other permanent cash value life insurance 244 
244 
244 
Miscellaneous reserves — 
— 
22,000 
Not subject to discretionary withdrawal or no cash values:


Term policies without cash value XXX XXX 2,253 
Miscellaneous reserves XXX XXX 38,185 
Total gross 2,067 
1,967 
65,084 
Reinsurance ceded — 
— 
4,466 
Total net (1)
$ 2,067 
1,967 
60,618 




(1) Balances reflected within this disclosure reside in the Company's general account; the Company's separate accounts do not contain Life business.
The Company does not have any Life policies with either guarantees or nonguarantees in the separate account.














Reconciliation of total life actuarial reserves: 2023 2022
Life, Accident, and Health Annual Statement:

Life insurance, net $ 3,016 
$ 3,112 
Miscellaneous reserves, net 57,788 
57,506 
Total life actuarial reserves $ 60,804 
$ 60,618 






Statutory Financial Statements for the year ended December 31, 2023










38 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(12)    Separate Accounts
The Company’s separate accounts represent funds held for the benefit of contract holders entitled to payments under variable annuity contracts issued through the Company’s separate accounts and underwritten by the Company.
As of December 31, 2023 and 2022, the Company's separate accounts are classified as nonguaranteed. Information regarding the Company’s separate accounts for the years ended December 31 is as follows:













2023
2022
Premiums, considerations, or deposits $ 884,944 

597,807 
Reserves:


Reserves for accounts with assets at fair value 2,149,845 

1,915,239 
Reserves for account, with assets at amortized cost 3,006,145 

2,247,336 
Total reserves 5,155,990 

4,162,575 
By withdrawal characteristics:


At fair value 2,149,388 

1,581,648 
At book value without MV adjustment and with current surrender charge of 5% or more 2,129,600 

1,914,787 
At book value without MV adjustment and with current surrender charge of less than 5% 876,546 

665,687 
Subtotal 5,155,534 

4,162,122 
Not subject to discretionary withdrawal 456 

453 
Total $ 5,155,990 

4,162,575 
As of December 31, 2023 and 2022, the Company’s separate accounts included legally insulated assets and non-insulated assets attributed to the following products/transactions:





























2023
2022
Product/transaction
Legally insulated
Not legally insulated
Legally insulated
Not legally insulated
Variable Annuities
$ 1,591,701 

— 

1,621,829 

— 
Variable Annuities (Non-Unitized Non-Insulated)
— 

3,807,794 

— 

2,725,697 
Total
$ 1,591,701 

3,807,794 

1,621,829 

2,725,697 
The Company’s separate account liabilities contain guaranteed benefits. The liabilities for guaranteed benefits are supported by the Company’s general account assets. To compensate the general account for the risk taken, the separate account paid risk charges of $24,002, $24,891, $25,752, $26,544, and $37,538 during the past five years, respectively. The general account of the Company paid $5,133, $7,256, $191, $929, and $1,019 towards separate account guarantees during the past five years, respectively.
A reconciliation of net transfers to separate accounts for the years ended December 31 is included in the following table:























2023
2022
2021
Transfers as reported in the Summary of Operations of the Separate Accounts Annual Statement:





Transfers to separate accounts
$ 884,944 

597,807 

643,502 
Transfers from separate accounts
(487,002)

(246,810)

(285,061)
Net transfers to separate accounts
397,942 

350,997 

358,441 
Reconciling adjustments:





Other adjustments
(1,373)

289 

97 
Transfers as reported in the Statutory Statements of Operations
$ 396,569 

351,286 

358,538 
Statutory Financial Statements for the year ended December 31, 2023










39 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(13)     Related-Party Transactions
(a)     Real Estate
The Company subleases office space from an affiliate. In connection with this agreement, the Company incurred rent expense of $83, $83, and $82 in 2023, 2022, and 2021, respectively, which is included in General and administrative expenses on the Statutory Statements of Operations.
(b)     Service Fees
The Company incurred fees for administrative services provided by Allianz Life of $17,933, $17,134 and $14,025 in 2023, 2022, and 2021, respectively. The Company’s liability for these expenses was $2,854 and $1,510 as of December 31, 2023 and 2022, respectively, and is included in Payable to parent and affiliates on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. In the normal course of business, the outstanding amount is settled in cash.
The Company incurred fees for investment advisory services provided by affiliated companies of $3,747, $1,992, and $1,486 in 2023, 2022, and 2021, respectively. The Company’s liability for these charges was $407 and $232 as of December 31, 2023 and 2022, respectively, and is included in Payable to parent and affiliates on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus. In the normal course of business, the outstanding amount is settled in cash.
The Company has an agreement with Allianz Investment Management, LLC which has subsequent agreements with its affiliates Pacific Investment Management Company (PIMCO), and with certain other related parties whereby (1) specific investment options managed by PIMCO are made available through the Company's separate accounts to holders of the Company's variable annuity products, and (2) the Company receives compensation for providing administrative and recordkeeping services relating to the investment options managed by PIMCO. Income recognized by the Company from this affiliate for distribution and in-force related costs as a result of providing investment options to the contractholders was $435, $575, and $729 during 2023, 2022, and 2021, respectively, which is included in Fees from separate accounts on the Statutory Statements of Operations. The related receivable for the fees was $34 and $45 at December 31, 2023 and 2022, respectively, which is included in Other assets on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
The Company has incurred commission expense related to the distribution of variable annuity products from Allianz Life Financial Services, LLC, (ALFS), an affiliated company, in the amount of $61,230, $44,736, and $46,892 for the years ended December 31, 2023, 2022, and 2021, respectively.
The Company has an agreement with ALFS, whereby 12b-1 fee receivables are assigned to the Company and Allianz Life. The Company has also agreed with Allianz Life to share in reimbursing ALFS for direct and indirect expenses incurred in performing services for the Company and Allianz Life. In the event that assigned receivables exceed expenses, ALFS records a loss on the transaction with the Company and a dividend-in-kind to Allianz Life. The Company recorded revenue from this agreement of $3,303, $3,586, and $4,261 for the years ended December 31, 2023, 2022, and 2021, respectively. The Company recorded expenses related to this agreement of $12,245, $9,234, and $8,528 for the years ended December 31, 2023, 2022, and 2021, respectively.
(c)     Reinsurance
The Company cedes certain term life and universal life insurance policies to Allianz Life. At December 31, 2023 and 2022, the Company had no reinsurance recoverables and receivables from Allianz Life included in Other assets on the Statutory Statements of Admitted Assets, Liabilities, and Capital and Surplus.
Statutory Financial Statements for the year ended December 31, 2023










40 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



(d)     Line of Credit Agreement
The Company has a line of credit agreement with Allianz Life to provide liquidity as needed. The Company’s borrowing capacity under the agreement is limited to 5% of the general account admitted assets of the Company as of the preceding year end which amounts to $148,028. The Company's general account admitted assets include the book value portion of the non-insulated separate account assets. The interest rate for borrowing under the agreement is based on the Secured Overnight Financing Rate (SOFR). Borrowed amounts can be prepaid at any time with no prepayment penalty. Allianz Life provided $30,000 to the Company under the terms of this agreement on May 10, 2022 and the loan was paid in full on June 29, 2022. There was no interest accrued as of December 31, 2023 and 2022. There was no outstanding balance under the line of credit agreement as of December 31, 2023, and 2022.
(e)     Dividends and Capital Contributions
The Company did not pay dividends to Allianz Life during the years ended December 31, 2023, 2022 and 2021.
The Company received capital contributions of $30,000, $30,000, and $0 from Allianz Life during the years ended December 31, 2023, 2022 and 2021, respectively.
(14)    Employee Benefit Plans
The Company participates in the Allianz Asset Accumulation Plan (AAAP), a defined contribution plan sponsored by Allianz of America Corporation. Eligible employees are immediately enrolled in the AAAP on their first day of employment. The AAAP will accept participants’ pretax, Roth 401(k), and/or after-tax contributions up to 80% of the participants’ eligible compensation, although contributions remain subject to annual limitations set by the Internal Revenue Service. The Company matches up to a maximum of 7.5% of the employees’ eligible compensation. Participants are 100% vested in the Company’s matching contribution after three years of service.
The AAAP administration expenses and the trust fund, including trustee fees, investment manager fees, and audit fees, are payable from the trust fund but may, at the Company’s discretion, be paid by the Company. All legal fees are paid by the Company. It is the Company’s policy to fund the AAAP costs as incurred. The Company has expensed $395, $419, and $328 in 2023, 2022, and 2021, respectively, toward the AAAP matching contributions and administration expenses.
(15)    Statutory Capital and Surplus
Statutory accounting practices prescribed or permitted by the Company’s state of domicile are directed toward insurer solvency and protection of policyholders. As such, the Company is required to meet minimum statutory capital and surplus requirements. The Company’s statutory capital and surplus as of December 31, 2023 and 2022 were in compliance with these requirements. The maximum amount of dividends that can be paid by New York insurance companies to stockholders without prior approval of the Department is subject to restrictions relating to statutory earned surplus, also known as unassigned funds. Unassigned funds are determined in accordance with the accounting procedures and practices governing preparation of the statutory annual statement. In accordance with New York statutes, the Company may declare and pay from its Unassigned surplus cash dividends of not more than the lesser of 10% of its beginning-of-the year statutory surplus, or its net gain from operations before net realized capital gains of the insurer for the 12-month period ending the 31st day of the preceding year. Based on these restrictions, ordinary dividends of $18,520 can be paid in 2024 without prior approval of the Department. The Company paid no dividends in 2023, 2022, and 2021.
The Company has special surplus funds at December 31, 2023, of $11,618, which is due to admitted disallowed IMR. Refer to Note 5(i) regarding the admitted disallowed IMR.
Regulatory Risk-Based Capital
An insurance enterprise’s state of domicile imposes minimum risk-based capital requirements that were developed by the NAIC. The formulas for determining the amount of risk-based capital specify various weighting factors that are applied to financial balances or various levels of activity based on the perceived degree of risk. Regulatory
Statutory Financial Statements for the year ended December 31, 2023










41 of 42

    



ALLIANZ LIFE INSURANCE COMPANY OF NEW YORK
Notes to the Statutory Financial Statements
(Dollars in thousands, except share data and security holdings quantities)



compliance is determined by a ratio of an enterprise’s regulatory total adjusted capital to its authorized control level risk-based capital, as defined by the NAIC. Companies below specific trigger points or ratios are classified within certain levels, each of which requires specified corrective action. This ratio for the Company significantly exceeds required minimum thresholds as of December 31, 2023 and 2022.
(16)    Direct Premiums Written by Third-Party Administrators
The Company has direct premiums written by third-party administrators (TPAs). The types of business written by the TPAs include life, accidental death and dismemberment, medical, disability, excess risk, and LTC. The authority granted to the TPAs includes claims payment, claims adjustment, underwriting, binding authority, and premium collection. Total premiums written by TPAs were $3,686, $2,268, and $2,008 for 2023, 2022, and 2021, respectively. For the years ended December 31, 2023, 2022, and 2021, there were no individual TPAs that wrote premiums that equaled at least 5% of the capital and surplus of the Company.
(17)    Reconciliation to the Annual Statement
The Company is required to file an Annual Statement with the Department. As of December 31, 2023 and 2022, there is no difference in admitted assets or liabilities between this report and the Annual Statement. As of December 31, 2023, 2022, and 2021, there is no difference in capital and surplus or net income between this report and the Annual Statement.
(18)    Commitments and Contingencies
The Company may become subject to claims and lawsuits that arise in the ordinary course of business.
The Company is contingently liable for possible future assessments under regulatory requirements pertaining to insolvencies and impairments of unaffiliated insurance companies. Provision has been made for assessments currently received and assessments anticipated for known insolvencies.
The financial services industry, variable and fixed annuities, life insurance, distribution companies, and broker-dealers, is subject to close scrutiny by regulators, legislators, and the media.
Federal and state regulators, such as state insurance departments, state securities departments, the SEC, the Financial Industry Regulatory Authority, the Internal Revenue Service, and other regulatory bodies regularly make inquiries and conduct examinations or investigations concerning various selling practices, including suitability reviews, product exchanges, sales to seniors, and compliance with, among other things, insurance and securities law. The Company is and may become subject to ongoing market conduct examinations and investigations by regulators, which will or may result in fines and/or otherwise have a material adverse effect on the Company.
It can be expected that annuity and life product designs, management, and sales practices will be an ongoing source of regulatory scrutiny and enforcement actions, litigation, and rulemaking.
These matters could result in legal precedents and new industry-wide legislation, rules, and regulations that could significantly affect the financial services industry, including life insurance and annuity companies. It is unclear at this time whether any such litigation or regulatory actions will have a material adverse effect on the Company in the future.
(19)    Subsequent Events
The Company has evaluated subsequent events through April 8, 2024, which is the date the Statutory Financial Statements were available to be issued. No material subsequent events have occurred since December 31, 2023 that require adjustment to the Statutory Financial Statements.
In March 2024, the Company received a capital contribution of $30,000 from Allianz Life.



Statutory Financial Statements for the year ended December 31, 2023










42 of 42

   









   

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘N-VPFS’ Filing    Date    Other Filings
1/1/26
1/1/25
12/31/24
Filed on / Effective on:4/9/24
4/8/24
1/1/24
For Period end:12/31/2324F-2NT,  N-CEN
12/8/23
8/13/23
4/28/23
3/10/23
1/1/23
12/31/2224F-2NT,  N-CEN,  N-VPFS
8/16/22
6/29/22
6/10/22
5/10/22
1/1/22
12/31/2124F-2NT,  N-CEN,  N-VPFS
6/18/21
1/1/21
12/31/2024F-2NT,  N-CEN
3/12/20N-CEN
3/1/20
1/1/20
12/31/1924F-2NT,  N-CEN
12/31/1724F-2NT,  NSAR-U
 List all Filings 


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/26/24  Allianz Life of NY Var Account C  485BPOS     5/01/24    8:7.4M
 4/26/24  Allianz Life of NY Var Account C  485BPOS     5/01/24    8:7.4M
 4/26/24  Allianz Life of NY Var Account C  485BPOS     5/01/24    8:5.4M
 4/17/24  Allianz Life Ins Co. of New York  S-1/A                  7:4M
 4/17/24  Allianz Life Ins Co. of New York  POS AM                 6:3.9M
 4/17/24  Allianz Life Ins Co. of New York  POS AM                 5:3.6M
 4/17/24  Allianz Life of NY Var Account C  N-4/A       4/17/24   14:12M                                    Donnelley … Solutions/FA
 4/17/24  Allianz Life of NY Var Account C  485BPOS     5/01/24   14:10M                                    Donnelley … Solutions/FA
 4/17/24  Allianz Life of NY Var Account C  485BPOS     5/01/24    8:6M
Top
Filing Submission 0000845775-24-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 11:31:10.3am ET